data_5kqc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5kqc _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.298 88.8 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 121.593 0.552 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 119.597 -0.239 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 113.446 0.138 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 . . . . . 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.829 0.347 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 . . . . . 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 113.274 0.07 . . . . 0.0 113.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 CA-C-O 120.052 -0.305 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 . . . . . 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 85.8 m-85 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.289 0.09 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 . . . . . 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.207 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.926 0.393 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -76.31 -7.24 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.9 146.19 30.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 110.484 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -173.51 141.84 0.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.752 1.621 . . . . 0.0 110.768 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -138.41 151.04 47.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.427 0.691 . . . . 0.0 112.477 165.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -133.14 156.18 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.309 59.0 m-85 -76.54 6.53 5.67 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.328 7.0 t80 -56.86 141.61 44.15 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 126.96 29.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.09 169.35 43.94 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.127 0.87 . . . . 0.0 112.795 166.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.9 t 65.49 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.791 2.436 . . . . 0.0 114.374 -166.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -97.87 7.0 47.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.221 1.808 . . . . 0.0 113.342 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -76.68 136.16 39.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.66 -149.04 16.93 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.44 1.019 . . . . 0.0 112.523 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.49 153.01 16.86 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.254 54.0 t80 -135.73 93.38 2.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.53 -19.39 47.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -71.6 -11.84 61.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.015 1.279 . . . . 0.0 114.365 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.4 p -61.04 145.97 88.6 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.142 -0.974 . . . . 0.0 112.394 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -53.63 -40.99 77.35 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.567 2.844 . . . . 0.0 114.602 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -150.41 -32.94 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -150.29 147.16 27.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.533 1.933 . . . . 0.0 111.416 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.02 158.43 8.53 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.482 -0.762 . . . . 0.0 114.57 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 20.3 ttpt -111.9 159.66 18.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.433 2.293 . . . . 0.0 112.927 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -112.34 123.71 50.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.662 2.385 . . . . 0.0 109.321 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.402 ' CE1' ' HE3' ' A' ' 75' ' ' LYS 0.298 88.8 m-85 -89.19 25.45 1.87 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -128.53 156.27 43.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -148.08 178.67 8.35 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 111.82 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -77.09 -37.0 55.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.052 -1.03 . . . . 0.0 113.119 -170.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.47 -29.14 21.62 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.325 1.05 . . . . 0.0 112.562 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.39 -25.21 9.54 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.115 1.34 . . . . 0.0 114.713 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.25 -139.65 25.23 Favored Glycine 0 N--CA 1.47 0.906 0 CA-C-N 119.774 1.787 . . . . 0.0 110.459 -165.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.99 157.81 32.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.353 4.4 p30 -69.54 -4.98 21.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 171.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -62.48 -21.98 65.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.4 85.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.275 0.941 . . . . 0.0 114.678 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -140.26 -24.32 0.81 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.599 1.56 . . . . 0.0 115.19 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -95.91 139.24 32.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p -65.8 0.31 1.82 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.62 14.82 2.01 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.517 1.053 . . . . 0.0 114.931 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.93 136.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.911 1.355 . . . . 0.0 110.828 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -114.61 -19.53 11.07 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.141 1.376 . . . . 0.0 114.467 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.9 t -149.22 156.69 42.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.504 1.521 . . . . 0.0 113.059 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.439 0.2 OUTLIER 72.47 11.83 5.65 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.47 172.85 15.68 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.578 1.085 . . . . 0.0 115.35 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.73 135.16 51.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.8 0.84 . . . . 0.0 112.644 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -161.34 149.84 15.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.592 1.557 . . . . 0.0 110.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 81.99 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.47 0.546 0 O-C-N 120.972 -1.08 . . . . 0.0 112.852 -174.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -68.91 156.43 38.52 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.959 1.304 . . . . 0.0 114.184 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.33 13.38 16.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.479 1.912 . . . . 0.0 112.914 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -58.43 -48.05 81.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.32 123.59 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.462 1.105 . . . . 0.0 112.14 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -153.89 118.39 4.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.11 1.764 . . . . 0.0 114.42 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -150.36 132.27 15.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.799 1.64 . . . . 0.0 114.915 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.344 31.1 t80 -55.64 125.82 22.77 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 -167.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -23.28 67.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.723 2.009 . . . . 0.0 116.182 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.47 48.04 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.384 0.993 . . . . 0.0 113.912 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -165.37 168.78 16.46 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.545 0.738 . . . . 0.0 112.461 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.87 15.0 12.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.981 1.312 . . . . 0.0 114.104 166.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.14 156.57 33.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.89 -136.36 15.15 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.338 -0.851 . . . . 0.0 111.167 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -51.99 142.86 14.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.785 1.293 . . . . 0.0 112.931 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.269 83.0 t80 -87.94 160.51 17.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.313 1.445 . . . . 0.0 114.314 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -44.4 105.13 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.718 2.407 . . . . 0.0 112.993 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 45.6 37.45 3.22 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.042 2.137 . . . . 0.0 115.086 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.8 m -141.0 89.21 9.9 Favored Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -67.93 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.308 3.339 . . . . 0.0 117.277 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.06 -13.86 7.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.18 2.5 7.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 135.19 5.77 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.531 1.539 . . . . 0.0 112.377 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 162.33 26.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.726 -0.867 . . . . 0.0 113.113 -175.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -98.65 112.58 24.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.302 1.841 . . . . 0.0 110.403 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 -82.41 26.5 0.55 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.0 157.89 23.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -143.6 149.75 37.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.056 1.742 . . . . 0.0 110.058 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.1 mp0 -70.26 -30.85 68.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.1 mp -103.71 -37.16 7.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.474 1.11 . . . . 0.0 111.489 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.95 -14.46 81.7 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 115.548 0.979 . . . . 0.0 115.548 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.75 -135.13 35.35 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.361 1.58 . . . . 0.0 111.719 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -67.31 150.71 48.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.19 -29.46 70.39 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -71.63 -12.23 61.24 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.65 -5.6 56.94 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.947 1.539 . . . . 0.0 116.947 162.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -113.29 -22.27 10.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.078 1.439 . . . . 0.0 114.199 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.15 146.14 23.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p -63.41 133.39 53.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.88 -16.41 1.96 Allowed Glycine 0 CA--C 1.541 1.668 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.9 132.82 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.869 1.835 . . . . 0.0 111.293 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -76.65 10.83 1.93 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.896 1.678 . . . . 0.0 114.638 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -153.65 163.4 40.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.534 1.934 . . . . 0.0 113.23 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -33.78 76.34 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.96 98.55 0.56 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.913 0.768 . . . . 0.0 112.816 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.56 138.19 58.28 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 110.684 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -159.55 143.18 14.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -81.64 55.21 2.6 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 127.112 2.165 . . . . 0.0 111.286 -171.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t 52.03 35.53 16.42 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.388 1.475 . . . . 0.0 114.667 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.69 158.54 32.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.577 1.551 . . . . 0.0 113.597 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -143.62 147.02 33.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.507 1.523 . . . . 0.0 111.869 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 56.14 24.26 7.8 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.832 2.053 . . . . 0.0 114.589 -171.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.33 1.35 48.85 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.612 -1.305 . . . . 0.0 112.103 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -54.18 -27.43 33.98 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 120.908 3.67 . . . . 0.0 120.908 -161.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.353 59.5 t80 -64.2 138.8 58.62 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -61.4 -49.53 76.5 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.7 150.29 5.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.747 1.165 . . . . 0.0 113.171 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -72.39 -12.96 61.34 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -171.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 57.21 33.86 23.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.204 1.802 . . . . 0.0 114.641 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.62 141.52 42.82 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.93 -136.04 10.74 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.874 1.225 . . . . 0.0 113.041 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -71.29 135.52 47.45 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.363 -1.08 . . . . 0.0 111.821 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -52.66 137.22 31.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.95 -32.34 6.1 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -76.37 -40.09 52.02 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 121.152 1.796 . . . . 0.0 112.906 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -76.3 140.84 69.5 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.001 1.32 . . . . 0.0 112.592 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.16 -12.38 19.31 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.293 2.662 . . . . 0.0 113.968 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.378 59.0 m-85 -69.04 -0.34 5.6 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.7 3.222 . . . . 0.0 119.7 -169.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.354 84.1 m-20 64.34 32.64 11.99 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.43 174.2 54.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.625 2.06 . . . . 0.0 115.18 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -109.5 124.72 51.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.956 1.302 . . . . 0.0 113.703 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -107.87 126.58 52.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 111.655 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 -98.82 22.91 9.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -129.55 159.28 36.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.3 156.8 48.14 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.077 2.551 . . . . 0.0 111.798 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -69.13 -48.53 62.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.484 1.514 . . . . 0.0 113.535 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.62 -27.47 15.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.817 1.647 . . . . 0.0 111.346 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.42 -20.66 74.37 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.6 -147.21 49.53 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.018 1.409 . . . . 0.0 111.808 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.94 153.7 20.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -56.49 -38.33 71.6 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -160.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -80.29 -3.71 50.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 15.94 60.4 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 161.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.68 -27.21 5.53 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 -86.57 139.1 31.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 168.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p -65.99 134.8 53.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.86 -31.77 0.5 Allowed Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.366 1.46 . . . . 0.0 116.386 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.98 126.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.439 1.619 . . . . 0.0 111.155 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -75.58 -46.8 29.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.819 0.448 . . . . 0.0 111.713 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.264 0.6 OUTLIER -66.09 169.76 6.54 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.4 t -70.84 -25.28 62.76 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.02 101.26 2.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.87 1.224 . . . . 0.0 113.552 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.16 133.97 55.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.527 0.731 . . . . 0.0 110.553 170.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -154.8 144.16 21.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.69 -0.631 . . . . 0.0 112.378 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.86 83.61 2.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.291 1.036 . . . . 0.0 112.734 -170.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.122 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.7 p -158.37 167.04 30.78 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.431 -1.041 . . . . 0.0 113.738 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 62.75 17.94 10.25 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.523 1.929 . . . . 0.0 115.974 165.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -60.5 141.58 56.32 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.626 1.17 . . . . 0.0 111.001 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.67 158.09 34.78 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.59 138.52 29.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.51 -34.68 65.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.265 14.0 t80 -123.92 122.56 38.27 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.721 2.008 . . . . 0.0 115.985 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -96.93 26.96 4.26 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.18 -164.28 47.47 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.405 1.002 . . . . 0.0 114.852 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.0 p -160.71 160.67 31.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.707 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.92 32.56 1.39 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.987 1.315 . . . . 0.0 113.224 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.81 146.09 40.19 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.72 -134.62 10.36 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.325 0.964 . . . . 0.0 112.279 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.41 135.88 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.982 1.391 . . . . 0.0 110.527 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.11 111.57 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.12 142.64 58.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -167.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 55.58 15.81 1.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.321 2.249 . . . . 0.0 114.937 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -136.52 70.79 59.8 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.312 1.445 . . . . 0.0 111.092 -163.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.38 -13.26 32.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.078 3.185 . . . . 0.0 114.383 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.285 59.7 m-85 -99.17 -29.92 12.58 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 174.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.6 -20.11 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.82 -120.47 5.22 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.107 1.337 . . . . 0.0 114.758 162.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -93.54 135.69 34.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.312 1.845 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.74 112.95 25.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 109.48 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -86.56 20.48 2.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.71 2.004 . . . . 0.0 114.745 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -144.78 92.03 2.23 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -162.91 -45.26 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.652 1.181 . . . . 0.0 111.512 -166.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -53.19 151.12 5.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.191 1.797 . . . . 0.0 112.179 171.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.91 -23.56 63.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.673 1.189 . . . . 0.0 112.578 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -78.62 3.95 61.98 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 126.105 1.812 . . . . 0.0 116.39 171.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.44 -132.78 11.38 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.89 1.845 . . . . 0.0 113.162 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.92 140.41 56.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -63.57 -19.48 64.85 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.59 -11.28 60.84 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.39 15.91 45.42 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 160.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.04 -24.79 0.68 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 -87.92 147.71 24.94 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -64.18 3.58 0.42 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.5 25.08 1.84 Allowed Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.905 1.23 . . . . 0.0 114.49 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mt -112.91 122.35 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.159 1.384 . . . . 0.0 108.961 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 -39.69 27.83 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.81 156.04 34.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 122.37 16.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.61 -148.45 19.52 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.459 1.028 . . . . 0.0 114.446 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.33 160.02 31.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 112.1 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.07 156.14 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 110.856 162.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.69 50.53 1.52 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.524 0 C-N-CA 125.2 1.4 . . . . 0.0 113.561 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.0 m -145.03 123.98 12.74 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.108 0.954 . . . . 0.0 112.956 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -72.04 -35.19 69.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -65.59 -13.96 60.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.51 -10.53 59.46 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -99.02 157.57 16.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.135 0.974 . . . . 0.0 112.167 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.45 14.64 4.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -160.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.276 26.0 t80 -76.62 142.34 40.71 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -68.32 -17.12 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.72 58.58 4.2 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.107 1.321 . . . . 0.0 115.104 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 63.57 155.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.743 2.017 . . . . 0.0 115.052 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.88 16.61 2.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.325 2.25 . . . . 0.0 113.267 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -72.12 145.11 48.37 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.04 -18.68 56.27 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.995 1.284 . . . . 0.0 116.066 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 149.4 28.62 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.499 1.65 . . . . 0.0 113.445 173.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.4 176.79 5.0 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.638 1.575 . . . . 0.0 107.028 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -153.35 161.2 42.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.786 1.234 . . . . 0.0 112.375 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 52.38 66.18 1.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.713 2.005 . . . . 0.0 113.194 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -151.51 145.43 17.88 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.73 1.212 . . . . 0.0 111.614 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.32 -25.72 30.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.701 2.267 . . . . 0.0 112.934 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.53 -41.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.696 2.85 . . . . 0.0 118.696 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.27 23.8 m-20 -68.28 143.56 55.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.92 -54.4 0.01 OUTLIER Glycine 0 N--CA 1.471 0.992 0 C-N-CA 124.859 1.219 . . . . 0.0 113.283 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -73.54 160.18 32.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.25 1.02 . . . . 0.0 111.012 165.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -152.11 127.51 9.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 -112.21 22.58 14.61 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -135.21 156.89 48.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -149.48 173.12 13.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.07 1.348 . . . . 0.0 111.967 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.8 -21.72 54.7 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.051 -1.03 . . . . 0.0 113.137 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.34 -47.17 83.27 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.386 1.874 . . . . 0.0 111.998 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.82 20.49 1.28 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.87 -132.4 13.77 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.263 1.531 . . . . 0.0 112.253 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -68.1 145.86 54.01 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.42 -21.02 33.9 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -16.59 5.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.175 1.39 . . . . 0.0 114.365 172.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.38 27.91 62.76 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.218 0.913 . . . . 0.0 114.657 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -157.73 -28.18 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.169 1.788 . . . . 0.0 114.473 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 -89.67 143.99 26.36 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p -59.66 127.32 31.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 66.32 2.93 16.49 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.088 -1.396 . . . . 0.0 116.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.31 133.99 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.578 2.189 . . . . 0.0 109.857 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.63 -53.74 5.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.999 1.319 . . . . 0.0 112.562 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.01 176.32 8.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.7 40.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.82 -148.34 28.74 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.188 0.899 . . . . 0.0 114.856 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.05 151.42 39.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.115 1.766 . . . . 0.0 111.297 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -159.95 142.65 13.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 0.0 112.428 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.4 61.48 4.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 125.277 1.431 . . . . 0.0 113.252 -174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.4 m -96.17 -42.88 7.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.176 1.39 . . . . 0.0 112.861 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -66.25 144.76 56.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.35 1.46 . . . . 0.0 112.94 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . 0.28 55.0 m95 -81.03 48.81 1.15 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.61 154.69 24.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.984 2.113 . . . . 0.0 113.677 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -144.07 161.45 38.77 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.284 16.9 t80 -147.44 87.42 1.65 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.273 21.0 t80 -63.07 127.67 32.33 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 160.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -70.35 -3.04 15.49 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -170.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 -174.26 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 149.28 46.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.954 1.302 . . . . 0.0 111.729 155.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -139.03 20.35 2.63 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -163.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 -77.09 129.86 36.6 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 -50.63 0.81 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.103 1.811 . . . . 0.0 113.693 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -147.68 159.74 43.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.594 1.158 . . . . 0.0 113.773 -165.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.6 128.57 49.88 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -100.35 -34.26 10.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.241 1.417 . . . . 0.0 113.677 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.08 146.63 50.8 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . 0.256 2.9 m 63.26 160.92 0.12 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.916 2.086 . . . . 0.0 115.462 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -66.42 7.78 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.803 3.002 . . . . 0.0 119.735 -156.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.323 1.1 p90 -129.56 147.29 51.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -167.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -72.81 51.81 0.29 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.186 2.194 . . . . 0.0 116.509 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.39 143.8 48.86 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 120.567 -1.333 . . . . 0.0 115.06 -171.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -93.03 147.83 22.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.673 1.589 . . . . 0.0 110.519 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -138.68 109.42 6.66 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.592 0.71 . . . . 0.0 112.26 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 -86.78 29.61 0.79 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -128.16 150.31 50.05 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -157.81 164.91 36.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.507 1.123 . . . . 0.0 110.916 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -61.63 -22.47 65.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.996 0.918 . . . . 0.0 112.573 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 tp -49.7 -32.39 13.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.532 1.933 . . . . 0.0 114.227 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.78 45.47 0.03 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.672 1.029 . . . . 0.0 115.672 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.7 -133.9 25.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 118.415 1.107 . . . . 0.0 113.446 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -66.08 160.45 23.86 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -54.62 -26.53 33.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -81.42 -2.48 49.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.11 70.5 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.682 1.135 . . . . 0.0 115.399 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -122.43 -24.17 5.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 114.229 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -95.63 138.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p -61.98 114.58 3.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.97 1.77 80.22 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 117.934 1.934 . . . . 0.0 117.934 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.97 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 121.405 2.603 . . . . 0.0 111.03 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.51 -43.85 25.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -64.93 166.16 9.64 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -70.91 -29.61 65.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.58 152.68 22.1 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.769 1.175 . . . . 0.0 113.685 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.86 147.58 22.87 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.793 1.237 . . . . 0.0 112.902 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -145.91 145.87 30.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.91 0.884 . . . . 0.0 112.231 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -119.62 76.96 1.18 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.591 1.556 . . . . 0.0 112.054 -168.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.7 p 59.21 -2.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 170.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -75.66 163.48 27.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.411 1.884 . . . . 0.0 112.899 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -111.43 -26.12 9.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.623 1.569 . . . . 0.0 113.362 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 54' ' ' PHE . 74.8 tt0 -72.68 133.83 44.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.209 1.404 . . . . 0.0 112.798 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.11 8.24 44.3 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 121.081 -1.012 . . . . 0.0 111.506 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.403 ' H ' ' HG2' ' A' ' 52' ' ' GLU 0.314 73.3 m-85 -127.86 25.15 5.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.361 2.264 . . . . 0.0 117.047 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.287 35.7 t80 -63.64 147.94 50.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.44 68.36 2.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.999 1.32 . . . . 0.0 113.146 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.96 16.08 49.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.996 2.713 . . . . 0.0 116.314 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.7 p -141.77 137.05 31.31 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.012 1.406 . . . . 0.0 109.38 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -144.93 29.29 1.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -155.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -75.09 165.79 24.67 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -133.71 11.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.396 1.474 . . . . 0.0 110.834 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -68.62 148.6 50.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.45 0.7 . . . . 0.0 111.352 170.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.33 177.53 2.3 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.922 0.489 . . . . 0.0 110.145 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -52.92 156.13 2.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.782 1.233 . . . . 0.0 112.555 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -56.11 127.11 29.0 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.51 -0.744 . . . . 0.0 111.67 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.4 m -171.68 163.64 4.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.808 1.643 . . . . 0.0 111.047 -169.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.71 -35.31 87.06 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.283 2.656 . . . . 0.0 112.715 160.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.292 61.5 t80 -62.1 125.99 25.79 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 166.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 6.4 p30 -110.76 3.65 19.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -165.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.5 169.56 33.02 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.87 138.55 54.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.32 1.448 . . . . 0.0 112.676 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -76.53 -31.48 57.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.649 1.58 . . . . 0.0 112.455 167.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 63.63 8.1 3.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.61 169.46 17.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -148.79 165.89 30.09 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.082 1.753 . . . . 0.0 110.371 166.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.29 -26.85 68.25 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.52 1.528 . . . . 0.0 112.648 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.25 152.0 31.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.896 2.078 . . . . 0.0 108.552 166.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.43 -29.34 1.01 Allowed Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 113.657 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.75 -136.02 21.29 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.373 1.086 . . . . 0.0 112.026 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.41 155.82 17.32 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -47.65 -42.16 23.83 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -74.14 -12.07 60.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.18 78.02 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.213 0.911 . . . . 0.0 115.33 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -114.04 -27.07 7.83 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.822 1.311 . . . . 0.0 114.0 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -97.1 135.31 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -71.13 140.15 50.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.29 23.5 70.03 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.929 1.252 . . . . 0.0 115.89 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 53.3 mt -87.41 149.62 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.79 1.236 . . . . 0.0 112.143 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -119.69 -25.87 5.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.319 1.848 . . . . 0.0 112.95 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.1 t -70.29 173.78 6.38 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 p -55.57 -17.9 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.65 178.95 46.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 120.214 1.37 . . . . 0.0 115.825 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.57 144.78 41.66 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.599 1.559 . . . . 0.0 113.772 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -162.3 174.69 12.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.431 1.493 . . . . 0.0 111.381 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.59 78.62 9.81 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 112.687 -176.112 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.817 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.7 m -74.47 -20.57 59.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -99.21 -25.75 14.41 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -146.72 154.23 41.18 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.976 1.262 . . . . 0.0 113.159 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -71.9 144.27 49.05 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.199 1.4 . . . . 0.0 112.303 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -104.76 174.69 5.77 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.552 2.341 . . . . 0.0 115.68 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.387 50.3 m-85 -71.11 7.96 1.09 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 56' ' ' ARG 0.29 33.7 t80 -56.74 177.02 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 158.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.8 mmt180 -61.62 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.869 2.067 . . . . 0.0 114.89 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.83 97.34 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.031 1.777 . . . . 0.0 112.753 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.2 t -93.05 138.14 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -86.52 2.23 48.72 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.272 1.429 . . . . 0.0 114.125 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -79.66 140.21 37.13 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.68 -26.24 21.08 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.768 2.128 . . . . 0.0 115.545 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -146.14 132.63 19.73 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.943 1.371 . . . . 0.0 113.697 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CG ' ' N ' ' A' ' 68' ' ' GLN 0.337 34.9 t80 -103.0 -169.22 1.62 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.084 2.554 . . . . 0.0 116.101 -171.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' A' ' 67' ' ' TYR . 31.0 tt0 -58.78 132.96 55.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.36 1.864 . . . . 0.0 111.863 174.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -58.16 114.84 2.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.826 1.251 . . . . 0.0 110.544 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -156.86 154.75 27.23 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.376 1.471 . . . . 0.0 112.726 -162.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -57.06 -31.67 90.91 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.586 2.857 . . . . 0.0 116.242 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -134.33 148.19 50.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.47 22.9 m-20 49.53 52.15 15.07 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 170.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.32 4.45 0.6 Allowed Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.98 2.229 . . . . 0.0 117.695 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -80.85 159.16 25.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.213 2.205 . . . . 0.0 112.262 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -155.65 109.39 2.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -95.09 25.04 4.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -119.6 122.63 42.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.7 t30 53.24 25.28 4.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.47 3.108 . . . . 0.0 116.0 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -78.33 -1.72 34.61 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.94 -1.1 . . . . 0.0 112.614 165.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 -45.67 0.1 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 111.554 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.55 106.74 0.2 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.09 0.853 . . . . 0.0 113.155 169.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.63 -157.44 29.79 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 117.905 0.852 . . . . 0.0 113.274 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.67 146.27 54.97 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.88 -13.91 18.75 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -62.09 -3.95 1.48 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.496 1.918 . . . . 0.0 115.955 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.3 -8.85 66.02 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.147 1.356 . . . . 0.0 115.839 164.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -144.36 -13.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 -91.81 144.66 25.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p -58.67 134.51 56.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.88 -7.79 5.12 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 mt -79.74 140.93 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.826 . . . . 0.0 109.345 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -82.54 -46.14 13.76 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.265 -0.897 . . . . 0.0 110.986 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.6 t -71.18 170.83 12.17 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 168.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.4 p -84.55 -37.05 21.69 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.69 112.02 3.67 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.653 1.12 . . . . 0.0 112.742 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.54 153.95 30.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -158.54 140.71 14.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 0.0 111.509 169.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.08 55.33 0.57 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.326 2.251 . . . . 0.0 111.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -82.19 158.32 23.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.232 1.413 . . . . 0.0 113.17 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -141.14 159.26 42.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.336 1.854 . . . . 0.0 112.66 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.0 m95 64.95 35.53 8.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.898 2.079 . . . . 0.0 115.106 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 54.51 31.36 14.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.205 1.402 . . . . 0.0 113.594 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -75.38 159.83 30.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.033 1.733 . . . . 0.0 112.788 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -126.39 159.0 34.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.879 2.072 . . . . 0.0 113.881 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.0 -17.69 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 -166.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -60.42 -46.41 90.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.481 1.113 . . . . 0.0 113.526 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.28 172.7 55.24 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 122.108 0.838 . . . . 0.0 114.604 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 t -71.18 143.49 50.49 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.679 1.192 . . . . 0.0 112.606 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -81.11 7.4 11.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.961 1.304 . . . . 0.0 113.658 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -73.42 149.59 42.33 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.83 -46.95 3.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 127.392 2.425 . . . . 0.0 113.265 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -141.37 145.18 35.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -60.83 141.43 57.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 163.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -58.47 127.2 30.96 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.75 -0.594 . . . . 0.0 111.334 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.263 30.0 m170 58.61 22.33 9.69 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 95.4 34.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.783 1.233 . . . . 0.0 110.372 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -63.8 -31.47 68.28 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 115.118 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -133.23 -36.82 0.99 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.718 0.69 . . . . 0.0 112.013 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 27.2 m-20 -84.62 13.46 5.64 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.11 0.24 Allowed Glycine 0 N--CA 1.468 0.803 0 O-C-N 120.742 -1.223 . . . . 0.0 113.402 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -98.99 158.72 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.54 1.536 . . . . 0.0 111.899 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -149.72 98.6 2.77 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -171.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 -76.42 21.54 0.19 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -143.14 -177.72 5.49 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 67.01 -59.08 0.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.863 3.265 . . . . 0.0 116.752 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -63.35 122.01 15.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.89 0.768 . . . . 0.0 112.541 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.2 tp 65.62 -17.3 0.1 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.846 2.458 . . . . 0.0 116.754 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.43 93.04 0.09 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 117.758 1.863 . . . . 0.0 117.758 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.67 -134.23 46.86 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 118.151 0.975 . . . . 0.0 113.59 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.12 139.71 58.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.01 -24.5 66.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -68.0 -10.02 50.24 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.31 12.33 29.35 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.87 -22.06 0.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 -88.71 151.41 22.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -65.44 131.35 46.19 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.48 -4.7 6.4 Favored Glycine 0 CA--C 1.542 1.737 0 N-CA-C 116.824 1.49 . . . . 0.0 116.824 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 64.6 mt -79.57 122.28 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 120.597 2.198 . . . . 0.0 109.797 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -63.65 -49.33 73.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 0.6 OUTLIER -75.31 1.72 13.0 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 117.357 2.354 . . . . 0.0 117.357 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.453 0.2 OUTLIER 65.13 -0.98 0.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 -174.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.99 22.25 0.34 Allowed Glycine 0 CA--C 1.544 1.852 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -169.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 54.5 14.21 0.78 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 120.718 3.599 . . . . 0.0 120.718 161.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -68.5 138.56 55.29 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.761 -1.212 . . . . 0.0 113.481 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -103.58 81.76 1.94 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--O 1.242 0.692 0 C-N-CA 128.09 2.556 . . . . 0.0 110.323 174.013 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.994 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -158.71 154.93 27.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.018 1.327 . . . . 0.0 111.203 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -136.98 -8.6 1.81 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.648 1.579 . . . . 0.0 114.547 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -116.33 141.42 48.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.376 1.471 . . . . 0.0 110.538 172.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -116.55 100.12 7.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.57 1.148 . . . . 0.0 109.666 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.42 119.41 33.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.847 1.659 . . . . 0.0 114.923 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -148.2 157.86 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.572 2.349 . . . . 0.0 111.622 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.319 28.0 t80 -70.31 114.41 8.42 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 163.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.88 105.22 17.37 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.761 1.224 . . . . 0.0 111.873 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.29 -26.0 31.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.193 0.901 . . . . 0.0 113.028 166.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -151.77 158.12 42.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.926 1.29 . . . . 0.0 112.857 172.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.44 19.38 6.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.429 1.492 . . . . 0.0 112.958 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -84.34 157.85 21.34 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.6 -114.57 4.98 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.49 1.043 . . . . 0.0 110.821 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.55 148.21 52.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.763 1.281 . . . . 0.0 112.825 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -81.93 122.98 28.45 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 43.69 54.41 5.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.008 1.323 . . . . 0.0 113.406 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 m80 59.66 4.0 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.2 t -65.86 120.55 69.89 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 120.591 1.541 . . . . 0.0 112.868 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.14 -9.86 18.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.37 2.713 . . . . 0.0 116.363 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.58 164.06 36.16 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -168.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.329 6.6 t0 63.62 -70.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.93 115.08 3.99 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.004 1.288 . . . . 0.0 114.135 -168.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 142.75 27.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.932 2.093 . . . . 0.0 110.792 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -126.05 117.34 22.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.945 1.698 . . . . 0.0 111.349 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -86.22 21.59 2.0 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -162.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -149.06 154.2 38.94 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -150.0 -172.0 4.05 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.94 2.096 . . . . 0.0 111.299 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -75.85 -29.33 58.54 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 tt -118.62 -41.37 2.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.348 1.059 . . . . 0.0 112.068 -168.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.63 -20.45 70.07 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.602 -0.686 . . . . 0.0 112.4 161.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.41 -136.11 39.44 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 118.789 1.295 . . . . 0.0 110.547 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -60.98 163.32 5.98 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.09 -46.19 44.33 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -69.71 -3.72 16.56 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.26 83.15 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.688 1.613 . . . . 0.0 116.556 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.0 -27.25 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -90.39 137.7 32.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p -64.79 -14.01 57.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -125.88 18.67 6.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.175 1.369 . . . . 0.0 114.271 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.0 mt -129.62 127.52 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 118.488 1.144 . . . . 0.0 110.246 -170.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -84.46 25.1 0.91 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.866 1.667 . . . . 0.0 114.394 -169.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.2 t -159.8 164.99 33.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.154 2.182 . . . . 0.0 109.169 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.29 0.7 OUTLIER -67.2 -13.22 61.76 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.44 61.62 0.85 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 126.689 2.09 . . . . 0.0 114.658 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.59 149.38 8.17 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.465 2.306 . . . . 0.0 113.549 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -161.72 141.79 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.172 0.989 . . . . 0.0 112.135 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.11 98.54 8.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.445 1.498 . . . . 0.0 110.316 167.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 CA-C-O 119.583 -0.565 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -78.37 153.33 31.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.037 1.335 . . . . 0.0 111.697 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -132.56 166.51 21.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.211 1.404 . . . . 0.0 112.821 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -104.4 -51.92 3.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.0 112.532 166.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -78.94 160.06 27.42 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 0.0 113.265 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.296 1.0 OUTLIER -134.42 157.54 46.18 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 178.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.277 63.0 m-85 -74.48 80.15 1.93 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.258 29.6 t80 -59.8 131.44 50.91 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 168.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -70.46 15.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.14 -21.58 77.87 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.702 -1.249 . . . . 0.0 113.854 162.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.4 p -159.92 -179.51 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.22 1.408 . . . . 0.0 112.529 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -111.27 26.51 10.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.205 1.802 . . . . 0.0 112.934 157.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -78.21 153.31 32.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.19 -149.09 21.15 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.433 1.016 . . . . 0.0 112.243 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -50.47 143.05 9.62 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.753 1.276 . . . . 0.0 112.948 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.279 51.0 t80 -111.95 179.0 4.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.902 1.681 . . . . 0.0 114.725 -168.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -51.95 156.24 1.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.672 1.189 . . . . 0.0 112.061 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -63.69 124.99 22.86 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.601 -1.312 . . . . 0.0 112.193 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -175.22 148.82 1.1 Allowed Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.102 1.761 . . . . 0.0 112.892 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.17 -24.82 14.31 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.263 2.642 . . . . 0.0 115.86 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -128.33 -12.76 5.04 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -174.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.79 14.33 23.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.072 2.149 . . . . 0.0 116.317 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.0 -6.99 40.93 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -156.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HE2' ' CE2' ' A' ' 77' ' ' TYR . 78.4 tttt -136.7 134.97 37.78 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.156 1.478 . . . . 0.0 110.184 172.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -103.35 109.26 20.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.907 1.683 . . . . 0.0 109.256 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.403 ' CE2' ' HE2' ' A' ' 75' ' ' LYS 0.255 85.8 m-85 -78.46 27.4 0.21 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -170.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -148.43 150.02 32.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -153.43 162.79 40.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.333 1.053 . . . . 0.0 112.977 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.27 -28.17 65.01 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.32 -18.69 25.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 114.242 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 -13.35 4.06 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.221 1.391 . . . . 0.0 114.907 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.79 -142.04 32.84 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.459 1.13 . . . . 0.0 111.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.82 146.18 53.23 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -74.46 -4.06 34.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.332 1.053 . . . . 0.0 113.714 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.46 24.83 60.09 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 157.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.43 -24.46 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.369 1.989 . . . . 0.0 116.369 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 -89.03 146.17 25.02 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -73.92 130.47 39.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.03 10.95 42.73 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 42.7 mt -74.09 -31.42 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.295 2.047 . . . . 0.0 112.487 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 51.84 29.44 5.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.443 1.497 . . . . 0.0 113.78 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.329 0.2 OUTLIER -143.81 34.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.812 2.045 . . . . 0.0 116.415 -169.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER 69.13 -25.64 0.14 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -167.41 167.04 39.68 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 120.535 1.516 . . . . 0.0 116.358 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.55 146.67 53.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 -163.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -157.33 147.4 20.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.963 2.105 . . . . 0.0 110.13 154.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -101.26 74.85 1.59 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 124.203 1.001 . . . . 0.0 113.511 -167.652 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.2 t -90.76 169.66 10.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.639 1.175 . . . . 0.0 111.838 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -56.37 136.97 53.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.986 1.714 . . . . 0.0 112.176 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -84.48 151.33 24.68 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -68.32 117.01 9.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.855 1.262 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.04 136.94 49.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.367 8.1 p90 -109.1 -1.77 18.58 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 -172.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.295 47.8 t80 -64.74 139.64 58.78 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -62.77 -6.04 3.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.86 143.7 45.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.193 0.906 . . . . 0.0 113.581 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -49.04 127.99 15.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.39 1.876 . . . . 0.0 115.143 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -107.92 -3.3 19.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -154.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 -66.33 153.1 43.55 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.22 -139.37 14.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.396 0.998 . . . . 0.0 113.118 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.17 150.59 24.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.348 1.074 . . . . 0.0 113.36 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -150.74 126.65 10.4 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 -164.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -59.68 -32.47 70.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -163.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -83.57 -6.81 59.55 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.859 1.209 . . . . 0.0 113.484 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -107.92 156.62 37.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.003 1.721 . . . . 0.0 111.098 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.36 176.65 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.735 2.957 . . . . 0.0 115.839 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -47.82 -43.75 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -94.19 15.55 17.0 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.77 165.21 43.74 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.726 1.631 . . . . 0.0 114.662 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.77 143.2 29.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.105 1.762 . . . . 0.0 110.93 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -91.92 118.2 30.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.67 0.788 . . . . 0.0 109.492 164.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 -81.08 30.19 0.33 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -164.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -119.89 137.77 53.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -125.93 145.31 50.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.45 1.9 . . . . 0.0 111.927 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -62.92 -25.49 68.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -173.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.49 -41.72 4.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.261 1.425 . . . . 0.0 111.659 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.06 68.8 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 115.64 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.31 -140.8 30.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.03 1.415 . . . . 0.0 111.928 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -71.98 156.37 39.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -67.07 -23.66 65.89 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.01 -21.08 63.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.6 89.4 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.159 1.361 . . . . 0.0 114.506 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -112.85 -33.07 6.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.078 1.439 . . . . 0.0 113.64 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -88.39 146.01 25.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p -69.74 139.65 53.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.54 -31.14 1.01 Allowed Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.999 1.285 . . . . 0.0 115.677 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.4 133.68 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.264 1.532 . . . . 0.0 111.73 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.55 38.32 2.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.01 1.724 . . . . 0.0 111.966 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.253 1.3 t -142.17 156.55 45.35 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.474 2.31 . . . . 0.0 112.885 167.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.268 1.7 m -70.56 -25.69 63.21 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.97 97.79 0.94 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.764 1.173 . . . . 0.0 114.464 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.37 147.43 52.12 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.76 0.78 . . . . 0.0 111.956 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -164.92 153.04 11.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.78 1.232 . . . . 0.0 111.799 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -99.91 74.79 1.84 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.24 0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 111.551 -172.649 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -65.31 143.99 57.41 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.152 1.381 . . . . 0.0 114.169 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -68.06 -30.14 69.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.639 0.775 . . . . 0.0 112.49 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -67.61 -19.44 65.23 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -74.57 -21.32 59.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.848 0.859 . . . . 0.0 112.444 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -57.88 144.88 37.4 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -72.82 81.9 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.955 1.302 . . . . 0.0 112.169 168.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 38.1 t80 -62.71 130.38 44.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -71.3 147.51 48.04 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -162.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.17 -11.84 0.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.126 1.346 . . . . 0.0 115.774 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -69.32 139.35 54.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -94.44 28.15 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.825 1.65 . . . . 0.0 112.894 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.27 149.61 47.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.12 -165.92 12.45 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.106 1.336 . . . . 0.0 112.614 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.47 133.04 53.23 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.497 -1.59 . . . . 0.0 111.113 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -54.13 152.27 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 164.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.08 -32.48 61.47 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -155.66 133.88 11.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.403 2.281 . . . . 0.0 110.12 165.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.6 t -160.48 114.04 1.38 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.837 1.255 . . . . 0.0 111.607 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.67 22.34 0.94 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.692 2.928 . . . . 0.0 113.499 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -134.5 -52.49 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -105.58 -27.02 11.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.92 -70.73 0.96 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.13 1.347 . . . . 0.0 113.513 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HE2' ' CE2' ' A' ' 77' ' ' TYR . 72.8 tttt -95.07 122.72 38.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.747 1.619 . . . . 0.0 109.998 169.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -76.48 97.36 4.3 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.973 0.909 . . . . 0.0 109.684 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' CE2' ' HE2' ' A' ' 75' ' ' LYS . 94.2 m-85 -78.73 91.84 4.73 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.147 -0.346 . . . . 0.0 111.009 164.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -121.27 157.78 29.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -146.63 156.45 43.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.365 1.866 . . . . 0.0 111.267 164.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -55.63 -54.87 38.82 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.82 6.41 47.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.829 1.251 . . . . 0.0 113.527 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.88 -30.87 7.67 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.758 1.17 . . . . 0.0 113.052 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 -145.3 46.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.212 -1.169 . . . . 0.0 110.694 -162.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -67.67 152.22 45.97 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.31 78.7 m-20 -67.0 4.0 0.97 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 165.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -74.59 -12.78 60.54 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.72 2.008 . . . . 0.0 115.47 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.92 6.1 87.14 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -157.93 2.73 0.11 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.66 145.04 44.66 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p -67.6 -3.92 10.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.16 41.57 0.9 Allowed Glycine 0 CA--C 1.536 1.366 0 CA-C-N 120.586 1.539 . . . . 0.0 115.25 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.9 mt -125.66 139.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.867 1.334 . . . . 0.0 111.091 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -97.8 -14.89 20.52 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 p -74.47 168.93 18.75 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.129 -0.982 . . . . 0.0 113.615 162.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 0.2 OUTLIER -74.72 -0.99 19.92 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.4 -177.03 47.24 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.949 1.261 . . . . 0.0 115.441 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -145.16 134.96 23.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.063 1.745 . . . . 0.0 110.49 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -156.01 147.24 22.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.2 1.0 . . . . 0.0 111.682 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -121.44 68.95 0.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.469 0.509 0 C-N-CA 125.597 1.559 . . . . 0.0 112.45 -163.85 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 m -61.95 161.27 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.72 0.808 . . . . 0.0 112.57 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -51.79 -27.1 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -163.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -77.03 9.47 2.95 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.25 111.83 1.69 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.956 1.702 . . . . 0.0 113.461 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -81.92 36.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.264 15.8 t80 -50.37 -35.69 29.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -56.3 -31.53 63.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -80.95 -5.56 57.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.768 2.027 . . . . 0.0 112.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.49 5.76 89.17 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.616 1.579 . . . . 0.0 114.307 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.5 m -68.24 126.23 28.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.549 1.175 . . . . 0.0 112.644 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -90.88 23.76 3.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.307 1.843 . . . . 0.0 113.767 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.58 155.65 38.89 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.36 -49.98 3.78 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.388 1.947 . . . . 0.0 113.164 172.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -135.28 141.89 45.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.952 1.301 . . . . 0.0 112.98 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -87.48 152.34 22.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.857 2.063 . . . . 0.0 108.238 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -85.66 -13.98 46.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -153.89 58.65 0.73 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.838 1.255 . . . . 0.0 114.114 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -84.54 121.9 74.96 Favored Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 120.244 -1.535 . . . . 0.0 110.582 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.97 -30.01 14.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.137 2.558 . . . . 0.0 112.782 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.12 157.87 27.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.544 1.538 . . . . 0.0 112.935 166.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -55.17 145.62 20.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.41 -178.7 41.84 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -135.1 151.44 50.73 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.052 1.341 . . . . 0.0 113.451 -173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -113.78 107.3 15.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 111.891 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 -90.67 27.86 1.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -172.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -146.96 179.96 7.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.25 13.1 t30 65.33 -80.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.03 2.532 . . . . 0.0 114.964 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 32.67 -91.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.148 2.979 . . . . 0.0 114.233 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -143.94 25.87 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.309 2.244 . . . . 0.0 110.832 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.01 27.55 0.08 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 117.844 1.898 . . . . 0.0 117.844 -165.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.45 -130.62 29.08 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 119.159 1.479 . . . . 0.0 112.141 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -69.35 158.2 35.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.7 -34.34 62.22 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 119.72 3.23 . . . . 0.0 119.72 -165.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -72.2 -6.98 46.69 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.54 14.45 69.57 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.984 1.278 . . . . 0.0 114.822 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -107.96 -29.55 8.95 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.253 1.527 . . . . 0.0 112.842 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.92 135.51 44.47 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.0 t -61.55 131.69 50.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.79 15.8 71.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.44 1.019 . . . . 0.0 115.518 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 41.0 mt -89.71 130.14 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.903 1.351 . . . . 0.0 111.699 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 8.49 12.25 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.3 1.44 . . . . 0.0 113.619 163.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -76.71 179.79 5.83 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.805 1.642 . . . . 0.0 114.399 161.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -16.1 64.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.82 179.67 48.79 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.053 -1.029 . . . . 0.0 114.877 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.5 150.44 18.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.155 1.382 . . . . 0.0 113.251 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -163.21 175.29 11.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.966 1.306 . . . . 0.0 111.65 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -122.68 87.58 2.78 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.559 1.143 . . . . 0.0 113.436 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -68.16 125.85 27.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.475 1.11 . . . . 0.0 112.27 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -152.52 -6.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -168.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -87.92 142.87 27.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 110.117 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -103.44 -1.75 28.0 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -130.87 171.54 13.05 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.265 81.4 m-85 -112.65 -20.1 11.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.272 17.5 t80 -50.86 122.01 6.78 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 58.64 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.422 2.689 . . . . 0.0 116.344 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.59 -32.3 74.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.637 1.589 . . . . 0.0 113.658 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.7 m -57.81 132.71 54.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 112.066 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -112.49 12.99 20.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.357 1.463 . . . . 0.0 114.361 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.32 133.47 43.87 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.65 -77.06 0.4 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.074 1.321 . . . . 0.0 113.444 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -125.86 153.68 43.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.971 2.508 . . . . 0.0 112.875 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.72 119.52 24.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.482 1.913 . . . . 0.0 115.304 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 50.57 -164.15 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.257 1.823 . . . . 0.0 114.782 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -69.65 -45.5 68.29 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.706 -1.246 . . . . 0.0 112.306 163.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t 38.37 72.3 0.93 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.833 2.453 . . . . 0.0 114.912 163.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.68 -22.28 57.8 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.378 2.052 . . . . 0.0 112.855 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.335 27.6 t80 -79.02 -73.44 0.33 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -81.15 -49.7 10.51 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -167.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.85 -60.21 0.96 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 127.603 2.525 . . . . 0.0 115.997 170.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -71.14 152.02 43.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.674 1.99 . . . . 0.0 112.658 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -138.03 93.73 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.853 0.835 . . . . 0.0 112.731 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 -80.08 25.58 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -127.45 122.46 33.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -98.08 147.65 24.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.432 1.493 . . . . 0.0 112.331 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.76 -12.02 31.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.89 -31.52 5.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.629 1.572 . . . . 0.0 112.659 167.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.65 -13.2 70.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.079 1.323 . . . . 0.0 115.583 -168.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -148.73 51.56 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.771 1.786 . . . . 0.0 111.406 -167.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.81 152.67 44.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.54 -20.55 13.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.48 -9.52 5.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.485 1.514 . . . . 0.0 115.068 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 3.2 72.3 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.978 1.275 . . . . 0.0 114.943 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.49 -18.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.518 1.527 . . . . 0.0 114.337 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -90.85 140.73 29.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -61.16 -13.97 21.56 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.37 12.72 8.97 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.234 1.397 . . . . 0.0 114.625 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mt -125.6 123.35 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -76.08 -32.12 59.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.355 0.662 . . . . 0.0 112.656 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -67.43 152.39 45.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 167.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -68.49 -15.58 63.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.67 104.2 1.66 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.194 0.902 . . . . 0.0 112.367 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.23 147.99 51.45 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.69 0.796 . . . . 0.0 112.552 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -151.51 145.93 25.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.165 . . . . 0.0 112.158 167.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -109.31 84.12 1.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -165.577 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.298 88.8 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 175' ' ' PRO . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 159' ' ' HIS . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.414 ' CD2' HD13 ' A' ' 124' ' ' LEU . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 79' ' ' ILE . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 121.593 0.552 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 159' ' ' HIS . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 119.597 -0.239 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.409 ' CD2' HD13 ' A' ' 124' ' ' LEU . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 158' ' ' LEU . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 113.446 0.138 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 . . . . . 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.413 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.829 0.347 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HD12 ' A' ' 79' ' ' ILE . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 . . . . . 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.452 HD12 HD22 ' A' ' 158' ' ' LEU . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 113.274 0.07 . . . . 0.0 113.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 89' ' ' ILE . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 79' ' ' ILE . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 158' ' ' LEU . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 CA-C-O 120.052 -0.305 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 159' ' ' HIS . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 89' ' ' ILE . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.419 ' CD2' HD13 ' A' ' 124' ' ' LEU . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 . . . . . 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.434 ' HG2' HD12 ' A' ' 79' ' ' ILE . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 85.8 m-85 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.289 0.09 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 . . . . . 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' HIS . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.454 ' HG2' HD12 ' A' ' 79' ' ' ILE . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.207 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.4 ' H ' HG21 ' A' ' 149' ' ' THR . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.4 HG21 ' H ' ' A' ' 108' ' ' LYS . 11.0 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.926 0.393 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -76.31 -7.24 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.9 146.19 30.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 110.484 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -173.51 141.84 0.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.752 1.621 . . . . 0.0 110.768 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -138.41 151.04 47.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.427 0.691 . . . . 0.0 112.477 165.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -133.14 156.18 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.309 59.0 m-85 -76.54 6.53 5.67 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.328 7.0 t80 -56.86 141.61 44.15 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 126.96 29.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.09 169.35 43.94 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.127 0.87 . . . . 0.0 112.795 166.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.9 t 65.49 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.791 2.436 . . . . 0.0 114.374 -166.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -97.87 7.0 47.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.221 1.808 . . . . 0.0 113.342 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -76.68 136.16 39.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.66 -149.04 16.93 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.44 1.019 . . . . 0.0 112.523 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.49 153.01 16.86 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.254 54.0 t80 -135.73 93.38 2.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.53 -19.39 47.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -71.6 -11.84 61.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.015 1.279 . . . . 0.0 114.365 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.4 p -61.04 145.97 88.6 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.142 -0.974 . . . . 0.0 112.394 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -53.63 -40.99 77.35 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.567 2.844 . . . . 0.0 114.602 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -150.41 -32.94 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -150.29 147.16 27.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.533 1.933 . . . . 0.0 111.416 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.02 158.43 8.53 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.482 -0.762 . . . . 0.0 114.57 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 20.3 ttpt -111.9 159.66 18.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.433 2.293 . . . . 0.0 112.927 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -112.34 123.71 50.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.662 2.385 . . . . 0.0 109.321 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CE1' ' HE3' ' A' ' 75' ' ' LYS 0.298 88.8 m-85 -89.19 25.45 1.87 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -128.53 156.27 43.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -148.08 178.67 8.35 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 111.82 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -77.09 -37.0 55.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.052 -1.03 . . . . 0.0 113.119 -170.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.47 -29.14 21.62 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.325 1.05 . . . . 0.0 112.562 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.39 -25.21 9.54 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.115 1.34 . . . . 0.0 114.713 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.25 -139.65 25.23 Favored Glycine 0 N--CA 1.47 0.906 0 CA-C-N 119.774 1.787 . . . . 0.0 110.459 -165.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.99 157.81 32.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.353 4.4 p30 -69.54 -4.98 21.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 171.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -62.48 -21.98 65.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.4 85.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.275 0.941 . . . . 0.0 114.678 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -140.26 -24.32 0.81 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.599 1.56 . . . . 0.0 115.19 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -95.91 139.24 32.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p -65.8 0.31 1.82 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.62 14.82 2.01 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.517 1.053 . . . . 0.0 114.931 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.93 136.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.911 1.355 . . . . 0.0 110.828 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -114.61 -19.53 11.07 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.141 1.376 . . . . 0.0 114.467 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.9 t -149.22 156.69 42.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.504 1.521 . . . . 0.0 113.059 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.439 0.2 OUTLIER 72.47 11.83 5.65 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.47 172.85 15.68 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.578 1.085 . . . . 0.0 115.35 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.73 135.16 51.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.8 0.84 . . . . 0.0 112.644 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -161.34 149.84 15.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.592 1.557 . . . . 0.0 110.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 81.99 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.47 0.546 0 O-C-N 120.972 -1.08 . . . . 0.0 112.852 -174.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -68.91 156.43 38.52 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.959 1.304 . . . . 0.0 114.184 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.33 13.38 16.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.479 1.912 . . . . 0.0 112.914 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -58.43 -48.05 81.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.32 123.59 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.462 1.105 . . . . 0.0 112.14 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -153.89 118.39 4.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.11 1.764 . . . . 0.0 114.42 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -150.36 132.27 15.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.799 1.64 . . . . 0.0 114.915 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.344 31.1 t80 -55.64 125.82 22.77 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 -167.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -23.28 67.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.723 2.009 . . . . 0.0 116.182 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.47 48.04 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.384 0.993 . . . . 0.0 113.912 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -165.37 168.78 16.46 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.545 0.738 . . . . 0.0 112.461 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.87 15.0 12.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.981 1.312 . . . . 0.0 114.104 166.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.14 156.57 33.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.89 -136.36 15.15 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.338 -0.851 . . . . 0.0 111.167 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -51.99 142.86 14.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.785 1.293 . . . . 0.0 112.931 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.269 83.0 t80 -87.94 160.51 17.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.313 1.445 . . . . 0.0 114.314 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -44.4 105.13 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.718 2.407 . . . . 0.0 112.993 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 45.6 37.45 3.22 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.042 2.137 . . . . 0.0 115.086 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.8 m -141.0 89.21 9.9 Favored Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -67.93 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.308 3.339 . . . . 0.0 117.277 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.06 -13.86 7.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.18 2.5 7.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 135.19 5.77 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.531 1.539 . . . . 0.0 112.377 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 162.33 26.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.726 -0.867 . . . . 0.0 113.113 -175.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -98.65 112.58 24.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.302 1.841 . . . . 0.0 110.403 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 -82.41 26.5 0.55 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 175' ' ' PRO . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.0 157.89 23.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -143.6 149.75 37.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.056 1.742 . . . . 0.0 110.058 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.1 mp0 -70.26 -30.85 68.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.1 mp -103.71 -37.16 7.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.474 1.11 . . . . 0.0 111.489 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.95 -14.46 81.7 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 115.548 0.979 . . . . 0.0 115.548 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.75 -135.13 35.35 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.361 1.58 . . . . 0.0 111.719 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -67.31 150.71 48.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.19 -29.46 70.39 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -71.63 -12.23 61.24 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.65 -5.6 56.94 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.947 1.539 . . . . 0.0 116.947 162.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -113.29 -22.27 10.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.078 1.439 . . . . 0.0 114.199 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.15 146.14 23.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 159' ' ' HIS . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p -63.41 133.39 53.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.88 -16.41 1.96 Allowed Glycine 0 CA--C 1.541 1.668 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.9 132.82 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.869 1.835 . . . . 0.0 111.293 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -76.65 10.83 1.93 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.896 1.678 . . . . 0.0 114.638 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -153.65 163.4 40.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.534 1.934 . . . . 0.0 113.23 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -33.78 76.34 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.96 98.55 0.56 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.913 0.768 . . . . 0.0 112.816 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.56 138.19 58.28 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 110.684 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -159.55 143.18 14.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.414 ' CD2' HD13 ' A' ' 124' ' ' LEU . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 79' ' ' ILE . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -81.64 55.21 2.6 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 127.112 2.165 . . . . 0.0 111.286 -171.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t 52.03 35.53 16.42 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.388 1.475 . . . . 0.0 114.667 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.69 158.54 32.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.577 1.551 . . . . 0.0 113.597 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -143.62 147.02 33.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.507 1.523 . . . . 0.0 111.869 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 56.14 24.26 7.8 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.832 2.053 . . . . 0.0 114.589 -171.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.33 1.35 48.85 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.612 -1.305 . . . . 0.0 112.103 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -54.18 -27.43 33.98 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 120.908 3.67 . . . . 0.0 120.908 -161.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.353 59.5 t80 -64.2 138.8 58.62 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -61.4 -49.53 76.5 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.7 150.29 5.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.747 1.165 . . . . 0.0 113.171 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -72.39 -12.96 61.34 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -171.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 57.21 33.86 23.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.204 1.802 . . . . 0.0 114.641 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.62 141.52 42.82 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.93 -136.04 10.74 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.874 1.225 . . . . 0.0 113.041 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -71.29 135.52 47.45 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.363 -1.08 . . . . 0.0 111.821 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -52.66 137.22 31.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.95 -32.34 6.1 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -76.37 -40.09 52.02 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 121.152 1.796 . . . . 0.0 112.906 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -76.3 140.84 69.5 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.001 1.32 . . . . 0.0 112.592 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.16 -12.38 19.31 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.293 2.662 . . . . 0.0 113.968 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.378 59.0 m-85 -69.04 -0.34 5.6 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.7 3.222 . . . . 0.0 119.7 -169.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.354 84.1 m-20 64.34 32.64 11.99 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.43 174.2 54.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.625 2.06 . . . . 0.0 115.18 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -109.5 124.72 51.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.956 1.302 . . . . 0.0 113.703 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -107.87 126.58 52.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 111.655 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 -98.82 22.91 9.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -129.55 159.28 36.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.3 156.8 48.14 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.077 2.551 . . . . 0.0 111.798 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -69.13 -48.53 62.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.484 1.514 . . . . 0.0 113.535 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.62 -27.47 15.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.817 1.647 . . . . 0.0 111.346 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.42 -20.66 74.37 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.6 -147.21 49.53 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.018 1.409 . . . . 0.0 111.808 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.94 153.7 20.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -56.49 -38.33 71.6 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -160.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -80.29 -3.71 50.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 15.94 60.4 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 161.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.68 -27.21 5.53 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 -86.57 139.1 31.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 168.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p -65.99 134.8 53.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.86 -31.77 0.5 Allowed Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.366 1.46 . . . . 0.0 116.386 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.98 126.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.439 1.619 . . . . 0.0 111.155 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -75.58 -46.8 29.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.819 0.448 . . . . 0.0 111.713 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.264 0.6 OUTLIER -66.09 169.76 6.54 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.4 t -70.84 -25.28 62.76 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.02 101.26 2.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.87 1.224 . . . . 0.0 113.552 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.16 133.97 55.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.527 0.731 . . . . 0.0 110.553 170.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -154.8 144.16 21.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.69 -0.631 . . . . 0.0 112.378 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.86 83.61 2.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.291 1.036 . . . . 0.0 112.734 -170.978 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.122 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.7 p -158.37 167.04 30.78 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.431 -1.041 . . . . 0.0 113.738 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 62.75 17.94 10.25 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.523 1.929 . . . . 0.0 115.974 165.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -60.5 141.58 56.32 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.626 1.17 . . . . 0.0 111.001 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.67 158.09 34.78 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.59 138.52 29.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.51 -34.68 65.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.265 14.0 t80 -123.92 122.56 38.27 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.721 2.008 . . . . 0.0 115.985 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -96.93 26.96 4.26 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.18 -164.28 47.47 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.405 1.002 . . . . 0.0 114.852 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.0 p -160.71 160.67 31.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.707 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.92 32.56 1.39 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.987 1.315 . . . . 0.0 113.224 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.81 146.09 40.19 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.72 -134.62 10.36 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.325 0.964 . . . . 0.0 112.279 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.41 135.88 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.982 1.391 . . . . 0.0 110.527 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.11 111.57 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.12 142.64 58.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -167.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 55.58 15.81 1.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.321 2.249 . . . . 0.0 114.937 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -136.52 70.79 59.8 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.312 1.445 . . . . 0.0 111.092 -163.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.38 -13.26 32.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.078 3.185 . . . . 0.0 114.383 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.285 59.7 m-85 -99.17 -29.92 12.58 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 174.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.6 -20.11 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.82 -120.47 5.22 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.107 1.337 . . . . 0.0 114.758 162.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -93.54 135.69 34.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.312 1.845 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.74 112.95 25.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 109.48 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -86.56 20.48 2.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.71 2.004 . . . . 0.0 114.745 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -144.78 92.03 2.23 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -162.91 -45.26 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.652 1.181 . . . . 0.0 111.512 -166.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 106' ' ' GLY . 18.1 tp10 -53.19 151.12 5.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.191 1.797 . . . . 0.0 112.179 171.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.91 -23.56 63.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.673 1.189 . . . . 0.0 112.578 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' H ' ' HG3' ' A' ' 104' ' ' GLU . . . -78.62 3.95 61.98 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 126.105 1.812 . . . . 0.0 116.39 171.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.44 -132.78 11.38 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.89 1.845 . . . . 0.0 113.162 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.92 140.41 56.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -63.57 -19.48 64.85 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.59 -11.28 60.84 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.39 15.91 45.42 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 160.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.04 -24.79 0.68 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 -87.92 147.71 24.94 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 159' ' ' HIS . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -64.18 3.58 0.42 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.5 25.08 1.84 Allowed Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.905 1.23 . . . . 0.0 114.49 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mt -112.91 122.35 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.159 1.384 . . . . 0.0 108.961 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 -39.69 27.83 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.81 156.04 34.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 122.37 16.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.61 -148.45 19.52 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.459 1.028 . . . . 0.0 114.446 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.33 160.02 31.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 112.1 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.07 156.14 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 110.856 162.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.409 ' CD2' HD13 ' A' ' 124' ' ' LEU . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.69 50.53 1.52 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.524 0 C-N-CA 125.2 1.4 . . . . 0.0 113.561 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.0 m -145.03 123.98 12.74 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.108 0.954 . . . . 0.0 112.956 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -72.04 -35.19 69.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -65.59 -13.96 60.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.51 -10.53 59.46 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -99.02 157.57 16.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.135 0.974 . . . . 0.0 112.167 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.45 14.64 4.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -160.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.276 26.0 t80 -76.62 142.34 40.71 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -68.32 -17.12 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.72 58.58 4.2 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.107 1.321 . . . . 0.0 115.104 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 63.57 155.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.743 2.017 . . . . 0.0 115.052 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.88 16.61 2.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.325 2.25 . . . . 0.0 113.267 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -72.12 145.11 48.37 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.04 -18.68 56.27 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.995 1.284 . . . . 0.0 116.066 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 149.4 28.62 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.499 1.65 . . . . 0.0 113.445 173.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.4 176.79 5.0 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.638 1.575 . . . . 0.0 107.028 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -153.35 161.2 42.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.786 1.234 . . . . 0.0 112.375 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 52.38 66.18 1.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.713 2.005 . . . . 0.0 113.194 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -151.51 145.43 17.88 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.73 1.212 . . . . 0.0 111.614 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.32 -25.72 30.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.701 2.267 . . . . 0.0 112.934 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.53 -41.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.696 2.85 . . . . 0.0 118.696 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.27 23.8 m-20 -68.28 143.56 55.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.92 -54.4 0.01 OUTLIER Glycine 0 N--CA 1.471 0.992 0 C-N-CA 124.859 1.219 . . . . 0.0 113.283 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -73.54 160.18 32.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.25 1.02 . . . . 0.0 111.012 165.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -152.11 127.51 9.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 -112.21 22.58 14.61 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 158' ' ' LEU . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -135.21 156.89 48.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -149.48 173.12 13.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.07 1.348 . . . . 0.0 111.967 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.8 -21.72 54.7 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.051 -1.03 . . . . 0.0 113.137 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.34 -47.17 83.27 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.386 1.874 . . . . 0.0 111.998 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.82 20.49 1.28 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.87 -132.4 13.77 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.263 1.531 . . . . 0.0 112.253 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -68.1 145.86 54.01 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.42 -21.02 33.9 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -16.59 5.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.175 1.39 . . . . 0.0 114.365 172.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.38 27.91 62.76 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.218 0.913 . . . . 0.0 114.657 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -157.73 -28.18 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.169 1.788 . . . . 0.0 114.473 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 -89.67 143.99 26.36 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p -59.66 127.32 31.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 66.32 2.93 16.49 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.088 -1.396 . . . . 0.0 116.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.31 133.99 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.578 2.189 . . . . 0.0 109.857 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.63 -53.74 5.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.999 1.319 . . . . 0.0 112.562 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.01 176.32 8.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.7 40.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.82 -148.34 28.74 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.188 0.899 . . . . 0.0 114.856 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.05 151.42 39.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.115 1.766 . . . . 0.0 111.297 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -159.95 142.65 13.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 0.0 112.428 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.4 61.48 4.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 125.277 1.431 . . . . 0.0 113.252 -174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.4 m -96.17 -42.88 7.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.176 1.39 . . . . 0.0 112.861 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -66.25 144.76 56.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.35 1.46 . . . . 0.0 112.94 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . 0.28 55.0 m95 -81.03 48.81 1.15 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.61 154.69 24.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.984 2.113 . . . . 0.0 113.677 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -144.07 161.45 38.77 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.284 16.9 t80 -147.44 87.42 1.65 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.273 21.0 t80 -63.07 127.67 32.33 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 160.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -70.35 -3.04 15.49 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -170.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 -174.26 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 149.28 46.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.954 1.302 . . . . 0.0 111.729 155.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -139.03 20.35 2.63 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -163.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 -77.09 129.86 36.6 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 -50.63 0.81 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.103 1.811 . . . . 0.0 113.693 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -147.68 159.74 43.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.594 1.158 . . . . 0.0 113.773 -165.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.6 128.57 49.88 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -100.35 -34.26 10.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.241 1.417 . . . . 0.0 113.677 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.08 146.63 50.8 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . 0.256 2.9 m 63.26 160.92 0.12 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.916 2.086 . . . . 0.0 115.462 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -66.42 7.78 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.803 3.002 . . . . 0.0 119.735 -156.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.323 1.1 p90 -129.56 147.29 51.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -167.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -72.81 51.81 0.29 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.186 2.194 . . . . 0.0 116.509 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.39 143.8 48.86 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 120.567 -1.333 . . . . 0.0 115.06 -171.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -93.03 147.83 22.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.673 1.589 . . . . 0.0 110.519 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -138.68 109.42 6.66 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.592 0.71 . . . . 0.0 112.26 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 -86.78 29.61 0.79 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -128.16 150.31 50.05 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -157.81 164.91 36.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.507 1.123 . . . . 0.0 110.916 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -61.63 -22.47 65.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.996 0.918 . . . . 0.0 112.573 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 tp -49.7 -32.39 13.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.532 1.933 . . . . 0.0 114.227 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.78 45.47 0.03 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.672 1.029 . . . . 0.0 115.672 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.7 -133.9 25.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 118.415 1.107 . . . . 0.0 113.446 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -66.08 160.45 23.86 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -54.62 -26.53 33.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -81.42 -2.48 49.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.11 70.5 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.682 1.135 . . . . 0.0 115.399 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -122.43 -24.17 5.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 114.229 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -95.63 138.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p -61.98 114.58 3.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.97 1.77 80.22 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 117.934 1.934 . . . . 0.0 117.934 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.97 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 121.405 2.603 . . . . 0.0 111.03 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.51 -43.85 25.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -64.93 166.16 9.64 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -70.91 -29.61 65.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.58 152.68 22.1 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.769 1.175 . . . . 0.0 113.685 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.86 147.58 22.87 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.793 1.237 . . . . 0.0 112.902 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -145.91 145.87 30.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.91 0.884 . . . . 0.0 112.231 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -119.62 76.96 1.18 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.591 1.556 . . . . 0.0 112.054 -168.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.7 p 59.21 -2.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 170.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -75.66 163.48 27.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.411 1.884 . . . . 0.0 112.899 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -111.43 -26.12 9.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.623 1.569 . . . . 0.0 113.362 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 54' ' ' PHE . 74.8 tt0 -72.68 133.83 44.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.209 1.404 . . . . 0.0 112.798 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.11 8.24 44.3 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 121.081 -1.012 . . . . 0.0 111.506 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.488 ' H ' ' HG2' ' A' ' 52' ' ' GLU 0.314 73.3 m-85 -127.86 25.15 5.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.361 2.264 . . . . 0.0 117.047 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.287 35.7 t80 -63.64 147.94 50.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.44 68.36 2.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.999 1.32 . . . . 0.0 113.146 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.96 16.08 49.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.996 2.713 . . . . 0.0 116.314 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.7 p -141.77 137.05 31.31 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.012 1.406 . . . . 0.0 109.38 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -144.93 29.29 1.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -155.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -75.09 165.79 24.67 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -133.71 11.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.396 1.474 . . . . 0.0 110.834 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -68.62 148.6 50.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.45 0.7 . . . . 0.0 111.352 170.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.33 177.53 2.3 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.922 0.489 . . . . 0.0 110.145 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -52.92 156.13 2.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.782 1.233 . . . . 0.0 112.555 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -56.11 127.11 29.0 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.51 -0.744 . . . . 0.0 111.67 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.4 m -171.68 163.64 4.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.808 1.643 . . . . 0.0 111.047 -169.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.71 -35.31 87.06 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.283 2.656 . . . . 0.0 112.715 160.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.292 61.5 t80 -62.1 125.99 25.79 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 166.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 6.4 p30 -110.76 3.65 19.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -165.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.5 169.56 33.02 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.87 138.55 54.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.32 1.448 . . . . 0.0 112.676 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -76.53 -31.48 57.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.649 1.58 . . . . 0.0 112.455 167.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 63.63 8.1 3.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.413 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.61 169.46 17.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -148.79 165.89 30.09 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.082 1.753 . . . . 0.0 110.371 166.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.29 -26.85 68.25 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.52 1.528 . . . . 0.0 112.648 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.25 152.0 31.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.896 2.078 . . . . 0.0 108.552 166.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.43 -29.34 1.01 Allowed Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 113.657 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.75 -136.02 21.29 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.373 1.086 . . . . 0.0 112.026 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.41 155.82 17.32 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -47.65 -42.16 23.83 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -74.14 -12.07 60.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.18 78.02 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.213 0.911 . . . . 0.0 115.33 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -114.04 -27.07 7.83 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.822 1.311 . . . . 0.0 114.0 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -97.1 135.31 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -71.13 140.15 50.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.29 23.5 70.03 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.929 1.252 . . . . 0.0 115.89 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 53.3 mt -87.41 149.62 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.79 1.236 . . . . 0.0 112.143 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -119.69 -25.87 5.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.319 1.848 . . . . 0.0 112.95 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.1 t -70.29 173.78 6.38 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 p -55.57 -17.9 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.65 178.95 46.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 120.214 1.37 . . . . 0.0 115.825 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.57 144.78 41.66 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.599 1.559 . . . . 0.0 113.772 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -162.3 174.69 12.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.431 1.493 . . . . 0.0 111.381 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HD12 ' A' ' 79' ' ' ILE . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.59 78.62 9.81 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 112.687 -176.112 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.817 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.7 m -74.47 -20.57 59.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -99.21 -25.75 14.41 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -146.72 154.23 41.18 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.976 1.262 . . . . 0.0 113.159 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -71.9 144.27 49.05 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.199 1.4 . . . . 0.0 112.303 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -104.76 174.69 5.77 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.552 2.341 . . . . 0.0 115.68 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.387 50.3 m-85 -71.11 7.96 1.09 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 56' ' ' ARG 0.29 33.7 t80 -56.74 177.02 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 158.009 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.8 mmt180 -61.62 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.869 2.067 . . . . 0.0 114.89 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.83 97.34 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.031 1.777 . . . . 0.0 112.753 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.2 t -93.05 138.14 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -86.52 2.23 48.72 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.272 1.429 . . . . 0.0 114.125 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -79.66 140.21 37.13 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.68 -26.24 21.08 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.768 2.128 . . . . 0.0 115.545 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -146.14 132.63 19.73 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.943 1.371 . . . . 0.0 113.697 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 68' ' ' GLN 0.337 34.9 t80 -103.0 -169.22 1.62 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.084 2.554 . . . . 0.0 116.101 -171.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 67' ' ' TYR . 31.0 tt0 -58.78 132.96 55.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.36 1.864 . . . . 0.0 111.863 174.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -58.16 114.84 2.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.826 1.251 . . . . 0.0 110.544 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -156.86 154.75 27.23 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.376 1.471 . . . . 0.0 112.726 -162.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -57.06 -31.67 90.91 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.586 2.857 . . . . 0.0 116.242 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -134.33 148.19 50.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.47 22.9 m-20 49.53 52.15 15.07 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 170.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.32 4.45 0.6 Allowed Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.98 2.229 . . . . 0.0 117.695 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -80.85 159.16 25.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.213 2.205 . . . . 0.0 112.262 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -155.65 109.39 2.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -95.09 25.04 4.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.452 HD12 HD22 ' A' ' 158' ' ' LEU . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -119.6 122.63 42.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.7 t30 53.24 25.28 4.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.47 3.108 . . . . 0.0 116.0 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -78.33 -1.72 34.61 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.94 -1.1 . . . . 0.0 112.614 165.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 -45.67 0.1 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 111.554 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.55 106.74 0.2 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.09 0.853 . . . . 0.0 113.155 169.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.63 -157.44 29.79 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 117.905 0.852 . . . . 0.0 113.274 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.67 146.27 54.97 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.88 -13.91 18.75 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -62.09 -3.95 1.48 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.496 1.918 . . . . 0.0 115.955 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.3 -8.85 66.02 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.147 1.356 . . . . 0.0 115.839 164.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -144.36 -13.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 -91.81 144.66 25.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p -58.67 134.51 56.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.88 -7.79 5.12 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 mt -79.74 140.93 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.826 . . . . 0.0 109.345 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -82.54 -46.14 13.76 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.265 -0.897 . . . . 0.0 110.986 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.6 t -71.18 170.83 12.17 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 168.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.4 p -84.55 -37.05 21.69 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.69 112.02 3.67 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.653 1.12 . . . . 0.0 112.742 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.54 153.95 30.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -158.54 140.71 14.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 0.0 111.509 169.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 89' ' ' ILE . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 79' ' ' ILE . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.08 55.33 0.57 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.326 2.251 . . . . 0.0 111.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -82.19 158.32 23.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.232 1.413 . . . . 0.0 113.17 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -141.14 159.26 42.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.336 1.854 . . . . 0.0 112.66 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.0 m95 64.95 35.53 8.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.898 2.079 . . . . 0.0 115.106 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 54.51 31.36 14.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.205 1.402 . . . . 0.0 113.594 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -75.38 159.83 30.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.033 1.733 . . . . 0.0 112.788 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -126.39 159.0 34.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.879 2.072 . . . . 0.0 113.881 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.0 -17.69 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 -166.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -60.42 -46.41 90.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.481 1.113 . . . . 0.0 113.526 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.28 172.7 55.24 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 122.108 0.838 . . . . 0.0 114.604 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 t -71.18 143.49 50.49 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.679 1.192 . . . . 0.0 112.606 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -81.11 7.4 11.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.961 1.304 . . . . 0.0 113.658 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -73.42 149.59 42.33 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.83 -46.95 3.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 127.392 2.425 . . . . 0.0 113.265 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -141.37 145.18 35.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -60.83 141.43 57.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 163.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -58.47 127.2 30.96 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.75 -0.594 . . . . 0.0 111.334 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.263 30.0 m170 58.61 22.33 9.69 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 95.4 34.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.783 1.233 . . . . 0.0 110.372 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -63.8 -31.47 68.28 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 115.118 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -133.23 -36.82 0.99 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.718 0.69 . . . . 0.0 112.013 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 27.2 m-20 -84.62 13.46 5.64 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.11 0.24 Allowed Glycine 0 N--CA 1.468 0.803 0 O-C-N 120.742 -1.223 . . . . 0.0 113.402 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -98.99 158.72 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.54 1.536 . . . . 0.0 111.899 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -149.72 98.6 2.77 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -171.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 -76.42 21.54 0.19 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 158' ' ' LEU . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -143.14 -177.72 5.49 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 67.01 -59.08 0.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.863 3.265 . . . . 0.0 116.752 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -63.35 122.01 15.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.89 0.768 . . . . 0.0 112.541 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.2 tp 65.62 -17.3 0.1 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.846 2.458 . . . . 0.0 116.754 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.43 93.04 0.09 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 117.758 1.863 . . . . 0.0 117.758 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.67 -134.23 46.86 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 118.151 0.975 . . . . 0.0 113.59 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.12 139.71 58.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.01 -24.5 66.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -68.0 -10.02 50.24 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.31 12.33 29.35 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.87 -22.06 0.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 -88.71 151.41 22.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 159' ' ' HIS . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -65.44 131.35 46.19 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.48 -4.7 6.4 Favored Glycine 0 CA--C 1.542 1.737 0 N-CA-C 116.824 1.49 . . . . 0.0 116.824 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 64.6 mt -79.57 122.28 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 120.597 2.198 . . . . 0.0 109.797 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -63.65 -49.33 73.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 0.6 OUTLIER -75.31 1.72 13.0 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 117.357 2.354 . . . . 0.0 117.357 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.453 0.2 OUTLIER 65.13 -0.98 0.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 -174.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.99 22.25 0.34 Allowed Glycine 0 CA--C 1.544 1.852 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -169.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 54.5 14.21 0.78 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 120.718 3.599 . . . . 0.0 120.718 161.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -68.5 138.56 55.29 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.761 -1.212 . . . . 0.0 113.481 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 89' ' ' ILE . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.419 ' CD2' HD13 ' A' ' 124' ' ' LEU . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -103.58 81.76 1.94 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--O 1.242 0.692 0 C-N-CA 128.09 2.556 . . . . 0.0 110.323 174.013 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.994 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -158.71 154.93 27.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.018 1.327 . . . . 0.0 111.203 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -136.98 -8.6 1.81 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.648 1.579 . . . . 0.0 114.547 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -116.33 141.42 48.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.376 1.471 . . . . 0.0 110.538 172.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -116.55 100.12 7.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.57 1.148 . . . . 0.0 109.666 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.42 119.41 33.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.847 1.659 . . . . 0.0 114.923 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -148.2 157.86 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.572 2.349 . . . . 0.0 111.622 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.319 28.0 t80 -70.31 114.41 8.42 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 163.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.88 105.22 17.37 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.761 1.224 . . . . 0.0 111.873 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.29 -26.0 31.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.193 0.901 . . . . 0.0 113.028 166.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -151.77 158.12 42.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.926 1.29 . . . . 0.0 112.857 172.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.44 19.38 6.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.429 1.492 . . . . 0.0 112.958 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -84.34 157.85 21.34 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.6 -114.57 4.98 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.49 1.043 . . . . 0.0 110.821 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.55 148.21 52.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.763 1.281 . . . . 0.0 112.825 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -81.93 122.98 28.45 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 43.69 54.41 5.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.008 1.323 . . . . 0.0 113.406 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 m80 59.66 4.0 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.2 t -65.86 120.55 69.89 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 120.591 1.541 . . . . 0.0 112.868 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.14 -9.86 18.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.37 2.713 . . . . 0.0 116.363 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.58 164.06 36.16 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -168.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.329 6.6 t0 63.62 -70.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.93 115.08 3.99 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.004 1.288 . . . . 0.0 114.135 -168.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 142.75 27.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.932 2.093 . . . . 0.0 110.792 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -126.05 117.34 22.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.945 1.698 . . . . 0.0 111.349 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -86.22 21.59 2.0 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -162.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -149.06 154.2 38.94 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -150.0 -172.0 4.05 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.94 2.096 . . . . 0.0 111.299 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -75.85 -29.33 58.54 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 tt -118.62 -41.37 2.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.348 1.059 . . . . 0.0 112.068 -168.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.63 -20.45 70.07 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.602 -0.686 . . . . 0.0 112.4 161.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.41 -136.11 39.44 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 118.789 1.295 . . . . 0.0 110.547 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -60.98 163.32 5.98 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.09 -46.19 44.33 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -69.71 -3.72 16.56 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.26 83.15 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.688 1.613 . . . . 0.0 116.556 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.0 -27.25 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -90.39 137.7 32.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p -64.79 -14.01 57.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -125.88 18.67 6.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.175 1.369 . . . . 0.0 114.271 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.0 mt -129.62 127.52 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 118.488 1.144 . . . . 0.0 110.246 -170.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -84.46 25.1 0.91 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.866 1.667 . . . . 0.0 114.394 -169.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.2 t -159.8 164.99 33.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.154 2.182 . . . . 0.0 109.169 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.29 0.7 OUTLIER -67.2 -13.22 61.76 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.44 61.62 0.85 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 126.689 2.09 . . . . 0.0 114.658 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.59 149.38 8.17 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.465 2.306 . . . . 0.0 113.549 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -161.72 141.79 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.172 0.989 . . . . 0.0 112.135 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.434 ' HG2' HD12 ' A' ' 79' ' ' ILE . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.11 98.54 8.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.445 1.498 . . . . 0.0 110.316 167.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 CA-C-O 119.583 -0.565 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -78.37 153.33 31.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.037 1.335 . . . . 0.0 111.697 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -132.56 166.51 21.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.211 1.404 . . . . 0.0 112.821 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -104.4 -51.92 3.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.0 112.532 166.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -78.94 160.06 27.42 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 0.0 113.265 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.296 1.0 OUTLIER -134.42 157.54 46.18 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 178.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.277 63.0 m-85 -74.48 80.15 1.93 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.258 29.6 t80 -59.8 131.44 50.91 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 168.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -70.46 15.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.14 -21.58 77.87 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.702 -1.249 . . . . 0.0 113.854 162.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.4 p -159.92 -179.51 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.22 1.408 . . . . 0.0 112.529 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -111.27 26.51 10.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.205 1.802 . . . . 0.0 112.934 157.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -78.21 153.31 32.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.19 -149.09 21.15 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.433 1.016 . . . . 0.0 112.243 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -50.47 143.05 9.62 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.753 1.276 . . . . 0.0 112.948 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.279 51.0 t80 -111.95 179.0 4.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.902 1.681 . . . . 0.0 114.725 -168.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -51.95 156.24 1.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.672 1.189 . . . . 0.0 112.061 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -63.69 124.99 22.86 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.601 -1.312 . . . . 0.0 112.193 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -175.22 148.82 1.1 Allowed Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.102 1.761 . . . . 0.0 112.892 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.17 -24.82 14.31 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.263 2.642 . . . . 0.0 115.86 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -128.33 -12.76 5.04 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -174.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.79 14.33 23.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.072 2.149 . . . . 0.0 116.317 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.0 -6.99 40.93 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -156.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -136.7 134.97 37.78 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.156 1.478 . . . . 0.0 110.184 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -103.35 109.26 20.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.907 1.683 . . . . 0.0 109.256 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 85.8 m-85 -78.46 27.4 0.21 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -170.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -148.43 150.02 32.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -153.43 162.79 40.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.333 1.053 . . . . 0.0 112.977 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.27 -28.17 65.01 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.32 -18.69 25.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 114.242 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 -13.35 4.06 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.221 1.391 . . . . 0.0 114.907 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.79 -142.04 32.84 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.459 1.13 . . . . 0.0 111.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.82 146.18 53.23 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -74.46 -4.06 34.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.332 1.053 . . . . 0.0 113.714 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.46 24.83 60.09 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 157.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.43 -24.46 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.369 1.989 . . . . 0.0 116.369 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 -89.03 146.17 25.02 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 151' ' ' ILE . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -73.92 130.47 39.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.03 10.95 42.73 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 148' ' ' ASN . 42.7 mt -74.09 -31.42 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.295 2.047 . . . . 0.0 112.487 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 51.84 29.44 5.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.443 1.497 . . . . 0.0 113.78 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.329 0.2 OUTLIER -143.81 34.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.812 2.045 . . . . 0.0 116.415 -169.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER 69.13 -25.64 0.14 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -167.41 167.04 39.68 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 120.535 1.516 . . . . 0.0 116.358 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.55 146.67 53.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 -163.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -157.33 147.4 20.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.963 2.105 . . . . 0.0 110.13 154.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -101.26 74.85 1.59 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 124.203 1.001 . . . . 0.0 113.511 -167.652 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.2 t -90.76 169.66 10.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.639 1.175 . . . . 0.0 111.838 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -56.37 136.97 53.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.986 1.714 . . . . 0.0 112.176 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -84.48 151.33 24.68 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -68.32 117.01 9.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.855 1.262 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.04 136.94 49.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.367 8.1 p90 -109.1 -1.77 18.58 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 -172.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.295 47.8 t80 -64.74 139.64 58.78 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -62.77 -6.04 3.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.86 143.7 45.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.193 0.906 . . . . 0.0 113.581 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -49.04 127.99 15.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.39 1.876 . . . . 0.0 115.143 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -107.92 -3.3 19.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -154.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 -66.33 153.1 43.55 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.22 -139.37 14.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.396 0.998 . . . . 0.0 113.118 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.17 150.59 24.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.348 1.074 . . . . 0.0 113.36 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -150.74 126.65 10.4 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 -164.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -59.68 -32.47 70.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -163.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -83.57 -6.81 59.55 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.859 1.209 . . . . 0.0 113.484 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -107.92 156.62 37.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.003 1.721 . . . . 0.0 111.098 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.36 176.65 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.735 2.957 . . . . 0.0 115.839 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -47.82 -43.75 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -94.19 15.55 17.0 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.77 165.21 43.74 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.726 1.631 . . . . 0.0 114.662 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.77 143.2 29.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.105 1.762 . . . . 0.0 110.93 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -91.92 118.2 30.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.67 0.788 . . . . 0.0 109.492 164.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 -81.08 30.19 0.33 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -164.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -119.89 137.77 53.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -125.93 145.31 50.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.45 1.9 . . . . 0.0 111.927 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -62.92 -25.49 68.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -173.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.49 -41.72 4.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.261 1.425 . . . . 0.0 111.659 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.06 68.8 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 115.64 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.31 -140.8 30.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.03 1.415 . . . . 0.0 111.928 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -71.98 156.37 39.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -67.07 -23.66 65.89 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.01 -21.08 63.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.6 89.4 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.159 1.361 . . . . 0.0 114.506 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -112.85 -33.07 6.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.078 1.439 . . . . 0.0 113.64 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -88.39 146.01 25.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p -69.74 139.65 53.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.54 -31.14 1.01 Allowed Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.999 1.285 . . . . 0.0 115.677 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.4 133.68 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.264 1.532 . . . . 0.0 111.73 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.55 38.32 2.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.01 1.724 . . . . 0.0 111.966 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.253 1.3 t -142.17 156.55 45.35 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.474 2.31 . . . . 0.0 112.885 167.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.268 1.7 m -70.56 -25.69 63.21 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.97 97.79 0.94 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.764 1.173 . . . . 0.0 114.464 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.37 147.43 52.12 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.76 0.78 . . . . 0.0 111.956 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -164.92 153.04 11.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.78 1.232 . . . . 0.0 111.799 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -99.91 74.79 1.84 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.24 0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 111.551 -172.649 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -65.31 143.99 57.41 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.152 1.381 . . . . 0.0 114.169 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -68.06 -30.14 69.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.639 0.775 . . . . 0.0 112.49 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -67.61 -19.44 65.23 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -74.57 -21.32 59.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.848 0.859 . . . . 0.0 112.444 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -57.88 144.88 37.4 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -72.82 81.9 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.955 1.302 . . . . 0.0 112.169 168.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 38.1 t80 -62.71 130.38 44.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -71.3 147.51 48.04 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -162.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.17 -11.84 0.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.126 1.346 . . . . 0.0 115.774 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -69.32 139.35 54.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -94.44 28.15 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.825 1.65 . . . . 0.0 112.894 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.27 149.61 47.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.12 -165.92 12.45 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.106 1.336 . . . . 0.0 112.614 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.47 133.04 53.23 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.497 -1.59 . . . . 0.0 111.113 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -54.13 152.27 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 164.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.08 -32.48 61.47 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -155.66 133.88 11.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.403 2.281 . . . . 0.0 110.12 165.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.6 t -160.48 114.04 1.38 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.837 1.255 . . . . 0.0 111.607 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.67 22.34 0.94 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.692 2.928 . . . . 0.0 113.499 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -134.5 -52.49 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -105.58 -27.02 11.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.92 -70.73 0.96 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.13 1.347 . . . . 0.0 113.513 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HE2' ' CE2' ' A' ' 77' ' ' TYR . 72.8 tttt -95.07 122.72 38.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.747 1.619 . . . . 0.0 109.998 169.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -76.48 97.36 4.3 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.973 0.909 . . . . 0.0 109.684 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE2' ' HE2' ' A' ' 75' ' ' LYS . 94.2 m-85 -78.73 91.84 4.73 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.147 -0.346 . . . . 0.0 111.009 164.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -121.27 157.78 29.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -146.63 156.45 43.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.365 1.866 . . . . 0.0 111.267 164.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -55.63 -54.87 38.82 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.82 6.41 47.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.829 1.251 . . . . 0.0 113.527 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.88 -30.87 7.67 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.758 1.17 . . . . 0.0 113.052 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 -145.3 46.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.212 -1.169 . . . . 0.0 110.694 -162.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -67.67 152.22 45.97 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.31 78.7 m-20 -67.0 4.0 0.97 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 165.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -74.59 -12.78 60.54 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.72 2.008 . . . . 0.0 115.47 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.92 6.1 87.14 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -157.93 2.73 0.11 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.66 145.04 44.66 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' HIS . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p -67.6 -3.92 10.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.16 41.57 0.9 Allowed Glycine 0 CA--C 1.536 1.366 0 CA-C-N 120.586 1.539 . . . . 0.0 115.25 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.9 mt -125.66 139.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.867 1.334 . . . . 0.0 111.091 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -97.8 -14.89 20.52 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 p -74.47 168.93 18.75 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.129 -0.982 . . . . 0.0 113.615 162.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 0.2 OUTLIER -74.72 -0.99 19.92 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.4 -177.03 47.24 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.949 1.261 . . . . 0.0 115.441 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -145.16 134.96 23.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.063 1.745 . . . . 0.0 110.49 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -156.01 147.24 22.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.2 1.0 . . . . 0.0 111.682 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.454 ' HG2' HD12 ' A' ' 79' ' ' ILE . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -121.44 68.95 0.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.469 0.509 0 C-N-CA 125.597 1.559 . . . . 0.0 112.45 -163.85 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 m -61.95 161.27 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.72 0.808 . . . . 0.0 112.57 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -51.79 -27.1 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -163.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -77.03 9.47 2.95 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.25 111.83 1.69 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.956 1.702 . . . . 0.0 113.461 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -81.92 36.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.264 15.8 t80 -50.37 -35.69 29.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -56.3 -31.53 63.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -80.95 -5.56 57.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.768 2.027 . . . . 0.0 112.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.49 5.76 89.17 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.616 1.579 . . . . 0.0 114.307 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.5 m -68.24 126.23 28.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.549 1.175 . . . . 0.0 112.644 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -90.88 23.76 3.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.307 1.843 . . . . 0.0 113.767 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.58 155.65 38.89 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.36 -49.98 3.78 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.388 1.947 . . . . 0.0 113.164 172.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -135.28 141.89 45.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.952 1.301 . . . . 0.0 112.98 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -87.48 152.34 22.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.857 2.063 . . . . 0.0 108.238 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -85.66 -13.98 46.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -153.89 58.65 0.73 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.838 1.255 . . . . 0.0 114.114 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -84.54 121.9 74.96 Favored Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 120.244 -1.535 . . . . 0.0 110.582 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.97 -30.01 14.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.137 2.558 . . . . 0.0 112.782 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.12 157.87 27.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.544 1.538 . . . . 0.0 112.935 166.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -55.17 145.62 20.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.41 -178.7 41.84 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -135.1 151.44 50.73 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.052 1.341 . . . . 0.0 113.451 -173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -113.78 107.3 15.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 111.891 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 -90.67 27.86 1.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -172.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -146.96 179.96 7.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.25 13.1 t30 65.33 -80.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.03 2.532 . . . . 0.0 114.964 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 32.67 -91.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.148 2.979 . . . . 0.0 114.233 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -143.94 25.87 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.309 2.244 . . . . 0.0 110.832 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.01 27.55 0.08 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 117.844 1.898 . . . . 0.0 117.844 -165.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.45 -130.62 29.08 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 119.159 1.479 . . . . 0.0 112.141 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' H ' HG21 ' A' ' 149' ' ' THR . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -69.35 158.2 35.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.7 -34.34 62.22 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 119.72 3.23 . . . . 0.0 119.72 -165.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -72.2 -6.98 46.69 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.54 14.45 69.57 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.984 1.278 . . . . 0.0 114.822 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -107.96 -29.55 8.95 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.253 1.527 . . . . 0.0 112.842 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.92 135.51 44.47 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.579 ' HA ' HD12 ' A' ' 151' ' ' ILE . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.4 HG21 ' H ' ' A' ' 108' ' ' LYS . 11.0 t -61.55 131.69 50.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.79 15.8 71.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.44 1.019 . . . . 0.0 115.518 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 148' ' ' ASN . 41.0 mt -89.71 130.14 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.903 1.351 . . . . 0.0 111.699 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 8.49 12.25 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.3 1.44 . . . . 0.0 113.619 163.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -76.71 179.79 5.83 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.805 1.642 . . . . 0.0 114.399 161.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -16.1 64.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.82 179.67 48.79 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.053 -1.029 . . . . 0.0 114.877 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.5 150.44 18.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.155 1.382 . . . . 0.0 113.251 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -163.21 175.29 11.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.966 1.306 . . . . 0.0 111.65 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -122.68 87.58 2.78 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.559 1.143 . . . . 0.0 113.436 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -68.16 125.85 27.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.475 1.11 . . . . 0.0 112.27 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -152.52 -6.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -168.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -87.92 142.87 27.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 110.117 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -103.44 -1.75 28.0 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -130.87 171.54 13.05 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.265 81.4 m-85 -112.65 -20.1 11.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.272 17.5 t80 -50.86 122.01 6.78 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 58.64 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.422 2.689 . . . . 0.0 116.344 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.59 -32.3 74.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.637 1.589 . . . . 0.0 113.658 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.7 m -57.81 132.71 54.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 112.066 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -112.49 12.99 20.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.357 1.463 . . . . 0.0 114.361 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.32 133.47 43.87 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.65 -77.06 0.4 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.074 1.321 . . . . 0.0 113.444 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -125.86 153.68 43.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.971 2.508 . . . . 0.0 112.875 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.72 119.52 24.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.482 1.913 . . . . 0.0 115.304 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 50.57 -164.15 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.257 1.823 . . . . 0.0 114.782 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -69.65 -45.5 68.29 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.706 -1.246 . . . . 0.0 112.306 163.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t 38.37 72.3 0.93 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.833 2.453 . . . . 0.0 114.912 163.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.68 -22.28 57.8 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.378 2.052 . . . . 0.0 112.855 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.335 27.6 t80 -79.02 -73.44 0.33 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -81.15 -49.7 10.51 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -167.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.85 -60.21 0.96 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 127.603 2.525 . . . . 0.0 115.997 170.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -71.14 152.02 43.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.674 1.99 . . . . 0.0 112.658 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -138.03 93.73 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.853 0.835 . . . . 0.0 112.731 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 -80.08 25.58 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -127.45 122.46 33.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -98.08 147.65 24.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.432 1.493 . . . . 0.0 112.331 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.76 -12.02 31.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.89 -31.52 5.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.629 1.572 . . . . 0.0 112.659 167.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.65 -13.2 70.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.079 1.323 . . . . 0.0 115.583 -168.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -148.73 51.56 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.771 1.786 . . . . 0.0 111.406 -167.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.81 152.67 44.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.54 -20.55 13.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.48 -9.52 5.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.485 1.514 . . . . 0.0 115.068 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 3.2 72.3 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.978 1.275 . . . . 0.0 114.943 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.49 -18.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.518 1.527 . . . . 0.0 114.337 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -90.85 140.73 29.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -61.16 -13.97 21.56 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.37 12.72 8.97 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.234 1.397 . . . . 0.0 114.625 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mt -125.6 123.35 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -76.08 -32.12 59.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.355 0.662 . . . . 0.0 112.656 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -67.43 152.39 45.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 167.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -68.49 -15.58 63.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.67 104.2 1.66 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.194 0.902 . . . . 0.0 112.367 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.23 147.99 51.45 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.69 0.796 . . . . 0.0 112.552 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -151.51 145.93 25.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.165 . . . . 0.0 112.158 167.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -109.31 84.12 1.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -165.577 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.298 88.8 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 . . . . . 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.882 -0.044 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 . . . . . 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 175' ' ' PRO . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 159' ' ' HIS . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.414 ' CD2' HD13 ' A' ' 124' ' ' LEU . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 79' ' ' ILE . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 . . . . . 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 CA-C-O 121.593 0.552 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 159' ' ' HIS . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 119.597 -0.239 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.409 ' CD2' HD13 ' A' ' 124' ' ' LEU . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 158' ' ' LEU . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.895 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 . . . . . 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 . . . . . 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 113.446 0.138 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 . . . . . 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p . . . . . 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.413 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 112.026 -0.43 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.829 0.347 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HD12 ' A' ' 79' ' ' ILE . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 114.125 1.158 . . . . 0.0 114.125 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 . . . . . 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.452 HD12 HD22 ' A' ' 158' ' ' LEU . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 N-CA-C 113.274 0.07 . . . . 0.0 113.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 . . . . . 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 89' ' ' ILE . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 79' ' ' ILE . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? . . . . . 0 N--CA 1.477 0.905 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 . . . . . 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 158' ' ' LEU . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.217 0 CA-C-O 120.052 -0.305 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 159' ' ' HIS . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 89' ' ' ILE . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.419 ' CD2' HD13 ' A' ' 124' ' ' LEU . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 . . . . . 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 . . . . . 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.434 ' HG2' HD12 ' A' ' 79' ' ' ILE . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 85.8 m-85 . . . . . 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 . . . . . 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.76 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p . . . . . 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 120.289 0.09 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 . . . . . 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' HIS . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.454 ' HG2' HD12 ' A' ' 79' ' ' ILE . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 . . . . . 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.207 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.4 ' H ' HG21 ' A' ' 149' ' ' THR . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.4 HG21 ' H ' ' A' ' 108' ' ' LYS . 11.0 t . . . . . 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.926 0.393 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 . . . . . 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.057 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 85.8 p -76.31 -7.24 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 116.113 1.894 . . . . 0.0 116.113 -168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.9 146.19 30.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 110.484 175.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -173.51 141.84 0.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.752 1.621 . . . . 0.0 110.768 178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -138.41 151.04 47.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.427 0.691 . . . . 0.0 112.477 165.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -133.14 156.18 47.92 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 167.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.309 59.0 m-85 -76.54 6.53 5.67 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 118.51 2.782 . . . . 0.0 118.51 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.328 7.0 t80 -56.86 141.61 44.15 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 126.96 29.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -168.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -85.09 169.35 43.94 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.127 0.87 . . . . 0.0 112.795 166.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.9 t 65.49 132.47 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.791 2.436 . . . . 0.0 114.374 -166.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.9 mmp_? -97.87 7.0 47.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.221 1.808 . . . . 0.0 113.342 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.4 tt -69.88 155.57 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 120.996 -1.065 . . . . 0.0 112.044 -172.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 53.2 p -123.38 -75.98 0.59 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.625 1.57 . . . . 0.0 110.758 174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.88 111.37 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.328 1.851 . . . . 0.0 110.33 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.324 0.6 OUTLIER -85.17 175.67 8.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 177.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -76.68 136.16 39.12 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.787 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 122.66 -149.04 16.93 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.44 1.019 . . . . 0.0 112.523 -175.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.49 153.01 16.86 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.254 54.0 t80 -135.73 93.38 2.94 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -168.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.53 -19.39 47.92 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -172.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -71.6 -11.84 61.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.015 1.279 . . . . 0.0 114.365 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.4 p -61.04 145.97 88.6 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.142 -0.974 . . . . 0.0 112.394 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -53.63 -40.99 77.35 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.567 2.844 . . . . 0.0 114.602 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -150.41 -32.94 0.18 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 117.625 2.454 . . . . 0.0 117.625 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -150.29 147.16 27.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.533 1.933 . . . . 0.0 111.416 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.02 158.43 8.53 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.482 -0.762 . . . . 0.0 114.57 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.4 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 20.3 ttpt -111.9 159.66 18.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.433 2.293 . . . . 0.0 112.927 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -112.34 123.71 50.88 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.662 2.385 . . . . 0.0 109.321 168.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' CE1' ' HE3' ' A' ' 75' ' ' LYS 0.298 88.8 m-85 -89.19 25.45 1.87 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 116.783 2.142 . . . . 0.0 116.783 -164.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.84 -154.24 10.53 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.717 1.151 . . . . 0.0 112.786 -167.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mt -135.02 136.17 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.963 1.705 . . . . 0.0 110.166 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -110.92 131.3 55.17 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -119.4 122.98 43.0 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.59 1.156 . . . . 0.0 113.917 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 96.74 0.29 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.655 1.582 . . . . 0.0 111.545 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.3 mt -139.75 127.15 12.8 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 125.279 1.432 . . . . 0.0 109.44 -174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.71 162.48 37.11 Favored 'Trans proline' 0 C--O 1.241 0.625 0 C-N-CA 123.248 2.632 . . . . 0.0 112.764 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -58.98 137.13 58.05 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.611 0.72 . . . . 0.0 110.563 174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.51 2.7 90.06 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.179 1.371 . . . . 0.0 115.744 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.3 m -61.32 128.71 90.11 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 119.568 1.684 . . . . 0.0 112.648 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -71.64 129.75 16.07 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.175 2.583 . . . . 0.0 111.444 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.0 mm -106.69 137.17 38.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.225 1.81 . . . . 0.0 109.385 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -123.79 150.35 44.57 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.01 1.724 . . . . 0.0 109.243 -170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.7 129.83 92.24 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-O 118.604 -0.713 . . . . 0.0 110.353 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -70.98 -28.82 18.9 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.182 2.588 . . . . 0.0 112.826 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.3 p -135.06 162.19 33.18 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.054 2.142 . . . . 0.0 109.171 -172.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.93 120.84 14.87 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.33 -0.856 . . . . 0.0 108.981 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -140.1 -164.46 9.91 Favored Glycine 0 N--CA 1.472 1.035 0 O-C-N 121.596 -0.69 . . . . 0.0 114.295 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.94 136.91 22.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.326 1.85 . . . . 0.0 110.102 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -68.5 128.22 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 119.09 0.859 . . . . 0.0 112.476 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.274 3.2 p -126.38 -5.8 6.53 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -163.54 154.33 16.16 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.303 1.041 . . . . 0.0 110.612 160.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.2 mt -134.87 127.28 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.493 1.117 . . . . 0.0 110.086 168.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -155.57 177.06 11.81 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -128.53 156.27 43.55 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.439 1.095 . . . . 0.0 110.381 166.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -148.08 178.67 8.35 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.857 0.863 . . . . 0.0 111.82 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -77.09 -37.0 55.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.052 -1.03 . . . . 0.0 113.119 -170.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.47 -29.14 21.62 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.325 1.05 . . . . 0.0 112.562 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.39 -25.21 9.54 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.115 1.34 . . . . 0.0 114.713 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.25 -139.65 25.23 Favored Glycine 0 N--CA 1.47 0.906 0 CA-C-N 119.774 1.787 . . . . 0.0 110.459 -165.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -68.8 136.86 53.41 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.816 0.808 . . . . 0.0 111.768 169.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 t -129.11 121.57 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.838 1.655 . . . . 0.0 112.976 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -90.46 132.88 35.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.922 166.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.5 128.17 55.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.51 0.724 . . . . 0.0 112.932 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 35.9 mt -127.55 136.82 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.39 1.476 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -94.72 136.48 34.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.619 0.768 . . . . 0.0 110.422 164.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.99 157.81 32.49 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.229 0.612 . . . . 0.0 111.41 165.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.353 4.4 p30 -69.54 -4.98 21.31 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.735 2.124 . . . . 0.0 116.735 171.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -62.48 -21.98 65.9 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 4.4 85.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.275 0.941 . . . . 0.0 114.678 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -140.26 -24.32 0.81 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.599 1.56 . . . . 0.0 115.19 -176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -95.91 139.24 32.4 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -131.77 156.05 46.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.345 1.858 . . . . 0.0 110.591 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.16 139.28 41.03 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.025 1.33 . . . . 0.0 111.905 -174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.6 m0 -119.24 142.67 47.83 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.529 1.932 . . . . 0.0 113.0 169.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -126.4 111.66 14.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.994 1.717 . . . . 0.0 108.144 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.4 mt -95.74 169.14 10.22 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.219 0.918 . . . . 0.0 113.311 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 67.3 12.13 8.76 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.534 2.334 . . . . 0.0 115.294 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.2 mt -61.46 154.5 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.978 1.711 . . . . 0.0 112.953 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -99.05 -29.32 12.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.488 1.115 . . . . 0.0 111.078 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -159.2 157.52 30.93 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.523 1.129 . . . . 0.0 112.194 -163.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -125.44 132.3 52.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.519 1.528 . . . . 0.0 111.085 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 21.9 t30 -92.81 -14.21 28.09 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.147 1.379 . . . . 0.0 112.472 171.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.2 164.81 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.321 1.448 . . . . 0.0 112.994 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -132.27 156.52 46.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.411 1.485 . . . . 0.0 112.723 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.356 1.2 p -56.2 132.09 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.23 -14.63 63.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.342 1.449 . . . . 0.0 114.898 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -79.61 139.16 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.376 2.088 . . . . 0.0 109.647 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 139.76 40.59 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.618 1.167 . . . . 0.0 109.371 173.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.69 158.76 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -117.76 154.06 32.38 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.197 1.799 . . . . 0.0 112.27 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.32 112.22 0.85 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.946 0.879 . . . . 0.0 111.187 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.41 7.16 65.5 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.997 2.236 . . . . 0.0 115.324 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -71.3 129.75 39.66 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.271 1.535 . . . . 0.0 112.834 166.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.0 mm -61.73 121.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 121.342 0.592 . . . . 0.0 109.522 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.6 pt -106.54 -32.57 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.101 0.961 . . . . 0.0 112.141 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.63 -177.53 3.56 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.921 -1.112 . . . . 0.0 111.696 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -130.22 137.14 49.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.791 0.837 . . . . 0.0 111.377 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.4 t -64.93 151.75 44.93 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.071 0.948 . . . . 0.0 111.483 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.19 -149.61 5.21 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.81 1.672 . . . . 0.0 109.482 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -138.45 29.75 2.41 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.793 -0.828 . . . . 0.0 113.225 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 44.8 p -65.8 0.31 1.82 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -167.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.62 14.82 2.01 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.517 1.053 . . . . 0.0 114.931 171.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 67.2 mt -98.93 136.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.911 1.355 . . . . 0.0 110.828 -172.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -114.61 -19.53 11.07 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.141 1.376 . . . . 0.0 114.467 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.9 t -149.22 156.69 42.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.504 1.521 . . . . 0.0 113.059 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.439 0.2 OUTLIER 72.47 11.83 5.65 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 71.47 172.85 15.68 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.578 1.085 . . . . 0.0 115.35 169.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.73 135.16 51.72 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.8 0.84 . . . . 0.0 112.644 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -161.34 149.84 15.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.592 1.557 . . . . 0.0 110.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.6 tp -74.01 134.67 43.07 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 164.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -93.5 127.51 39.19 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 155.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.265 56.4 t80 -118.71 125.78 50.42 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 168.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -137.29 118.14 14.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.832 0.853 . . . . 0.0 111.298 -170.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -106.62 139.31 41.28 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.678 1.591 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 31.7 mtm -137.09 144.77 43.28 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.619 1.568 . . . . 0.0 110.378 -169.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -118.6 132.77 56.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.246 1.418 . . . . 0.0 111.403 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.88 -13.85 34.89 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 127.427 2.441 . . . . 0.0 115.28 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.06 -172.02 38.94 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.349 1.928 . . . . 0.0 111.473 175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.4 113.96 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 149.73 168.18 14.82 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.621 2.058 . . . . 0.0 112.607 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -55.79 -37.38 68.52 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.78 1.232 . . . . 0.0 113.267 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.57 -26.96 68.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.412 -0.805 . . . . 0.0 112.83 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -87.09 -6.4 58.7 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.32 151.27 37.08 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -141.95 151.74 42.86 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.117 1.367 . . . . 0.0 111.656 168.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -59.63 108.71 1.49 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.736 2.014 . . . . 0.0 114.972 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.78 -15.32 7.18 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.069 3.179 . . . . 0.0 113.35 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.03 -49.2 94.44 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 120.998 1.726 . . . . 0.0 112.792 -175.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.34 -26.4 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.96 2.44 . . . . 0.0 112.811 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -67.43 -26.56 66.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 170.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 62.6 mt -83.55 -38.96 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 125.541 1.536 . . . . 0.0 111.259 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -57.75 -12.79 3.27 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.36 -8.39 29.69 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.996 1.718 . . . . 0.0 115.159 173.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.0 mt -74.46 153.64 87.81 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.12 1.368 . . . . 0.0 112.891 -173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -65.19 -35.87 39.39 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.708 2.939 . . . . 0.0 113.493 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.318 68.2 m-20 -98.05 4.34 49.24 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 166.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.22 -136.31 45.5 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.049 -1.032 . . . . 0.0 110.773 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.47 -22.23 66.9 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.764 -1.433 . . . . 0.0 112.829 174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -71.02 -7.58 47.3 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.7 m -67.11 -20.9 65.86 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.853 0.751 . . . . 0.0 112.43 165.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.67 -28.82 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.044 0.838 . . . . 0.0 112.436 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -142.89 143.41 32.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -167.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 81.99 2.59 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.855 1.662 . . . . 0.0 114.287 168.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.47 0.546 0 O-C-N 120.972 -1.08 . . . . 0.0 112.852 -174.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.093 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -68.91 156.43 38.52 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.959 1.304 . . . . 0.0 114.184 -174.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.33 13.38 16.6 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.479 1.912 . . . . 0.0 112.914 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.2 t90 -58.43 -48.05 81.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -74.32 123.59 24.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.462 1.105 . . . . 0.0 112.14 -176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -153.89 118.39 4.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.11 1.764 . . . . 0.0 114.42 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -150.36 132.27 15.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.799 1.64 . . . . 0.0 114.915 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.344 31.1 t80 -55.64 125.82 22.77 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 118.985 2.957 . . . . 0.0 118.985 -167.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -23.28 67.06 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.723 2.009 . . . . 0.0 116.182 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.47 48.04 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 119.384 0.993 . . . . 0.0 113.912 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -165.37 168.78 16.46 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.545 0.738 . . . . 0.0 112.461 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.87 15.0 12.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.981 1.312 . . . . 0.0 114.104 166.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 tt -75.33 139.49 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 120.321 -1.487 . . . . 0.0 112.721 -168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.4 p -107.69 -45.07 4.11 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.429 1.892 . . . . 0.0 114.077 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mp0 -137.72 122.34 18.58 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.434 1.094 . . . . 0.0 110.494 173.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.357 0.6 OUTLIER -80.78 172.98 13.06 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 177.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -76.14 156.57 33.64 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.972 0.909 . . . . 0.0 112.564 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.89 -136.36 15.15 Favored Glycine 0 CA--C 1.527 0.811 0 O-C-N 121.338 -0.851 . . . . 0.0 111.167 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -51.99 142.86 14.9 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 118.785 1.293 . . . . 0.0 112.931 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.269 83.0 t80 -87.94 160.51 17.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.313 1.445 . . . . 0.0 114.314 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -44.4 105.13 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.718 2.407 . . . . 0.0 112.993 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 45.6 37.45 3.22 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 127.042 2.137 . . . . 0.0 115.086 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.8 m -141.0 89.21 9.9 Favored Pre-proline 0 N--CA 1.483 1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -168.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -67.93 -12.46 35.38 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 124.308 3.339 . . . . 0.0 117.277 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.06 -13.86 7.2 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -175.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.18 2.5 7.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 116.939 2.2 . . . . 0.0 116.939 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 135.19 5.77 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.531 1.539 . . . . 0.0 112.377 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 162.33 26.34 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.726 -0.867 . . . . 0.0 113.113 -175.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -98.65 112.58 24.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.302 1.841 . . . . 0.0 110.403 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.327 44.6 m-85 -82.41 26.5 0.55 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -168.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.97 -155.34 12.84 Favored Glycine 0 CA--C 1.526 0.732 0 O-C-N 120.977 -1.077 . . . . 0.0 112.32 -168.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' A' ' 175' ' ' PRO . 1.6 mt -137.18 134.09 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.611 1.564 . . . . 0.0 109.743 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -108.22 129.93 55.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.717 1.207 . . . . 0.0 114.023 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -122.15 126.96 49.47 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -171.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.19 49.45 0.19 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.97 2.508 . . . . 0.0 115.21 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.22 138.85 52.34 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 120.613 -1.305 . . . . 0.0 110.574 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.6 157.95 57.26 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.423 2.082 . . . . 0.0 111.797 169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -52.83 140.25 24.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.329 1.452 . . . . 0.0 111.085 176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.37 9.54 73.2 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.131 0.872 . . . . 0.0 115.109 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 90.0 m -62.89 128.8 92.55 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 119.374 1.587 . . . . 0.0 110.566 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -68.83 124.01 11.02 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.627 2.884 . . . . 0.0 111.53 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 21.7 mm -96.29 136.51 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.895 1.678 . . . . 0.0 108.724 173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -122.03 153.98 37.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.626 1.57 . . . . 0.0 110.771 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.88 124.93 90.67 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.079 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -73.27 -34.35 6.16 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.876 3.051 . . . . 0.0 113.335 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.7 p -130.39 162.73 28.47 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 128.531 2.732 . . . . 0.0 111.213 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -66.41 127.67 33.2 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.061 -1.024 . . . . 0.0 109.91 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.32 -168.27 15.18 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.624 0.609 . . . . 0.0 114.624 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -143.47 135.52 26.78 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.19 1.396 . . . . 0.0 110.82 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -67.28 130.32 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.729 0.812 . . . . 0.0 112.461 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 p -133.5 4.09 3.63 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.223 1.009 . . . . 0.0 111.693 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -179.64 146.5 0.27 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.55 1.94 . . . . 0.0 111.016 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.1 mt -140.62 124.82 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -150.01 174.41 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -116.0 157.89 23.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.962 1.305 . . . . 0.0 110.411 172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -143.6 149.75 37.81 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.056 1.742 . . . . 0.0 110.058 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.1 mp0 -70.26 -30.85 68.0 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.1 mp -103.71 -37.16 7.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.474 1.11 . . . . 0.0 111.489 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -74.95 -14.46 81.7 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 115.548 0.979 . . . . 0.0 115.548 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.75 -135.13 35.35 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.361 1.58 . . . . 0.0 111.719 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.75 128.85 36.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.239 1.016 . . . . 0.0 111.669 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 t -115.13 134.09 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.419 1.488 . . . . 0.0 113.528 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.7 tp -103.73 133.32 48.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.634 1.173 . . . . 0.0 110.489 164.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -115.89 129.97 56.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 174.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.6 mt -130.14 131.7 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.785 1.234 . . . . 0.0 109.977 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.01 125.53 37.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.753 1.221 . . . . 0.0 110.131 166.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -67.31 150.71 48.64 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.873 -1.142 . . . . 0.0 112.988 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -62.19 -29.46 70.39 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 -173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -71.63 -12.23 61.24 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.65 -5.6 56.94 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.947 1.539 . . . . 0.0 116.947 162.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -113.29 -22.27 10.52 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.078 1.439 . . . . 0.0 114.199 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.15 146.14 23.89 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 116.998 2.221 . . . . 0.0 116.998 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -135.91 154.7 51.05 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.284 1.833 . . . . 0.0 111.144 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -139.88 134.7 32.02 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.703 1.201 . . . . 0.0 111.296 -174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -111.74 136.9 50.36 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.873 1.669 . . . . 0.0 112.466 167.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -121.28 114.93 22.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.765 1.626 . . . . 0.0 107.07 172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 159' ' ' HIS . 2.4 mp -115.41 164.35 14.4 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.196 0.998 . . . . 0.0 112.555 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 66.77 19.76 10.69 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.34 2.256 . . . . 0.0 115.061 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.64 156.13 24.29 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.51 1.124 . . . . 0.0 112.105 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -96.78 -33.38 11.7 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.303 0.641 . . . . 0.0 109.484 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -156.18 155.11 31.9 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.824 0.85 . . . . 0.0 112.113 -160.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -121.16 120.64 35.83 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.709 1.604 . . . . 0.0 112.467 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -93.39 -10.53 34.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 0.0 112.358 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.48 163.45 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.917 2.087 . . . . 0.0 111.604 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -132.15 161.0 34.42 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.718 1.607 . . . . 0.0 112.198 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 20.2 t -55.44 135.47 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 121.38 0.609 . . . . 0.0 112.16 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.79 57.06 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.094 1.807 . . . . 0.0 114.663 -167.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -67.1 120.52 13.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.364 1.582 . . . . 0.0 114.83 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -72.3 127.81 33.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.726 1.211 . . . . 0.0 110.542 165.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.31 150.18 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.845 1.258 . . . . 0.0 112.452 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -115.77 149.85 37.85 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.979 1.712 . . . . 0.0 110.39 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.22 107.94 0.48 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.64 0.17 30.68 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 125.425 1.488 . . . . 0.0 115.995 -172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -71.3 125.7 27.66 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.747 1.619 . . . . 0.0 111.851 170.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 31.5 mm -63.22 121.05 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 119.27 0.941 . . . . 0.0 109.835 172.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -104.24 -30.42 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.549 1.14 . . . . 0.0 112.683 -177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.34 -179.55 3.53 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.745 -1.222 . . . . 0.0 110.684 -172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -132.46 137.51 47.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.279 0.632 . . . . 0.0 110.348 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 11.3 t -69.32 143.24 53.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.322 0.649 . . . . 0.0 112.191 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -138.47 -144.92 4.72 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.159 1.362 . . . . 0.0 110.896 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -138.94 25.57 2.52 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.6 p -63.41 133.39 53.92 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.494 1.14 . . . . 0.0 111.039 -173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 72.88 -16.41 1.96 Allowed Glycine 0 CA--C 1.541 1.668 0 N-CA-C 117.373 1.709 . . . . 0.0 117.373 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.9 132.82 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 119.869 1.835 . . . . 0.0 111.293 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -76.65 10.83 1.93 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.896 1.678 . . . . 0.0 114.638 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -153.65 163.4 40.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.534 1.934 . . . . 0.0 113.23 -172.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -33.78 76.34 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 117.016 2.228 . . . . 0.0 117.016 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.96 98.55 0.56 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.913 0.768 . . . . 0.0 112.816 -174.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.56 138.19 58.28 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.808 0.843 . . . . 0.0 110.684 176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -159.55 143.18 14.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.25 128.75 36.14 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.414 ' CD2' HD13 ' A' ' 124' ' ' LEU . 12.5 t60 -91.99 119.38 31.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 162.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -106.22 117.64 34.55 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.734 1.214 . . . . 0.0 113.802 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -123.93 103.75 8.51 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.46 1.104 . . . . 0.0 110.999 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -87.88 135.54 33.35 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.498 1.919 . . . . 0.0 110.699 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.8 mtm -135.84 148.59 48.73 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.342 1.457 . . . . 0.0 110.926 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -124.97 133.2 53.1 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 111.237 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.09 -24.68 7.69 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.791 2.138 . . . . 0.0 115.094 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -167.25 -166.84 27.01 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.5 1.524 . . . . 0.0 112.333 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -124.71 130.35 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 127.96 169.68 12.69 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.181 1.848 . . . . 0.0 112.421 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -55.0 -41.66 71.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.49 54.86 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -94.53 -4.72 47.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.978 1.311 . . . . 0.0 114.272 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.08 133.9 48.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.15 0.886 . . . . 0.0 112.92 -171.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -137.3 147.38 45.61 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 123.193 1.473 . . . . 0.0 113.275 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -60.0 109.51 2.05 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.867 1.667 . . . . 0.0 114.31 -153.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 79' ' ' ILE . 66.3 Cg_endo -82.79 -17.41 7.14 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.961 3.107 . . . . 0.0 114.033 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -58.82 -52.95 71.13 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-N 120.399 1.454 . . . . 0.0 112.067 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.46 -10.43 20.48 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.169 2.58 . . . . 0.0 113.304 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.255 1.8 t80 -77.13 -31.9 56.03 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 168.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.46 -31.85 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 121.156 -0.965 . . . . 0.0 111.118 173.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -49.41 -29.89 7.08 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 116.629 2.085 . . . . 0.0 116.629 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -100.04 -6.73 25.96 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.705 1.202 . . . . 0.0 113.67 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.7 mt -70.93 147.8 94.22 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.686 0.794 . . . . 0.0 111.551 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.44 -19.86 48.69 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 124.206 3.27 . . . . 0.0 113.588 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -118.56 9.89 12.4 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 63.08 -134.73 43.12 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 121.439 -0.788 . . . . 0.0 111.331 -174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -61.75 -24.48 66.84 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.613 -0.934 . . . . 0.0 111.99 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -79.2 -0.58 32.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.557 1.143 . . . . 0.0 112.884 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.9 m -77.02 -24.69 52.1 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.995 0.918 . . . . 0.0 112.917 161.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.42 -27.47 29.53 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.391 0.996 . . . . 0.0 111.658 174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -152.58 146.8 25.5 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 -171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -81.64 55.21 2.6 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 122.239 1.019 . . . . 0.0 110.885 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 C-N-CA 127.112 2.165 . . . . 0.0 111.286 -171.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.09 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t 52.03 35.53 16.42 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 125.388 1.475 . . . . 0.0 114.667 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -75.69 158.54 32.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.577 1.551 . . . . 0.0 113.597 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -143.62 147.02 33.74 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.507 1.523 . . . . 0.0 111.869 175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 56.14 24.26 7.8 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.832 2.053 . . . . 0.0 114.589 -171.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.33 1.35 48.85 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 120.612 -1.305 . . . . 0.0 112.103 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -54.18 -27.43 33.98 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 120.908 3.67 . . . . 0.0 120.908 -161.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.353 59.5 t80 -64.2 138.8 58.62 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -176.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -61.4 -49.53 76.5 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.517 1.673 . . . . 0.0 115.517 -166.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 156.7 150.29 5.63 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.747 1.165 . . . . 0.0 113.171 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.9 p -72.39 -12.96 61.34 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -171.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 57.21 33.86 23.95 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.204 1.802 . . . . 0.0 114.641 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 tt -85.35 148.59 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 O-C-N 120.772 -1.205 . . . . 0.0 112.042 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.252 2.0 p -111.87 -59.6 1.97 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.677 1.591 . . . . 0.0 113.151 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -117.04 115.25 25.04 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 108.98 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.394 0.3 OUTLIER -77.71 172.68 13.04 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.651 0.78 . . . . 0.0 112.705 162.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.62 141.52 42.82 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.988 -1.07 . . . . 0.0 110.587 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.93 -136.04 10.74 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.874 1.225 . . . . 0.0 113.041 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -71.29 135.52 47.45 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.363 -1.08 . . . . 0.0 111.821 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -52.66 137.22 31.46 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.95 -32.34 6.1 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 116.045 1.868 . . . . 0.0 116.045 -163.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -76.37 -40.09 52.02 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 121.152 1.796 . . . . 0.0 112.906 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -76.3 140.84 69.5 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.001 1.32 . . . . 0.0 112.592 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.16 -12.38 19.31 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.293 2.662 . . . . 0.0 113.968 169.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.378 59.0 m-85 -69.04 -0.34 5.6 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 119.7 3.222 . . . . 0.0 119.7 -169.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.354 84.1 m-20 64.34 32.64 11.99 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 174.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.43 174.2 54.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.625 2.06 . . . . 0.0 115.18 -174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -109.5 124.72 51.56 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.956 1.302 . . . . 0.0 113.703 -174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -107.87 126.58 52.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.932 1.693 . . . . 0.0 111.655 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.268 75.9 m-85 -98.82 22.91 9.46 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.325 2.342 . . . . 0.0 117.325 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.8 -150.66 7.3 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.061 -1.025 . . . . 0.0 113.377 -169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.61 142.02 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 110.09 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -115.46 127.73 55.53 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -115.74 127.61 55.25 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.6 1.16 . . . . 0.0 112.818 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.06 72.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.169 1.788 . . . . 0.0 112.236 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 65.1 mt -107.22 122.94 39.79 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.094 1.758 . . . . 0.0 109.545 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -63.13 164.95 18.12 Favored 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.383 2.722 . . . . 0.0 113.163 -176.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.31 135.35 50.03 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.74 0.816 . . . . 0.0 110.032 174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.68 2.47 89.93 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-O 118.176 -1.347 . . . . 0.0 115.956 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.1 m -60.09 128.33 87.13 Favored Pre-proline 0 N--CA 1.479 1.0 0 CA-C-N 120.533 2.167 . . . . 0.0 112.745 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.86 130.94 16.29 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.687 2.925 . . . . 0.0 111.29 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.3 mm -107.56 137.62 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.2 1.8 . . . . 0.0 109.391 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -122.62 150.84 42.11 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.116 1.366 . . . . 0.0 111.117 -169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.38 123.32 87.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.844 172.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 -27.5 16.13 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.367 2.711 . . . . 0.0 113.471 176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.8 p -140.15 165.03 28.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.255 2.222 . . . . 0.0 110.429 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -67.19 125.12 25.05 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 121.33 -0.856 . . . . 0.0 110.876 174.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -148.74 -173.89 19.9 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 121.955 0.753 . . . . 0.0 114.787 174.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -138.45 134.93 34.66 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.601 1.56 . . . . 0.0 110.309 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.0 123.33 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.9 p -111.5 -15.94 13.41 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -162.35 154.75 19.29 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.816 0.846 . . . . 0.0 111.249 169.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mt -133.2 130.68 57.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.667 1.187 . . . . 0.0 109.658 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -155.19 -175.47 5.45 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -175.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -129.55 159.28 36.84 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.942 1.297 . . . . 0.0 110.966 170.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -136.3 156.8 48.14 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.077 2.551 . . . . 0.0 111.798 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -69.13 -48.53 62.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.484 1.514 . . . . 0.0 113.535 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.62 -27.47 15.3 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.817 1.647 . . . . 0.0 111.346 170.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.42 -20.66 74.37 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 115.098 0.799 . . . . 0.0 115.098 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.6 -147.21 49.53 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.018 1.409 . . . . 0.0 111.808 -172.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -67.69 129.96 41.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.725 -0.868 . . . . 0.0 111.622 172.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.0 t -115.95 135.07 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.437 1.495 . . . . 0.0 112.046 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 tp -104.85 131.66 52.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.98 0.912 . . . . 0.0 110.045 165.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -117.49 123.39 46.22 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.8 mt -124.94 133.98 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.601 1.561 . . . . 0.0 109.457 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.15 129.63 43.4 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.459 0.704 . . . . 0.0 109.803 163.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.94 153.7 20.56 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.426 1.091 . . . . 0.0 112.483 172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -56.49 -38.33 71.6 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.354 1.612 . . . . 0.0 115.354 -160.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -80.29 -3.71 50.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.92 15.94 60.4 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 161.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -119.68 -27.21 5.53 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 64.2 m-85 -86.57 139.1 31.16 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 168.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -126.3 152.25 46.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.961 1.305 . . . . 0.0 111.04 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -137.77 134.93 35.84 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.631 1.173 . . . . 0.0 111.484 -175.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.3 m0 -113.85 140.49 48.29 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.053 1.741 . . . . 0.0 112.611 170.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -123.41 121.06 34.79 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mt -108.09 166.03 11.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.12 0.968 . . . . 0.0 112.538 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 66.42 22.59 10.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.463 1.905 . . . . 0.0 115.049 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.5 152.85 40.69 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.611 1.164 . . . . 0.0 111.889 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 t0 -86.25 -44.84 11.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.754 1.222 . . . . 0.0 110.23 161.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -154.5 159.15 40.82 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -152.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -128.39 115.61 18.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.64 1.576 . . . . 0.0 112.045 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -79.51 -10.05 59.73 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 112.013 171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.63 165.03 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 126.432 1.893 . . . . 0.0 111.874 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -132.51 160.24 37.09 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.586 1.555 . . . . 0.0 111.938 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.95 135.24 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.494 0.717 . . . . 0.0 112.571 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.69 -11.47 64.08 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.432 1.491 . . . . 0.0 115.156 -167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -73.64 124.35 25.78 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.234 2.017 . . . . 0.0 115.357 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.86 131.72 40.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.513 1.125 . . . . 0.0 111.401 168.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.85 153.53 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.454 1.502 . . . . 0.0 114.032 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -118.76 146.25 44.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.222 1.409 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.37 107.24 0.17 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.997 1.319 . . . . 0.0 112.32 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.23 3.69 31.17 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 126.727 2.108 . . . . 0.0 115.8 -175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.54 130.32 38.66 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 126.228 1.811 . . . . 0.0 113.072 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.0 mm -59.0 121.55 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 119.702 1.137 . . . . 0.0 110.023 167.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 25.0 pt -105.82 -33.04 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.923 1.289 . . . . 0.0 112.171 178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.56 -175.74 2.93 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.898 -1.126 . . . . 0.0 111.65 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -135.19 142.52 46.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.516 0.727 . . . . 0.0 112.572 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.1 t -67.74 148.59 51.08 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.572 1.149 . . . . 0.0 112.012 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.52 -149.63 5.04 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.687 1.613 . . . . 0.0 110.198 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -132.18 27.03 4.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.261 -1.141 . . . . 0.0 113.184 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.9 p -65.99 134.8 53.69 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.664 1.186 . . . . 0.0 112.899 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.86 -31.77 0.5 Allowed Glycine 0 CA--C 1.541 1.71 0 C-N-CA 125.366 1.46 . . . . 0.0 116.386 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.98 126.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.439 1.619 . . . . 0.0 111.155 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -75.58 -46.8 29.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.819 0.448 . . . . 0.0 111.713 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.264 0.6 OUTLIER -66.09 169.76 6.54 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 -178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.4 t -70.84 -25.28 62.76 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 174.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -82.02 101.26 2.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.87 1.224 . . . . 0.0 113.552 -176.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.16 133.97 55.94 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.527 0.731 . . . . 0.0 110.553 170.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -154.8 144.16 21.24 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.69 -0.631 . . . . 0.0 112.378 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.3 tp -74.32 128.73 36.28 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 167.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -87.85 132.88 34.03 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 157.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.299 57.6 t80 -124.58 127.86 48.02 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -138.99 114.06 9.43 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.26 1.024 . . . . 0.0 110.942 -169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.9 ttp85 -100.33 140.19 34.93 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.683 1.593 . . . . 0.0 110.558 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.0 mtm -138.35 155.4 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.234 1.813 . . . . 0.0 110.339 -173.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -135.69 130.19 33.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.544 1.137 . . . . 0.0 112.223 -173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.31 -18.31 10.85 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.151 1.834 . . . . 0.0 113.92 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.77 -167.76 31.58 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 127.611 2.529 . . . . 0.0 109.866 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.87 134.1 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 122.039 0.923 . . . . 0.0 108.598 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.83 162.65 10.1 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 126.875 2.178 . . . . 0.0 111.402 -164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -57.03 -36.44 70.46 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.345 -1.091 . . . . 0.0 113.265 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -66.48 -19.8 65.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.428 1.091 . . . . 0.0 113.614 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.36 -12.96 25.17 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.535 1.134 . . . . 0.0 113.692 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.63 143.53 57.22 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -130.03 160.41 33.76 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.857 2.063 . . . . 0.0 110.066 172.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -64.8 119.48 58.16 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.797 1.639 . . . . 0.0 109.477 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -84.06 -19.66 4.67 Favored 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 123.872 3.048 . . . . 0.0 112.312 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -55.91 -52.37 72.94 Favored Pre-proline 0 N--CA 1.481 1.113 0 CA-C-N 121.176 1.807 . . . . 0.0 112.896 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.32 -26.79 12.02 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.701 2.267 . . . . 0.0 112.027 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -65.49 -23.63 66.95 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 170.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 43.8 mt -88.16 -40.93 13.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 125.09 1.356 . . . . 0.0 111.706 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -63.22 -14.36 48.32 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.71 -6.66 48.69 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.921 2.489 . . . . 0.0 115.098 171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.23 154.31 86.25 Favored Pre-proline 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 0.0 112.477 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.94 -24.75 45.49 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.692 2.928 . . . . 0.0 114.475 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -112.53 7.13 18.83 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.088 1.755 . . . . 0.0 114.661 165.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 60.04 -142.09 47.6 Favored Glycine 0 CA--C 1.528 0.859 0 O-C-N 121.022 -1.049 . . . . 0.0 112.268 -172.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.93 -29.62 29.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.96 1.304 . . . . 0.0 114.017 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.3 mtm-85 -70.22 -14.79 62.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.718 0.807 . . . . 0.0 111.584 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 8.0 t -71.16 -7.88 49.7 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.567 -1.333 . . . . 0.0 112.827 171.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.25 -21.67 18.89 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.043 -0.979 . . . . 0.0 111.991 173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -148.67 149.43 31.45 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 117.636 2.458 . . . . 0.0 117.636 -169.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.86 83.61 2.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.082 1.753 . . . . 0.0 113.942 168.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 C--O 1.24 0.555 0 C-N-CA 124.291 1.036 . . . . 0.0 112.734 -170.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.122 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.7 p -158.37 167.04 30.78 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.431 -1.041 . . . . 0.0 113.738 -174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 62.75 17.94 10.25 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.523 1.929 . . . . 0.0 115.974 165.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -60.5 141.58 56.32 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.626 1.17 . . . . 0.0 111.001 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -157.67 158.09 34.78 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -143.59 138.52 29.13 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 117.755 2.502 . . . . 0.0 117.755 172.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -73.51 -34.68 65.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.265 14.0 t80 -123.92 122.56 38.27 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.721 2.008 . . . . 0.0 115.985 177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -96.93 26.96 4.26 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -161.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.18 -164.28 47.47 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.405 1.002 . . . . 0.0 114.852 173.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.0 p -160.71 160.67 31.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.661 1.584 . . . . 0.0 110.707 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.92 32.56 1.39 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.987 1.315 . . . . 0.0 113.224 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.3 tt -88.63 143.69 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 120.302 -1.498 . . . . 0.0 112.011 -176.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.9 p -111.64 -46.11 3.29 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.702 1.601 . . . . 0.0 113.31 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -136.14 119.66 17.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.357 1.463 . . . . 0.0 110.403 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.361 0.1 OUTLIER -78.93 171.09 15.68 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.171 1.389 . . . . 0.0 113.527 174.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -75.81 146.09 40.19 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.973 -1.079 . . . . 0.0 110.58 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.72 -134.62 10.36 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.325 0.964 . . . . 0.0 112.279 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -66.41 135.88 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.982 1.391 . . . . 0.0 110.527 170.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.11 111.57 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.12 142.64 58.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -167.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 55.58 15.81 1.65 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.321 2.249 . . . . 0.0 114.937 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -136.52 70.79 59.8 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.312 1.445 . . . . 0.0 111.092 -163.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.38 -13.26 32.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.078 3.185 . . . . 0.0 114.383 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.285 59.7 m-85 -99.17 -29.92 12.58 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 174.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -66.6 -20.11 65.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 170.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.82 -120.47 5.22 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.107 1.337 . . . . 0.0 114.758 162.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -93.54 135.69 34.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.312 1.845 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -99.74 112.95 25.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.318 1.447 . . . . 0.0 109.48 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -86.56 20.48 2.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.71 2.004 . . . . 0.0 114.745 -172.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.57 -156.84 12.39 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.942 1.258 . . . . 0.0 112.616 -170.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.6 mt -134.38 139.9 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 110.093 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -111.71 131.55 55.22 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -122.88 122.0 37.56 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -172.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.64 57.29 0.18 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 128.013 2.525 . . . . 0.0 113.544 174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.16 147.93 70.27 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 124.556 1.142 . . . . 0.0 109.612 166.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.49 153.23 74.24 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.418 1.412 . . . . 0.0 111.347 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -59.07 139.54 56.75 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.883 0.873 . . . . 0.0 110.406 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.83 9.14 85.85 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 115.375 -0.829 . . . . 0.0 114.87 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 32.5 m -67.34 130.72 93.42 Favored Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 119.447 1.624 . . . . 0.0 112.45 169.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 6.1 Cg_exo -72.28 131.25 17.49 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.528 2.819 . . . . 0.0 111.422 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.1 mm -107.13 136.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.082 1.753 . . . . 0.0 109.275 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -120.75 150.54 40.82 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 110.535 -171.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.37 120.59 69.09 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.502 168.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.24 -35.64 13.76 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.907 2.405 . . . . 0.0 112.136 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 164.29 24.64 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.561 2.745 . . . . 0.0 109.565 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -68.31 125.45 26.45 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 120.931 -1.105 . . . . 0.0 110.868 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -150.04 -158.72 8.32 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.253 0.918 . . . . 0.0 114.088 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -152.73 137.48 17.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.135 1.374 . . . . 0.0 111.136 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.67 128.58 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.407 1.003 . . . . 0.0 112.388 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.9 p -127.87 -14.11 5.1 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 118.459 -0.782 . . . . 0.0 112.645 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -159.04 156.55 29.49 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 119.407 1.003 . . . . 0.0 111.808 162.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.8 mt -135.47 133.07 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.033 1.733 . . . . 0.0 109.125 169.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -153.52 163.46 39.92 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 -176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -144.78 92.03 2.23 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.551 1.541 . . . . 0.0 109.583 176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -162.91 -45.26 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.652 1.181 . . . . 0.0 111.512 -166.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 106' ' ' GLY . 18.1 tp10 -53.19 151.12 5.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.191 1.797 . . . . 0.0 112.179 171.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.91 -23.56 63.59 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.673 1.189 . . . . 0.0 112.578 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' H ' ' HG3' ' A' ' 104' ' ' GLU . . . -78.62 3.95 61.98 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 126.105 1.812 . . . . 0.0 116.39 171.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.44 -132.78 11.38 Favored Glycine 0 N--CA 1.469 0.864 0 CA-C-N 119.89 1.845 . . . . 0.0 113.162 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -72.02 123.17 22.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.199 1.4 . . . . 0.0 111.505 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -112.49 138.75 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 127.241 2.216 . . . . 0.0 112.992 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.98 130.3 55.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.619 1.168 . . . . 0.0 110.441 165.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -114.46 125.86 54.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.684 0.794 . . . . 0.0 112.926 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.29 135.49 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.461 1.504 . . . . 0.0 110.144 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.74 125.97 42.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.059 1.343 . . . . 0.0 111.189 167.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -67.92 140.41 56.47 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.127 0.971 . . . . 0.0 113.335 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -63.57 -19.48 64.85 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 117.895 2.554 . . . . 0.0 117.895 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.59 -11.28 60.84 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.39 15.91 45.42 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 117.298 1.679 . . . . 0.0 117.298 160.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.04 -24.79 0.68 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.257 55.6 m-85 -87.92 147.71 24.94 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -127.49 158.18 38.08 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.782 2.033 . . . . 0.0 110.209 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -137.83 136.22 36.98 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.75 1.22 . . . . 0.0 110.949 -177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -116.42 139.95 49.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.235 1.814 . . . . 0.0 112.105 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -124.83 129.68 50.9 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.641 1.576 . . . . 0.0 107.149 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.409 HD13 ' CD2' ' A' ' 159' ' ' HIS . 4.0 mp -127.65 167.36 16.52 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.873 0.869 . . . . 0.0 113.032 -177.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 64.57 18.85 11.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.958 2.103 . . . . 0.0 114.206 -171.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.15 141.55 55.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.702 1.201 . . . . 0.0 111.647 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -93.71 -35.48 12.79 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.287 177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -153.95 155.26 35.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.146 1.778 . . . . 0.0 110.806 -161.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -132.19 113.71 13.61 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.899 1.68 . . . . 0.0 113.039 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -81.7 -18.91 42.74 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.709 -0.619 . . . . 0.0 112.483 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.54 165.72 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.792 1.637 . . . . 0.0 113.031 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -134.09 157.67 45.56 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.543 1.537 . . . . 0.0 113.01 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 p -53.78 136.69 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.021 0.929 . . . . 0.0 112.008 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.48 59.28 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.442 1.972 . . . . 0.0 114.881 -171.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -86.57 143.41 27.69 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.12 1.96 . . . . 0.0 109.928 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 -96.37 135.07 38.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.881 1.673 . . . . 0.0 110.993 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 m -129.99 150.24 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -114.34 148.05 38.18 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.253 1.421 . . . . 0.0 110.746 -175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.82 105.58 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.137 1.375 . . . . 0.0 112.141 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.46 5.11 28.31 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 126.219 1.866 . . . . 0.0 116.074 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -81.3 130.36 35.0 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.724 2.01 . . . . 0.0 113.885 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.78 123.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 119.539 1.063 . . . . 0.0 110.425 172.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.1 -33.79 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.59 1.156 . . . . 0.0 111.87 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.96 -176.15 2.93 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.071 -1.018 . . . . 0.0 111.422 -171.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -132.93 138.47 46.95 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.797 0.839 . . . . 0.0 111.955 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.4 t -72.6 142.58 48.38 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.55 1.14 . . . . 0.0 112.55 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.0 -147.52 4.57 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.122 1.344 . . . . 0.0 112.767 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -124.9 5.49 8.03 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.257 7.3 p -64.18 3.58 0.42 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 119.781 3.252 . . . . 0.0 119.781 -158.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.5 25.08 1.84 Allowed Glycine 0 N--CA 1.473 1.118 0 CA-C-N 119.905 1.23 . . . . 0.0 114.49 171.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mt -112.91 122.35 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.159 1.384 . . . . 0.0 108.961 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 -39.69 27.83 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.81 156.04 34.44 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 174.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 122.37 16.43 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 134.61 -148.45 19.52 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.459 1.028 . . . . 0.0 114.446 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.33 160.02 31.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 112.1 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -165.07 156.14 14.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.045 1.738 . . . . 0.0 110.856 162.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 44.8 tp -80.32 133.82 35.99 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.56 -0.712 . . . . 0.0 109.1 162.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.409 ' CD2' HD13 ' A' ' 124' ' ' LEU . 17.5 t60 -94.72 128.3 41.31 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 158.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 42.5 t80 -119.35 121.91 40.64 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.688 1.195 . . . . 0.0 114.188 170.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -131.29 103.04 6.23 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.733 1.213 . . . . 0.0 110.93 -169.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 13.6 ttp85 -89.8 139.59 30.43 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.819 1.648 . . . . 0.0 109.999 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 35.9 mtm -138.61 142.87 39.13 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.275 1.43 . . . . 0.0 111.447 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -113.26 130.52 56.22 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.081 1.352 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.48 -7.46 57.53 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 115.923 1.129 . . . . 0.0 115.923 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.44 -169.29 40.87 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.661 1.231 . . . . 0.0 112.382 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -122.3 131.32 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.31 164.95 11.46 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 126.195 1.855 . . . . 0.0 111.655 -176.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -52.1 -36.11 49.96 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -58.13 -27.06 63.41 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -90.37 -1.41 57.91 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 139.47 56.59 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -164.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -133.86 150.4 51.37 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.903 1.281 . . . . 0.0 113.003 171.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -63.57 114.67 13.98 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.497 1.519 . . . . 0.0 110.229 -160.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -80.54 -16.22 10.66 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.553 2.835 . . . . 0.0 112.57 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -54.86 52.19 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 120.554 1.524 . . . . 0.0 112.948 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.3 -23.4 51.86 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.445 2.097 . . . . 0.0 112.538 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -74.7 -29.77 61.31 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 175.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.88 -40.32 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.382 1.473 . . . . 0.0 110.924 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -54.58 -27.59 40.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.619 1.168 . . . . 0.0 113.814 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -86.24 -14.72 42.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.629 1.572 . . . . 0.0 114.936 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 88.9 mt -66.8 151.25 96.98 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 119.511 1.05 . . . . 0.0 111.879 -173.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -63.18 -34.8 67.3 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.365 2.71 . . . . 0.0 112.396 -173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.274 67.9 m-20 -102.24 7.57 40.72 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 169.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -135.0 45.52 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.927 -1.108 . . . . 0.0 110.85 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.54 -21.21 62.27 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.145 -1.209 . . . . 0.0 113.472 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -76.8 -6.22 51.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.0 m -74.65 -20.75 59.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.987 0.915 . . . . 0.0 113.069 162.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.24 -33.58 18.04 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.537 1.062 . . . . 0.0 111.678 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -143.19 140.12 30.61 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 117.081 2.252 . . . . 0.0 117.081 -172.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -81.69 50.53 1.52 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.686 0.755 . . . . 0.0 112.779 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.524 0 C-N-CA 125.2 1.4 . . . . 0.0 113.561 -166.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.0 m -145.03 123.98 12.74 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 118.108 0.954 . . . . 0.0 112.956 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -72.04 -35.19 69.29 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -65.59 -13.96 60.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.51 -10.53 59.46 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 170.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -99.02 157.57 16.24 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.135 0.974 . . . . 0.0 112.167 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.45 14.64 4.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 118.067 2.617 . . . . 0.0 118.067 -160.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.276 26.0 t80 -76.62 142.34 40.71 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -68.32 -17.12 64.19 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.72 58.58 4.2 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.107 1.321 . . . . 0.0 115.104 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 63.57 155.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.743 2.017 . . . . 0.0 115.052 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.88 16.61 2.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.325 2.25 . . . . 0.0 113.267 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.1 tt -60.65 143.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 123.222 0.609 . . . . 0.0 111.343 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.4 p -107.3 -44.28 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.066 1.746 . . . . 0.0 114.093 178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.77 129.66 34.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.9 1.68 . . . . 0.0 110.114 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.386 0.3 OUTLIER -98.25 167.71 10.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.901 1.68 . . . . 0.0 112.75 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -72.12 145.11 48.37 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 119.993 -1.692 . . . . 0.0 113.236 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.04 -18.68 56.27 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.995 1.284 . . . . 0.0 116.066 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.32 149.4 28.62 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.499 1.65 . . . . 0.0 113.445 173.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -117.4 176.79 5.0 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.638 1.575 . . . . 0.0 107.028 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -153.35 161.2 42.59 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.786 1.234 . . . . 0.0 112.375 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 52.38 66.18 1.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.713 2.005 . . . . 0.0 113.194 173.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.0 t -151.51 145.43 17.88 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 124.73 1.212 . . . . 0.0 111.614 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.32 -25.72 30.33 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.701 2.267 . . . . 0.0 112.934 171.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -126.53 -41.71 1.85 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 118.696 2.85 . . . . 0.0 118.696 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.27 23.8 m-20 -68.28 143.56 55.19 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.92 -54.4 0.01 OUTLIER Glycine 0 N--CA 1.471 0.992 0 C-N-CA 124.859 1.219 . . . . 0.0 113.283 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -73.54 160.18 32.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.25 1.02 . . . . 0.0 111.012 165.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -152.11 127.51 9.97 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.302 75.6 m-85 -112.21 22.58 14.61 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 117.272 2.323 . . . . 0.0 117.272 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -170.5 -153.78 9.02 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.194 1.378 . . . . 0.0 111.416 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.1 mt -142.5 145.37 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.693 1.597 . . . . 0.0 110.332 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -121.3 136.84 54.91 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -124.1 132.92 53.7 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.53 72.07 5.03 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.668 1.187 . . . . 0.0 113.618 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.2 mt -94.26 145.76 30.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.608 1.563 . . . . 0.0 111.642 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -71.82 157.75 54.48 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.972 2.448 . . . . 0.0 111.796 164.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -56.44 147.82 20.75 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.553 1.141 . . . . 0.0 111.012 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.9 2.86 53.75 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 117.905 -1.497 . . . . 0.0 115.857 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 47.7 m -58.71 127.68 82.81 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 120.397 2.099 . . . . 0.0 111.301 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -67.6 126.04 14.2 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.449 2.766 . . . . 0.0 111.189 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.44 HD12 HD22 ' A' ' 158' ' ' LEU . 21.6 mm -97.96 136.41 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 125.341 1.456 . . . . 0.0 108.91 175.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -119.64 152.78 36.54 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.609 1.564 . . . . 0.0 111.094 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.81 121.88 76.02 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.695 169.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.74 -33.68 16.19 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.865 3.043 . . . . 0.0 112.215 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 36.3 p -131.76 167.18 19.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.235 2.614 . . . . 0.0 108.573 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -72.56 124.12 24.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -153.69 -173.18 22.55 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 123.661 0.648 . . . . 0.0 114.639 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -140.12 135.69 32.78 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.13 -1.217 . . . . 0.0 111.446 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.8 t -67.81 122.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 118.655 0.662 . . . . 0.0 112.384 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.0 p -117.68 -12.72 10.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.251 1.021 . . . . 0.0 111.306 -173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ttt85 -162.26 153.58 18.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.353 1.061 . . . . 0.0 111.947 171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.9 mt -138.86 132.17 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.649 1.18 . . . . 0.0 108.659 168.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -154.62 -175.82 5.6 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -135.21 156.89 48.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.012 0.925 . . . . 0.0 110.673 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -149.48 173.12 13.94 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.07 1.348 . . . . 0.0 111.967 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.8 -21.72 54.7 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.051 -1.03 . . . . 0.0 113.137 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -63.34 -47.17 83.27 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.386 1.874 . . . . 0.0 111.998 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -148.82 20.49 1.28 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.87 -132.4 13.77 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.263 1.531 . . . . 0.0 112.253 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -70.63 125.91 28.14 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.487 1.115 . . . . 0.0 112.218 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.9 t -111.12 136.15 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.604 1.562 . . . . 0.0 112.645 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 44.5 tp -110.41 130.21 55.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.546 1.138 . . . . 0.0 110.0 165.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -117.51 124.27 48.34 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.497 0.719 . . . . 0.0 112.628 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.8 mt -126.61 132.9 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.358 1.463 . . . . 0.0 109.934 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.31 124.12 37.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.303 1.041 . . . . 0.0 111.158 167.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -68.1 145.86 54.01 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.067 -1.021 . . . . 0.0 112.228 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -57.42 -21.02 33.9 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 116.952 2.205 . . . . 0.0 116.952 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -16.59 5.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.175 1.39 . . . . 0.0 114.365 172.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.38 27.91 62.76 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.218 0.913 . . . . 0.0 114.657 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -157.73 -28.18 0.08 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.169 1.788 . . . . 0.0 114.473 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.279 41.4 m-85 -89.67 143.99 26.36 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -132.06 148.93 52.52 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.264 1.826 . . . . 0.0 110.183 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 112.322 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -118.43 137.59 53.04 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 126.35 1.86 . . . . 0.0 112.694 166.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -119.4 130.81 55.49 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.25 168.19 14.44 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.866 0.866 . . . . 0.0 112.068 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 66.34 18.45 10.89 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.446 1.898 . . . . 0.0 115.078 -177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.55 149.56 42.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.222 1.009 . . . . 0.0 112.067 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -93.01 -30.2 15.44 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.374 1.07 . . . . 0.0 109.382 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -162.12 155.55 20.82 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.398 1.479 . . . . 0.0 111.581 -160.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.66 141.66 46.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.486 1.514 . . . . 0.0 112.477 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -110.35 -10.02 14.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.35 1.06 . . . . 0.0 112.761 170.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.26 166.09 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 125.973 1.709 . . . . 0.0 111.624 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -130.44 156.37 44.87 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.829 1.651 . . . . 0.0 112.802 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.8 p -53.82 128.2 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-O 121.499 0.666 . . . . 0.0 111.677 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.14 -11.18 67.61 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 126.366 1.936 . . . . 0.0 115.219 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.05 122.37 24.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.315 2.057 . . . . 0.0 115.422 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.78 131.28 35.2 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 170.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.67 154.33 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.074 1.749 . . . . 0.0 112.516 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 150.36 37.56 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.996 1.319 . . . . 0.0 110.239 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 107.92 0.21 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.603 1.161 . . . . 0.0 112.584 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 110.0 1.47 30.15 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.839 1.685 . . . . 0.0 115.532 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -76.39 128.6 35.15 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.558 1.679 . . . . 0.0 112.919 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.1 mm -59.83 124.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.103 0.865 . . . . 0.0 109.899 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 29.5 pt -109.97 -28.13 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.028 1.331 . . . . 0.0 112.682 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.71 -178.29 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.699 1.2 . . . . 0.0 110.807 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -130.21 138.18 50.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.2 0.6 . . . . 0.0 110.239 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t -70.71 143.38 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.985 0.514 . . . . 0.0 111.906 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -135.89 -145.96 5.17 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.025 1.298 . . . . 0.0 110.598 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -132.93 27.53 4.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 168.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.2 p -59.66 127.32 31.4 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.144 0.973 . . . . 0.0 112.613 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 66.32 2.93 16.49 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 118.088 -1.396 . . . . 0.0 116.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.9 mt -71.31 133.99 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 120.578 2.189 . . . . 0.0 109.857 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -84.63 -53.74 5.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.999 1.319 . . . . 0.0 112.562 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.272 0.8 OUTLIER -77.01 176.32 8.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.59 147.7 40.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.82 -148.34 28.74 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.188 0.899 . . . . 0.0 114.856 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.05 151.42 39.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.115 1.766 . . . . 0.0 111.297 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -159.95 142.65 13.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 0.0 112.428 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.44 HD22 HD12 ' A' ' 89' ' ' ILE . 28.3 tp -78.02 127.81 32.9 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.269 -0.872 . . . . 0.0 108.807 167.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.7 t60 -89.46 135.04 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.648 0.658 . . . . 0.0 109.743 160.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.304 53.8 t80 -128.21 133.48 48.87 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -147.06 130.35 16.58 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.207 1.003 . . . . 0.0 110.979 -168.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -125.72 140.13 52.96 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.798 1.639 . . . . 0.0 110.725 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.1 mtm -140.6 136.35 32.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.61 1.564 . . . . 0.0 110.748 -165.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -104.09 132.68 50.1 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.459 1.027 . . . . 0.0 111.579 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.1 -12.09 45.61 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.374 1.94 . . . . 0.0 115.503 172.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 177.81 -166.77 37.23 Favored Glycine 0 CA--C 1.52 0.404 0 O-C-N 121.236 -1.155 . . . . 0.0 112.301 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -127.41 101.69 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.31 170.34 25.83 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.469 1.985 . . . . 0.0 113.075 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -59.32 -35.21 73.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.2 66.09 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.169 -0.957 . . . . 0.0 113.35 174.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -86.96 -17.46 33.05 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.118 0.967 . . . . 0.0 112.964 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.79 142.55 53.16 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.277 1.431 . . . . 0.0 114.001 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -140.15 156.1 46.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.715 1.606 . . . . 0.0 110.925 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -60.56 115.58 14.27 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 125.043 1.337 . . . . 0.0 113.434 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -86.81 -13.79 4.6 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 124.505 3.47 . . . . 0.0 113.402 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.79 -52.78 71.15 Favored Pre-proline 0 N--CA 1.482 1.132 0 CA-C-N 120.424 1.465 . . . . 0.0 113.125 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.4 -25.75 48.55 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.271 1.981 . . . . 0.0 112.251 175.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -70.39 -24.83 63.01 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 70.3 mt -85.79 -39.51 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.428 1.491 . . . . 0.0 111.553 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.95 -16.2 11.44 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -91.69 -13.59 31.46 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.563 1.945 . . . . 0.0 114.809 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 80.5 mt -72.94 151.72 90.79 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.936 1.294 . . . . 0.0 111.996 -172.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.63 -37.07 49.26 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.383 2.722 . . . . 0.0 112.991 -173.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -98.97 4.72 47.33 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.67 -137.52 44.52 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 120.801 -1.187 . . . . 0.0 110.608 -169.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.93 -28.86 17.9 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -75.71 -2.66 30.67 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.0 m -75.62 -18.46 59.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 117.893 -1.051 . . . . 0.0 113.559 162.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.9 -24.81 22.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.696 1.199 . . . . 0.0 112.08 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.91 146.12 24.73 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -171.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -80.4 61.48 4.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.164 0.986 . . . . 0.0 112.321 173.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.482 0 C-N-CA 125.277 1.431 . . . . 0.0 113.252 -174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.844 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.4 m -96.17 -42.88 7.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.176 1.39 . . . . 0.0 112.861 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -66.25 144.76 56.41 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.35 1.46 . . . . 0.0 112.94 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . 0.28 55.0 m95 -81.03 48.81 1.15 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 171.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -82.61 154.69 24.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.984 2.113 . . . . 0.0 113.677 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -144.07 161.45 38.77 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.284 16.9 t80 -147.44 87.42 1.65 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.273 21.0 t80 -63.07 127.67 32.33 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 160.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -70.35 -3.04 15.49 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -170.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.45 -174.26 27.87 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 163.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 m -71.11 149.28 46.6 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.954 1.302 . . . . 0.0 111.729 155.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -139.03 20.35 2.63 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -163.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -70.46 146.73 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 120.888 -1.133 . . . . 0.0 111.605 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.5 p -118.0 -38.2 3.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.495 1.918 . . . . 0.0 113.297 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -140.63 132.91 28.23 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.028 1.331 . . . . 0.0 110.527 172.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.341 0.6 OUTLIER -95.17 175.73 6.5 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.31 1.444 . . . . 0.0 112.911 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.293 27.5 t80 -77.09 129.86 36.6 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.87 -50.63 0.81 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.103 1.811 . . . . 0.0 113.693 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -147.68 159.74 43.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.594 1.158 . . . . 0.0 113.773 -165.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -123.6 128.57 49.88 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -100.35 -34.26 10.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.241 1.417 . . . . 0.0 113.677 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -70.08 146.63 50.8 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . 0.256 2.9 m 63.26 160.92 0.12 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.916 2.086 . . . . 0.0 115.462 -172.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -66.42 7.78 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.803 3.002 . . . . 0.0 119.735 -156.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.323 1.1 p90 -129.56 147.29 51.35 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 -167.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -72.81 51.81 0.29 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.186 2.194 . . . . 0.0 116.509 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.39 143.8 48.86 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 120.567 -1.333 . . . . 0.0 115.06 -171.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -93.03 147.83 22.51 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.673 1.589 . . . . 0.0 110.519 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -138.68 109.42 6.66 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.592 0.71 . . . . 0.0 112.26 -169.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.271 78.3 m-85 -86.78 29.61 0.79 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -174.32 -158.67 19.03 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.68 1.133 . . . . 0.0 113.112 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mt -135.7 140.57 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.418 1.887 . . . . 0.0 110.101 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -116.94 135.91 53.35 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -126.39 128.01 46.37 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.33 84.93 0.26 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.708 2.403 . . . . 0.0 112.658 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.6 mt -127.97 117.92 20.76 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.125 1.37 . . . . 0.0 109.167 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.26 158.58 30.19 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.834 2.356 . . . . 0.0 112.663 -177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -54.3 134.56 45.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.93 0.872 . . . . 0.0 110.402 172.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 82.29 2.06 90.52 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.487 1.518 . . . . 0.0 115.851 -172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.0 m -60.07 129.26 88.21 Favored Pre-proline 0 N--CA 1.481 1.078 0 CA-C-N 120.667 2.233 . . . . 0.0 112.3 168.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.43 128.78 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.016 2.477 . . . . 0.0 111.537 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -106.18 137.98 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.343 1.857 . . . . 0.0 108.944 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -123.06 152.1 41.34 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.01 1.724 . . . . 0.0 109.897 -170.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.86 128.13 92.03 Favored Pre-proline 0 CA--C 1.553 1.09 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.806 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.16 -30.77 10.25 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.494 2.796 . . . . 0.0 113.107 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -137.31 157.27 46.98 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.404 2.282 . . . . 0.0 112.331 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -62.59 121.82 14.27 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.356 -0.84 . . . . 0.0 111.455 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.13 -169.27 14.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.452 1.025 . . . . 0.0 114.124 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -140.08 137.37 34.48 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.769 1.627 . . . . 0.0 110.796 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.47 127.89 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-N 118.703 0.683 . . . . 0.0 112.805 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.0 p -126.13 -10.96 6.48 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 117.899 -1.048 . . . . 0.0 112.94 -173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -158.98 153.62 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.947 1.249 . . . . 0.0 111.575 161.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.0 mt -134.55 130.25 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.674 1.589 . . . . 0.0 109.087 168.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -162.88 177.23 9.44 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.851 0.86 . . . . 0.0 112.463 -173.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -128.16 150.31 50.05 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.989 1.315 . . . . 0.0 110.063 166.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -157.81 164.91 36.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.507 1.123 . . . . 0.0 110.916 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -61.63 -22.47 65.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.996 0.918 . . . . 0.0 112.573 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.9 tp -49.7 -32.39 13.33 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.532 1.933 . . . . 0.0 114.227 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.78 45.47 0.03 OUTLIER Glycine 0 CA--C 1.53 0.999 0 N-CA-C 115.672 1.029 . . . . 0.0 115.672 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.7 -133.9 25.57 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 118.415 1.107 . . . . 0.0 113.446 177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -72.35 131.49 42.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.626 1.17 . . . . 0.0 111.913 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.8 t -117.73 136.52 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.768 1.627 . . . . 0.0 112.592 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.0 tp -107.35 131.76 53.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.533 1.133 . . . . 0.0 109.503 163.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -117.65 126.18 52.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.466 0.706 . . . . 0.0 112.521 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.6 mt -124.49 135.37 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.714 1.606 . . . . 0.0 109.272 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.04 134.01 39.58 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.678 0.791 . . . . 0.0 110.309 162.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -66.08 160.45 23.86 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 121.291 -0.881 . . . . 0.0 112.778 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -54.62 -26.53 33.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 119.026 2.973 . . . . 0.0 119.026 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -81.42 -2.48 49.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.2 11.11 70.5 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.682 1.135 . . . . 0.0 115.399 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -122.43 -24.17 5.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.692 1.597 . . . . 0.0 114.229 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -95.63 138.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -127.82 151.19 49.35 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.998 1.319 . . . . 0.0 110.033 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.7 132.96 39.48 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.647 1.179 . . . . 0.0 110.941 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.0 m0 -112.06 138.37 48.81 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.686 1.594 . . . . 0.0 113.265 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -120.87 120.72 36.33 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.173 1.789 . . . . 0.0 106.666 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.86 170.2 8.19 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.151 0.98 . . . . 0.0 112.672 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 64.55 18.17 11.24 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.978 2.111 . . . . 0.0 115.095 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.4 158.31 26.97 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.181 0.992 . . . . 0.0 112.049 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -108.85 -25.9 10.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.592 0.757 . . . . 0.0 110.282 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -157.41 155.86 31.22 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.391 1.076 . . . . 0.0 111.893 -164.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -123.43 134.37 53.96 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.866 1.266 . . . . 0.0 111.245 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -96.54 -12.68 23.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.403 1.081 . . . . 0.0 112.718 170.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 168.84 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.6 1.56 . . . . 0.0 112.38 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -132.02 156.11 46.83 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.195 1.398 . . . . 0.0 112.612 -173.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.307 5.2 p -56.52 130.69 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.17 -17.7 58.8 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.659 1.6 . . . . 0.0 114.919 -166.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -73.98 131.33 41.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.756 1.778 . . . . 0.0 114.868 -174.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.59 121.45 36.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.784 1.234 . . . . 0.0 109.562 -177.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.31 162.69 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -124.9 150.13 46.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.872 1.669 . . . . 0.0 112.018 -175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.03 109.16 0.69 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.88 0.872 . . . . 0.0 112.48 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.05 -0.16 38.48 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.412 1.958 . . . . 0.0 115.391 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.73 140.59 31.16 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 120.149 1.974 . . . . 0.0 108.723 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.0 mm -62.57 126.56 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.879 0.872 . . . . 0.0 110.975 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 26.6 pt -109.21 -32.28 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.706 1.602 . . . . 0.0 112.489 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.79 -177.29 3.39 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.536 -1.352 . . . . 0.0 111.178 -171.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.69 139.15 48.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.301 0.641 . . . . 0.0 111.958 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -62.35 148.71 44.38 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.384 1.074 . . . . 0.0 111.724 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.56 -151.79 5.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.617 1.58 . . . . 0.0 110.56 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -132.54 22.74 4.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 p -61.98 114.58 3.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 123.126 1.441 . . . . 0.0 109.891 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.97 1.77 80.22 Favored Glycine 0 CA--C 1.541 1.674 0 N-CA-C 117.934 1.934 . . . . 0.0 117.934 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.97 131.2 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 121.405 2.603 . . . . 0.0 111.03 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -78.51 -43.85 25.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 t -64.93 166.16 9.64 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -70.91 -29.61 65.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -90.58 152.68 22.1 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.769 1.175 . . . . 0.0 113.685 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -91.86 147.58 22.87 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.793 1.237 . . . . 0.0 112.902 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -145.91 145.87 30.86 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.91 0.884 . . . . 0.0 112.231 169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.39 134.65 42.43 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 166.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -91.78 133.6 35.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.919 0.781 . . . . 0.0 108.901 156.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.271 68.2 t80 -124.01 124.16 41.95 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 167.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -135.93 109.28 7.85 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.471 1.108 . . . . 0.0 110.577 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -94.3 139.58 30.88 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.049 1.34 . . . . 0.0 110.541 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.6 mtm -134.33 146.49 50.01 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.833 1.653 . . . . 0.0 110.42 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.59 133.49 55.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.68 1.592 . . . . 0.0 110.347 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.14 -17.7 5.89 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.223 1.392 . . . . 0.0 115.743 172.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -173.04 -166.59 31.74 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.534 1.54 . . . . 0.0 111.644 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.87 111.95 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -170.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 146.83 172.78 17.45 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 127.264 2.364 . . . . 0.0 111.912 -174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -64.83 -30.2 71.2 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.207 1.503 . . . . 0.0 114.249 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.17 -21.84 66.83 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.099 -1.001 . . . . 0.0 112.627 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -91.59 -13.93 31.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.39 142.9 56.58 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.445 1.098 . . . . 0.0 113.535 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -138.01 160.62 38.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.641 1.576 . . . . 0.0 110.737 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -62.08 112.47 6.35 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.125 1.37 . . . . 0.0 114.046 -175.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -88.54 -15.68 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.687 3.591 . . . . 0.0 113.256 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.94 -47.92 97.76 Favored Pre-proline 0 N--CA 1.48 1.026 0 CA-C-N 120.267 1.394 . . . . 0.0 113.023 -172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -73.09 -24.49 17.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.798 2.332 . . . . 0.0 112.765 174.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.66 -25.51 65.75 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.6 mt -83.63 -37.46 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.202 1.401 . . . . 0.0 111.378 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.258 75.4 m-20 -60.07 -10.7 4.6 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 174.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.1 -14.74 28.75 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 171.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.96 151.77 88.58 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.858 1.263 . . . . 0.0 113.452 -166.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.42 -18.72 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.313 3.342 . . . . 0.0 114.804 -171.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -119.62 6.67 11.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.851 1.66 . . . . 0.0 115.088 167.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 68.94 -142.11 37.39 Favored Glycine 0 CA--C 1.532 1.104 0 O-C-N 121.229 -0.919 . . . . 0.0 111.398 -171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -57.78 -25.74 60.94 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.352 -1.087 . . . . 0.0 111.968 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.9 mtp-105 -75.09 0.65 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.151 1.38 . . . . 0.0 111.658 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.4 t -75.89 -18.6 59.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.027 1.331 . . . . 0.0 112.005 164.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.14 -21.28 31.43 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.138 -0.976 . . . . 0.0 112.994 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -144.19 163.42 33.67 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -119.62 76.96 1.18 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.642 1.177 . . . . 0.0 111.133 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 125.591 1.556 . . . . 0.0 112.054 -168.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.7 p 59.21 -2.78 0.1 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 170.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -75.66 163.48 27.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.411 1.884 . . . . 0.0 112.899 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -111.43 -26.12 9.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.623 1.569 . . . . 0.0 113.362 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 54' ' ' PHE . 74.8 tt0 -72.68 133.83 44.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.209 1.404 . . . . 0.0 112.798 173.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -96.11 8.24 44.3 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 121.081 -1.012 . . . . 0.0 111.506 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.488 ' H ' ' HG2' ' A' ' 52' ' ' GLU 0.314 73.3 m-85 -127.86 25.15 5.99 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.361 2.264 . . . . 0.0 117.047 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.287 35.7 t80 -63.64 147.94 50.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.44 68.36 2.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.999 1.32 . . . . 0.0 113.146 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.96 16.08 49.38 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.996 2.713 . . . . 0.0 116.314 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 89.7 p -141.77 137.05 31.31 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.012 1.406 . . . . 0.0 109.38 159.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtp85 -144.93 29.29 1.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -155.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 tt -77.67 139.39 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.948 -1.095 . . . . 0.0 111.512 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -101.43 -50.27 3.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.492 1.517 . . . . 0.0 114.014 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -135.45 120.29 18.5 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.7 1.6 . . . . 0.0 109.692 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.38 0.1 OUTLIER -81.26 173.42 12.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.867 1.267 . . . . 0.0 114.063 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -75.09 165.79 24.67 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -171.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.8 -133.71 11.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.396 1.474 . . . . 0.0 110.834 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -68.62 148.6 50.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.45 0.7 . . . . 0.0 111.352 170.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.33 177.53 2.3 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 122.922 0.489 . . . . 0.0 110.145 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -52.92 156.13 2.15 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.782 1.233 . . . . 0.0 112.555 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -56.11 127.11 29.0 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.51 -0.744 . . . . 0.0 111.67 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.4 m -171.68 163.64 4.68 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.808 1.643 . . . . 0.0 111.047 -169.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.71 -35.31 87.06 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.283 2.656 . . . . 0.0 112.715 160.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.292 61.5 t80 -62.1 125.99 25.79 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 166.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 6.4 p30 -110.76 3.65 19.29 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -165.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.5 169.56 33.02 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 116.962 1.545 . . . . 0.0 116.962 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.87 138.55 54.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.32 1.448 . . . . 0.0 112.676 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -76.53 -31.48 57.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.649 1.58 . . . . 0.0 112.455 167.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.343 44.5 m-85 63.63 8.1 3.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 118.509 2.781 . . . . 0.0 118.509 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.6 -159.13 10.83 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.798 1.19 . . . . 0.0 112.76 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.413 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.6 mt -133.59 135.13 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.675 1.99 . . . . 0.0 109.439 177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -108.61 131.72 54.6 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -117.32 125.98 51.94 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.17 103.53 3.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.418 1.487 . . . . 0.0 111.844 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 30.0 mt -138.4 142.26 34.3 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 126.221 1.808 . . . . 0.0 108.144 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.95 154.55 66.86 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 122.475 2.117 . . . . 0.0 111.391 170.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.01 139.79 53.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.637 0.732 . . . . 0.0 110.518 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.33 5.49 88.71 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.011 1.767 . . . . 0.0 115.4 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.5 m -65.15 133.87 95.75 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-N 119.505 1.652 . . . . 0.0 111.361 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.31 134.23 17.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.539 2.826 . . . . 0.0 111.798 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.77 135.99 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.73 1.612 . . . . 0.0 109.386 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.28 154.67 38.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.683 1.593 . . . . 0.0 110.024 -168.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.52 124.27 87.85 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 119.063 -0.494 . . . . 0.0 110.273 170.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.17 -35.79 18.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.176 1.917 . . . . 0.0 111.329 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.0 p -134.45 163.11 30.43 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.704 2.402 . . . . 0.0 110.813 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -71.26 118.93 14.68 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.162 -0.961 . . . . 0.0 111.142 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -146.06 -163.55 10.37 Favored Glycine 0 N--CA 1.473 1.12 0 N-CA-C 115.776 1.07 . . . . 0.0 115.776 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -148.36 140.41 24.0 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.205 1.802 . . . . 0.0 110.712 176.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.7 t -69.55 127.21 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 p -123.75 -10.68 7.78 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 -174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -163.31 153.85 16.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.938 1.295 . . . . 0.0 110.575 164.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 41.4 mt -133.06 131.86 58.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.118 1.367 . . . . 0.0 109.6 168.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.13 -178.98 7.63 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -144.61 169.46 17.95 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.928 1.291 . . . . 0.0 112.126 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -148.79 165.89 30.09 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.082 1.753 . . . . 0.0 110.371 166.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -65.29 -26.85 68.25 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.52 1.528 . . . . 0.0 112.648 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.25 152.0 31.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.896 2.078 . . . . 0.0 108.552 166.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.43 -29.34 1.01 Allowed Glycine 0 CA--C 1.54 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 113.657 -170.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.75 -136.02 21.29 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 118.373 1.086 . . . . 0.0 112.026 174.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -67.4 129.05 38.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.468 1.107 . . . . 0.0 112.147 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.34 133.69 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.241 1.816 . . . . 0.0 113.021 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.9 tp -107.41 136.36 47.34 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.417 1.087 . . . . 0.0 110.462 166.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -119.76 126.42 51.01 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.9 mt -126.53 139.2 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.695 1.598 . . . . 0.0 109.608 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -102.31 133.13 47.72 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.137 0.975 . . . . 0.0 110.705 164.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.41 155.82 17.32 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.843 0.857 . . . . 0.0 112.46 168.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -47.65 -42.16 23.83 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.672 2.101 . . . . 0.0 116.672 -171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -74.14 -12.07 60.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 76.84 19.18 78.02 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.213 0.911 . . . . 0.0 115.33 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -114.04 -27.07 7.83 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.822 1.311 . . . . 0.0 114.0 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -97.1 135.31 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 169.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -127.71 153.08 46.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 111.164 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -136.79 137.83 40.23 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.697 1.199 . . . . 0.0 111.312 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.7 m0 -114.47 143.88 44.23 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.944 1.698 . . . . 0.0 112.985 166.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -127.6 122.55 33.44 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.113 1.765 . . . . 0.0 107.097 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.8 mp -122.45 168.95 11.48 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 64.49 31.34 12.53 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.934 2.094 . . . . 0.0 113.497 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.38 143.09 40.91 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.921 0.867 . . . . 0.0 113.299 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -81.7 -37.59 27.14 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.192 0.997 . . . . 0.0 110.433 170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -160.01 160.39 33.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.358 1.063 . . . . 0.0 111.867 -156.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -127.4 125.93 41.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.053 1.741 . . . . 0.0 110.487 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -89.42 -14.65 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.396 0.678 . . . . 0.0 112.143 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.24 168.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 125.939 1.696 . . . . 0.0 113.127 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -132.67 157.21 45.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.701 2.001 . . . . 0.0 113.825 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.308 4.5 p -56.19 129.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.16 -10.1 74.0 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.5 1.524 . . . . 0.0 115.317 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -84.16 136.34 34.01 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.078 1.939 . . . . 0.0 110.22 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -82.23 137.17 34.95 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.971 1.709 . . . . 0.0 111.131 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -127.49 155.08 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.672 1.189 . . . . 0.0 114.129 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.3 150.65 41.1 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.138 1.775 . . . . 0.0 110.364 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.04 119.01 4.17 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.054 0.93 . . . . 0.0 111.215 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.46 6.13 62.88 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.335 1.445 . . . . 0.0 115.158 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -82.02 137.64 35.05 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 mm -61.62 120.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 124.597 1.159 . . . . 0.0 109.212 173.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 33.0 pt -104.17 -31.89 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.172 0.989 . . . . 0.0 111.59 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.58 -175.36 2.79 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.039 -1.038 . . . . 0.0 110.837 -170.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -131.35 143.76 50.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.121 0.968 . . . . 0.0 111.518 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 13.2 t -73.49 144.71 46.1 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.186 0.903 . . . . 0.0 111.337 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.02 -151.34 5.51 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.673 1.606 . . . . 0.0 111.893 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -125.76 8.07 7.51 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -71.13 140.15 50.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.496 1.518 . . . . 0.0 113.976 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.29 23.5 70.03 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.929 1.252 . . . . 0.0 115.89 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 53.3 mt -87.41 149.62 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 124.79 1.236 . . . . 0.0 112.143 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -119.69 -25.87 5.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.319 1.848 . . . . 0.0 112.95 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 1.1 t -70.29 173.78 6.38 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.5 p -55.57 -17.9 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 117.907 2.558 . . . . 0.0 117.907 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 176.65 178.95 46.81 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-N 120.214 1.37 . . . . 0.0 115.825 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.57 144.78 41.66 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.599 1.559 . . . . 0.0 113.772 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 36.9 p-80 -162.3 174.69 12.48 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.431 1.493 . . . . 0.0 111.381 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.9 tp -99.53 139.03 35.79 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.104 -0.951 . . . . 0.0 109.463 155.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -99.25 124.58 44.44 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.386 0.994 . . . . 0.0 108.932 155.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.302 47.4 t80 -115.39 127.48 55.41 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -137.28 104.0 5.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.016 0.926 . . . . 0.0 112.238 -168.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -82.25 139.04 34.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.866 2.066 . . . . 0.0 111.419 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.5 mtm -135.61 147.8 48.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.285 1.834 . . . . 0.0 110.351 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -123.01 132.38 54.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.915 1.286 . . . . 0.0 111.293 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.1 -21.96 4.65 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.649 1.595 . . . . 0.0 114.973 176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -168.99 -167.53 29.74 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.29 1.424 . . . . 0.0 111.863 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.64 128.46 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 143.23 163.68 9.9 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.216 1.388 . . . . 0.0 112.675 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -61.01 -31.19 70.82 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.222 -1.163 . . . . 0.0 112.38 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.69 -15.98 59.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 171.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 99.9 m-85 -103.34 -8.25 20.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.386 1.474 . . . . 0.0 114.44 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.92 131.43 42.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.391 1.076 . . . . 0.0 113.272 -171.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -144.65 154.56 42.93 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.684 1.194 . . . . 0.0 113.471 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -54.18 111.7 3.13 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -160.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.413 ' HG2' HD12 ' A' ' 79' ' ' ILE . 42.9 Cg_endo -82.9 -17.06 7.18 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.509 3.473 . . . . 0.0 113.735 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -51.04 81.82 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-N 121.244 1.838 . . . . 0.0 112.534 -175.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.57 -19.67 27.93 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.039 2.493 . . . . 0.0 113.04 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -75.15 -25.82 58.67 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 167.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 80.8 mt -84.69 -38.9 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.742 1.617 . . . . 0.0 111.374 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -59.71 -8.79 2.23 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -102.17 -9.82 20.15 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.826 2.05 . . . . 0.0 114.354 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.2 mt -73.37 152.55 90.03 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.865 1.266 . . . . 0.0 112.616 -172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -64.12 -32.67 63.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.673 2.915 . . . . 0.0 113.591 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -105.29 6.1 32.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.138 1.775 . . . . 0.0 115.251 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.76 -141.03 46.33 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 120.26 -1.525 . . . . 0.0 111.144 -170.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.32 -25.46 61.93 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.418 -1.048 . . . . 0.0 113.149 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -71.12 -11.42 60.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.222 1.009 . . . . 0.0 111.642 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.4 m -68.81 -19.35 64.28 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.173 -0.955 . . . . 0.0 111.04 171.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.58 -30.18 29.76 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.944 0.898 . . . . 0.0 111.797 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -137.54 133.25 34.3 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.59 78.62 9.81 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 167.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.323 1.049 . . . . 0.0 112.687 -176.112 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.817 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.7 m -74.47 -20.57 59.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -99.21 -25.75 14.41 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -146.72 154.23 41.18 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.976 1.262 . . . . 0.0 113.159 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -71.9 144.27 49.05 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.199 1.4 . . . . 0.0 112.303 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -104.76 174.69 5.77 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.552 2.341 . . . . 0.0 115.68 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.387 50.3 m-85 -71.11 7.96 1.09 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 56' ' ' ARG 0.29 33.7 t80 -56.74 177.02 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 158.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.436 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.8 mmt180 -61.62 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 126.869 2.067 . . . . 0.0 114.89 173.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.83 97.34 0.68 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 126.031 1.777 . . . . 0.0 112.753 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.2 t -93.05 138.14 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -86.52 2.23 48.72 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.272 1.429 . . . . 0.0 114.125 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 tt -67.4 145.43 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 120.372 1.442 . . . . 0.0 113.372 -163.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.25 1.2 p -115.29 -32.57 5.6 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.176 1.79 . . . . 0.0 115.379 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -147.5 143.99 28.24 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.0 1.32 . . . . 0.0 111.623 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.423 0.0 OUTLIER -111.45 176.98 4.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.162 1.785 . . . . 0.0 113.19 176.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -79.66 140.21 37.13 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 119.827 -1.796 . . . . 0.0 115.73 -162.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.68 -26.24 21.08 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.768 2.128 . . . . 0.0 115.545 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -146.14 132.63 19.73 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.943 1.371 . . . . 0.0 113.697 -173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 68' ' ' GLN 0.337 34.9 t80 -103.0 -169.22 1.62 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.084 2.554 . . . . 0.0 116.101 -171.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.428 ' N ' ' CG ' ' A' ' 67' ' ' TYR . 31.0 tt0 -58.78 132.96 55.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.36 1.864 . . . . 0.0 111.863 174.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -58.16 114.84 2.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.826 1.251 . . . . 0.0 110.544 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -156.86 154.75 27.23 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.376 1.471 . . . . 0.0 112.726 -162.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -57.06 -31.67 90.91 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.586 2.857 . . . . 0.0 116.242 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -134.33 148.19 50.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.47 22.9 m-20 49.53 52.15 15.07 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 170.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.32 4.45 0.6 Allowed Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.98 2.229 . . . . 0.0 117.695 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.9 pttt -80.85 159.16 25.13 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 127.213 2.205 . . . . 0.0 112.262 -176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -155.65 109.39 2.8 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -95.09 25.04 4.44 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.93 -151.43 8.74 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.598 1.094 . . . . 0.0 113.688 -169.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.506 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.2 mt -138.48 152.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 127.528 2.331 . . . . 0.0 110.269 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.83 145.86 51.08 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 171.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -130.35 130.74 44.81 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -170.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.48 47.75 0.41 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 128.312 2.645 . . . . 0.0 115.786 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.83 150.24 86.08 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.261 1.024 . . . . 0.0 111.565 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.41 155.03 45.9 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.749 2.299 . . . . 0.0 111.85 163.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -50.41 140.36 13.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.625 1.57 . . . . 0.0 111.608 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.46 10.75 79.62 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.869 1.224 . . . . 0.0 115.289 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.4 m -64.64 134.53 96.05 Favored Pre-proline 0 N--CA 1.479 0.989 0 CA-C-N 119.915 1.857 . . . . 0.0 110.383 171.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.56 125.97 11.1 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.262 2.642 . . . . 0.0 111.4 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.452 HD12 HD22 ' A' ' 158' ' ' LEU . 15.4 mm -100.07 136.22 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 126.038 1.735 . . . . 0.0 108.999 179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 mtmt -121.88 149.81 42.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.354 1.462 . . . . 0.0 110.238 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.93 124.15 89.67 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-O 118.388 -0.815 . . . . 0.0 109.506 170.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 -28.3 28.06 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.08 2.52 . . . . 0.0 112.891 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.0 p -138.69 157.69 45.63 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.936 2.094 . . . . 0.0 107.201 -170.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -62.39 126.42 27.27 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 121.489 -0.757 . . . . 0.0 110.348 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -151.45 -173.28 21.14 Favored Glycine 0 N--CA 1.474 1.231 0 O-C-N 121.103 -0.998 . . . . 0.0 115.367 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -136.22 137.38 40.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.73 1.212 . . . . 0.0 110.68 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.85 128.04 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 76.9 p -122.85 -18.04 6.61 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.677 1.191 . . . . 0.0 113.379 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.6 ttm-85 -158.15 154.9 28.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.822 0.737 . . . . 0.0 112.2 170.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.1 mt -137.6 137.85 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.76 1.624 . . . . 0.0 108.877 169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -156.11 164.12 38.8 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -119.6 122.63 42.0 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.288 1.035 . . . . 0.0 112.642 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.7 t30 53.24 25.28 4.26 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 129.47 3.108 . . . . 0.0 116.0 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -78.33 -1.72 34.61 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 120.94 -1.1 . . . . 0.0 112.614 165.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 -45.67 0.1 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.397 1.879 . . . . 0.0 111.554 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 174.55 106.74 0.2 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.09 0.853 . . . . 0.0 113.155 169.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.63 -157.44 29.79 Favored Glycine 0 CA--C 1.536 1.35 0 CA-C-N 117.905 0.852 . . . . 0.0 113.274 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.95 124.65 22.11 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.624 -0.927 . . . . 0.0 110.999 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.3 t -112.65 136.47 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.416 1.486 . . . . 0.0 112.405 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 25.0 tp -111.43 133.28 53.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.423 1.089 . . . . 0.0 110.115 167.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -120.25 123.19 42.59 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.3 mt -125.87 134.72 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.638 1.575 . . . . 0.0 109.892 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.74 124.07 37.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.482 1.113 . . . . 0.0 110.558 167.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.67 146.27 54.97 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.463 -0.773 . . . . 0.0 112.292 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -60.88 -13.91 18.75 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 169.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -62.09 -3.95 1.48 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.496 1.918 . . . . 0.0 115.955 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.3 -8.85 66.02 Favored Glycine 0 N--CA 1.472 1.06 0 C-N-CA 125.147 1.356 . . . . 0.0 115.839 164.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -144.36 -13.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.251 47.1 m-85 -91.81 144.66 25.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -130.89 154.83 47.67 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.136 1.774 . . . . 0.0 110.209 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -133.56 136.11 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.628 1.171 . . . . 0.0 111.232 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -112.52 137.22 51.06 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.422 1.489 . . . . 0.0 113.028 166.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -118.64 124.51 47.58 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.155 1.782 . . . . 0.0 107.204 170.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.0 mt -111.25 164.2 13.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.001 0.92 . . . . 0.0 111.276 175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 64.2 40.86 6.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.935 1.35 . . . . 0.0 113.149 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.41 150.98 36.69 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.214 1.006 . . . . 0.0 110.814 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -92.63 -36.46 12.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.551 1.54 . . . . 0.0 109.609 163.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 50.3 tttt -154.71 155.94 35.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.312 1.045 . . . . 0.0 111.584 -158.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -117.65 135.27 54.11 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.531 1.532 . . . . 0.0 110.42 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -98.67 -13.19 20.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.255 1.022 . . . . 0.0 111.915 171.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.27 168.17 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.721 2.008 . . . . 0.0 110.999 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -137.19 158.76 43.73 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.6 1.56 . . . . 0.0 111.281 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.5 131.15 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.264 0.554 . . . . 0.0 110.538 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.38 -13.84 65.11 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.307 1.432 . . . . 0.0 115.876 -168.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -74.89 128.42 35.52 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.033 1.916 . . . . 0.0 114.242 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 122.9 32.14 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.537 1.135 . . . . 0.0 109.489 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.49 155.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.58 1.552 . . . . 0.0 113.567 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -112.31 153.03 27.84 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.82 1.648 . . . . 0.0 112.087 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.59 103.86 0.11 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.206 1.402 . . . . 0.0 111.891 170.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.73 -0.33 30.5 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 127.286 2.374 . . . . 0.0 115.362 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -77.68 134.53 38.12 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 120.144 1.972 . . . . 0.0 115.027 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.38 126.58 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.66 1.118 . . . . 0.0 111.492 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 37.1 pt -111.85 -29.11 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.35 1.46 . . . . 0.0 112.406 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.24 -176.08 2.45 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.454 -1.404 . . . . 0.0 111.9 -172.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -135.79 137.24 41.4 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.9 0.88 . . . . 0.0 109.393 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.5 t -77.4 147.65 35.92 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.81 0.732 . . . . 0.0 112.663 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -141.83 -152.22 5.68 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.198 1.856 . . . . 0.0 109.825 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.292 50.4 p30 -120.64 23.74 10.64 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 p -58.67 134.51 56.85 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 70.88 -7.79 5.12 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.9 mt -79.74 140.93 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.826 . . . . 0.0 109.345 175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -82.54 -46.14 13.76 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.265 -0.897 . . . . 0.0 110.986 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.6 t -71.18 170.83 12.17 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.258 1.947 . . . . 0.0 116.258 168.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.4 p -84.55 -37.05 21.69 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.69 112.02 3.67 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.653 1.12 . . . . 0.0 112.742 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.54 153.95 30.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -158.54 140.71 14.02 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.519 1.128 . . . . 0.0 111.509 169.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.452 HD22 HD12 ' A' ' 89' ' ' ILE . 19.0 tp -80.04 131.95 35.88 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.588 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -88.77 144.25 26.37 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.917 0.781 . . . . 0.0 110.845 162.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.285 64.0 t80 -133.51 130.4 38.48 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 166.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -140.63 110.26 6.37 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.599 1.159 . . . . 0.0 111.369 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -94.01 138.92 31.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.859 1.663 . . . . 0.0 110.669 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.6 mtm -138.01 138.46 38.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.357 1.463 . . . . 0.0 111.225 -171.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -109.84 132.51 54.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.821 1.248 . . . . 0.0 112.024 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.07 0.63 65.89 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.605 1.098 . . . . 0.0 114.68 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 176.01 -169.29 41.89 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.952 1.263 . . . . 0.0 111.29 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.62 131.86 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.626 1.17 . . . . 0.0 113.61 -176.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.97 167.29 12.45 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.628 1.585 . . . . 0.0 113.125 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -53.4 -37.81 62.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.85 63.93 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -100.23 -12.75 19.28 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.955 1.302 . . . . 0.0 112.583 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.4 143.4 57.08 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.427 1.091 . . . . 0.0 113.344 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -131.19 162.99 28.72 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.496 1.918 . . . . 0.0 110.319 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -69.29 110.59 6.52 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.166 1.386 . . . . 0.0 112.658 -173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.506 ' HG2' HD12 ' A' ' 79' ' ' ILE . 51.5 Cg_endo -82.94 -15.39 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.032 3.155 . . . . 0.0 113.547 -175.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -56.93 -52.76 71.53 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 120.758 1.617 . . . . 0.0 111.988 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.49 -21.26 30.35 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.473 2.115 . . . . 0.0 112.628 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -71.42 -31.83 67.68 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.84 -37.32 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 123.816 0.846 . . . . 0.0 111.533 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.95 -23.27 31.14 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -92.66 -5.6 51.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 79.6 mt -74.91 153.64 86.87 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.313 1.045 . . . . 0.0 113.469 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.15 -33.82 59.53 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.504 2.802 . . . . 0.0 113.274 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -107.89 4.84 25.8 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 169.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 65.96 -138.34 37.11 Favored Glycine 0 CA--C 1.529 0.912 0 O-C-N 120.317 -1.489 . . . . 0.0 110.341 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -60.09 -21.44 61.51 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.876 -1.367 . . . . 0.0 113.073 173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -76.79 0.28 21.25 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 120.75 -1.219 . . . . 0.0 114.009 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.1 m -83.43 -12.33 56.53 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.918 1.287 . . . . 0.0 113.83 159.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 -24.55 20.15 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.49 1.041 . . . . 0.0 110.676 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -150.81 141.15 22.36 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -174.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -74.08 55.33 0.57 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.044 1.738 . . . . 0.0 115.561 167.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 127.326 2.251 . . . . 0.0 111.528 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.167 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -82.19 158.32 23.64 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.232 1.413 . . . . 0.0 113.17 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -141.14 159.26 42.59 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.336 1.854 . . . . 0.0 112.66 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.0 m95 64.95 35.53 8.19 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.898 2.079 . . . . 0.0 115.106 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 54.51 31.36 14.7 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.205 1.402 . . . . 0.0 113.594 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -75.38 159.83 30.96 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.033 1.733 . . . . 0.0 112.788 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -126.39 159.0 34.48 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.879 2.072 . . . . 0.0 113.881 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -147.0 -17.69 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 -166.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -60.42 -46.41 90.12 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.481 1.113 . . . . 0.0 113.526 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.28 172.7 55.24 Favored Glycine 0 CA--C 1.536 1.403 0 CA-C-O 122.108 0.838 . . . . 0.0 114.604 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.7 t -71.18 143.49 50.49 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.679 1.192 . . . . 0.0 112.606 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? -81.11 7.4 11.12 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.961 1.304 . . . . 0.0 113.658 173.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.33 150.73 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 p -106.82 -49.49 3.29 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.52 1.928 . . . . 0.0 113.537 159.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -139.08 135.61 34.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.752 1.621 . . . . 0.0 111.732 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.317 1.0 OUTLIER -93.12 175.04 6.93 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.563 1.545 . . . . 0.0 114.342 173.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -73.42 149.59 42.33 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -165.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.83 -46.95 3.5 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 127.392 2.425 . . . . 0.0 113.265 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -141.37 145.18 35.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -60.83 141.43 57.08 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 163.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -58.47 127.2 30.96 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.75 -0.594 . . . . 0.0 111.334 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.263 30.0 m170 58.61 22.33 9.69 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 95.4 34.84 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.783 1.233 . . . . 0.0 110.372 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -63.8 -31.47 68.28 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.983 2.455 . . . . 0.0 115.118 -174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -133.23 -36.82 0.99 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.718 0.69 . . . . 0.0 112.013 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.257 27.2 m-20 -84.62 13.46 5.64 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 119.897 3.295 . . . . 0.0 119.897 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.63 104.11 0.24 Allowed Glycine 0 N--CA 1.468 0.803 0 O-C-N 120.742 -1.223 . . . . 0.0 113.402 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -98.99 158.72 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.54 1.536 . . . . 0.0 111.899 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -149.72 98.6 2.77 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -171.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.317 90.5 m-85 -76.42 21.54 0.19 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -172.84 -154.05 10.0 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.184 1.373 . . . . 0.0 113.57 -169.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.67 142.48 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.667 1.987 . . . . 0.0 110.026 175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -114.9 129.43 56.7 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -115.8 130.42 56.84 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.78 49.23 0.31 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.857 2.463 . . . . 0.0 114.746 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.2 mt -76.38 149.43 81.6 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.08 1.352 . . . . 0.0 111.306 175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.66 159.24 31.87 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.922 2.415 . . . . 0.0 112.075 166.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -57.48 148.41 23.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 122.04 0.924 . . . . 0.0 111.176 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.73 8.35 60.29 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.322 1.439 . . . . 0.0 114.968 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 29.7 m -64.95 129.76 94.59 Favored Pre-proline 0 N--CA 1.473 0.676 0 CA-C-N 118.937 1.368 . . . . 0.0 111.474 166.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' THR . 5.3 Cg_exo -72.02 135.49 25.38 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.339 2.692 . . . . 0.0 111.979 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.43 HD12 HD22 ' A' ' 158' ' ' LEU . 22.8 mm -109.38 133.42 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 125.976 1.71 . . . . 0.0 109.574 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.55 148.88 37.33 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.71 1.604 . . . . 0.0 110.474 -175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.11 130.45 89.68 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.1 171.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -71.67 -27.77 18.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.377 2.718 . . . . 0.0 113.119 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.7 p -139.69 159.93 41.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.359 2.263 . . . . 0.0 109.152 -172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -67.25 123.19 19.64 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.003 -1.061 . . . . 0.0 109.313 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.3 -170.62 14.37 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -139.35 136.38 34.72 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.483 1.513 . . . . 0.0 110.781 173.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.03 127.88 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.571 0.623 . . . . 0.0 112.274 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.9 p -122.5 -13.32 8.03 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.17 0.988 . . . . 0.0 112.939 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -161.58 155.64 22.21 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.454 1.024 . . . . 0.0 111.089 166.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.37 132.74 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 124.53 1.132 . . . . 0.0 108.834 167.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 -172.72 4.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.08 0.952 . . . . 0.0 111.717 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -143.14 -177.72 5.49 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.194 -0.941 . . . . 0.0 112.567 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 t30 67.01 -59.08 0.39 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.863 3.265 . . . . 0.0 116.752 176.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -63.35 122.01 15.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.89 0.768 . . . . 0.0 112.541 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.2 tp 65.62 -17.3 0.1 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.846 2.458 . . . . 0.0 116.754 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 169.43 93.04 0.09 OUTLIER Glycine 0 N--CA 1.474 1.208 0 N-CA-C 117.758 1.863 . . . . 0.0 117.758 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 54.67 -134.23 46.86 Favored Glycine 0 N--CA 1.474 1.217 0 CA-C-N 118.151 0.975 . . . . 0.0 113.59 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 127.25 32.68 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 118.62 1.21 . . . . 0.0 111.819 169.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.39 133.91 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.861 1.665 . . . . 0.0 112.921 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.0 tp -109.15 133.37 53.1 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.142 1.377 . . . . 0.0 110.231 169.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -121.38 127.01 50.78 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.6 0.76 . . . . 0.0 112.677 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 mt -129.65 136.08 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.621 1.569 . . . . 0.0 109.109 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -93.29 134.48 35.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.488 0.715 . . . . 0.0 110.618 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -66.12 139.71 58.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.869 0.867 . . . . 0.0 112.075 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -66.01 -24.5 66.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -68.0 -10.02 50.24 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.31 12.33 29.35 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 159.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.87 -22.06 0.57 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.262 62.9 m-85 -88.71 151.41 22.45 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -134.6 158.06 44.99 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.398 1.879 . . . . 0.0 111.087 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -139.24 141.99 37.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.289 1.436 . . . . 0.0 111.926 -175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -117.78 141.29 48.58 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 126.779 2.032 . . . . 0.0 112.925 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -125.34 129.1 49.27 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.645 1.978 . . . . 0.0 105.755 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.419 HD13 ' CD2' ' A' ' 159' ' ' HIS . 3.3 mp -128.71 163.75 24.44 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.849 0.859 . . . . 0.0 111.888 -174.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 68.48 20.45 8.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.638 1.975 . . . . 0.0 115.379 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt -65.81 158.23 28.3 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.659 1.183 . . . . 0.0 113.187 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -92.98 -41.34 10.06 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.997 0.919 . . . . 0.0 111.203 165.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -150.5 156.79 42.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.176 1.39 . . . . 0.0 111.76 -154.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.8 115.57 17.46 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.648 1.579 . . . . 0.0 111.093 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -76.14 -16.24 59.92 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.4 0.68 . . . . 0.0 112.046 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.75 169.75 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.401 1.88 . . . . 0.0 112.262 -175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -139.58 160.11 40.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.8 2.04 . . . . 0.0 111.942 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.319 3.2 p -53.02 129.45 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.72 -15.05 63.94 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.105 1.812 . . . . 0.0 115.265 -167.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -71.8 127.04 31.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.541 1.67 . . . . 0.0 114.474 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.9 mmm-85 -74.69 139.12 43.26 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.811 0.444 . . . . 0.0 111.66 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.78 156.77 41.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 124.758 1.223 . . . . 0.0 113.484 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.98 150.22 36.13 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.051 2.14 . . . . 0.0 110.984 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.77 103.99 0.2 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.51 1.124 . . . . 0.0 111.257 171.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.87 4.33 39.27 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 126.25 1.881 . . . . 0.0 115.049 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -89.18 142.11 27.93 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.676 1.238 . . . . 0.0 108.452 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 51.8 mm -67.48 127.96 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.026 0.931 . . . . 0.0 110.548 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 31.2 pt -111.42 -31.37 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.122 1.369 . . . . 0.0 112.429 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -167.67 -177.99 3.72 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 120.733 -1.229 . . . . 0.0 111.516 -170.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.73 136.77 47.87 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.491 0.716 . . . . 0.0 111.013 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.0 t -68.94 135.81 51.56 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.235 0.47 . . . . 0.0 110.028 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -117.57 -145.6 8.04 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 171.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -129.09 22.69 5.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.457 1.129 . . . . 0.0 113.42 168.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -65.44 131.35 46.19 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 122.656 1.217 . . . . 0.0 112.058 -168.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.48 -4.7 6.4 Favored Glycine 0 CA--C 1.542 1.737 0 N-CA-C 116.824 1.49 . . . . 0.0 116.824 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 64.6 mt -79.57 122.28 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 120.597 2.198 . . . . 0.0 109.797 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -63.65 -49.33 73.63 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.287 0.6 OUTLIER -75.31 1.72 13.0 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 117.357 2.354 . . . . 0.0 117.357 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.453 0.2 OUTLIER 65.13 -0.98 0.96 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 119.113 3.005 . . . . 0.0 119.113 -174.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -68.99 22.25 0.34 Allowed Glycine 0 CA--C 1.544 1.852 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 -169.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 54.5 14.21 0.78 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 120.718 3.599 . . . . 0.0 120.718 161.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -68.5 138.56 55.29 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.761 -1.212 . . . . 0.0 113.481 -173.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 89' ' ' ILE . 42.2 tp -75.1 123.53 25.38 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 167.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.419 ' CD2' HD13 ' A' ' 124' ' ' LEU . 9.3 t60 -89.59 127.12 35.85 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 161.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.259 62.1 t80 -120.26 130.59 54.56 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -145.42 120.08 9.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.816 0.847 . . . . 0.0 111.763 -166.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -108.15 143.95 36.22 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.368 1.467 . . . . 0.0 111.063 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.0 mtm -137.7 144.57 41.82 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.779 1.632 . . . . 0.0 110.727 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -112.48 127.25 56.0 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.39 1.476 . . . . 0.0 111.063 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 79.58 -6.14 58.87 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.544 1.069 . . . . 0.0 115.71 171.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 178.8 -166.77 36.7 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.201 1.382 . . . . 0.0 111.589 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -131.42 130.86 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.643 1.177 . . . . 0.0 113.832 -173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.73 162.83 10.96 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.693 1.616 . . . . 0.0 111.787 -170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -57.57 -30.92 65.65 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.79 -37.23 86.59 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.56 1.073 . . . . 0.0 112.53 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.84 -10.13 59.4 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.13 150.16 48.71 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -170.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -142.71 162.06 36.45 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.908 2.083 . . . . 0.0 111.273 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -69.15 118.4 61.42 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.613 1.565 . . . . 0.0 110.279 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.31 -16.79 5.78 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.484 3.456 . . . . 0.0 112.899 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -57.48 -52.79 71.66 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-N 121.019 1.736 . . . . 0.0 112.402 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.89 -20.38 25.94 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.041 2.494 . . . . 0.0 113.11 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -74.39 -28.28 61.03 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 116.92 2.193 . . . . 0.0 116.92 168.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.98 -36.6 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 124.91 1.284 . . . . 0.0 111.371 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -57.91 -19.53 30.43 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.761 1.225 . . . . 0.0 114.306 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -89.77 -15.79 31.64 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.905 1.682 . . . . 0.0 114.97 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.96 153.13 92.94 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.032 1.333 . . . . 0.0 113.704 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.81 -27.78 8.45 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.658 3.572 . . . . 0.0 114.825 -174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.65 -2.18 54.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 163.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 69.79 -142.02 35.84 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 -168.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.07 -21.88 65.31 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 120.698 -1.472 . . . . 0.0 112.782 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -70.47 -7.75 45.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.294 0.638 . . . . 0.0 112.112 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.6 m -63.15 -21.12 65.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.959 1.254 . . . . 0.0 112.099 166.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -87.1 -25.63 24.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 112.85 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -144.63 149.31 35.51 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -167.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -103.58 81.76 1.94 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 123.167 1.461 . . . . 0.0 114.031 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 C--O 1.242 0.692 0 C-N-CA 128.09 2.556 . . . . 0.0 110.323 174.013 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.994 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.1 p -158.71 154.93 27.16 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.018 1.327 . . . . 0.0 111.203 173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt -136.98 -8.6 1.81 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.648 1.579 . . . . 0.0 114.547 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 65.2 m95 -116.33 141.42 48.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.376 1.471 . . . . 0.0 110.538 172.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -116.55 100.12 7.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.57 1.148 . . . . 0.0 109.666 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -119.42 119.41 33.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.847 1.659 . . . . 0.0 114.923 -173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -148.2 157.86 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.572 2.349 . . . . 0.0 111.622 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.319 28.0 t80 -70.31 114.41 8.42 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 163.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.88 105.22 17.37 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.761 1.224 . . . . 0.0 111.873 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.29 -26.0 31.99 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.193 0.901 . . . . 0.0 113.028 166.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 93.2 p -151.77 158.12 42.91 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.926 1.29 . . . . 0.0 112.857 172.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.44 19.38 6.3 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.429 1.492 . . . . 0.0 112.958 175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -75.46 156.27 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.368 1.067 . . . . 0.0 111.559 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.264 1.3 p -127.26 -55.95 1.34 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -105.92 125.55 51.13 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.897 1.679 . . . . 0.0 109.32 167.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.486 0.1 OUTLIER -93.19 -178.6 4.82 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 165.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -84.34 157.85 21.34 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.752 -1.218 . . . . 0.0 113.205 -169.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.6 -114.57 4.98 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.49 1.043 . . . . 0.0 110.821 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -65.55 148.21 52.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.763 1.281 . . . . 0.0 112.825 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -81.93 122.98 28.45 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 43.69 54.41 5.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.008 1.323 . . . . 0.0 113.406 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 53.6 m80 59.66 4.0 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 117.776 2.51 . . . . 0.0 117.776 -177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.2 t -65.86 120.55 69.89 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 120.591 1.541 . . . . 0.0 112.868 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -63.14 -9.86 18.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.37 2.713 . . . . 0.0 116.363 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.58 164.06 36.16 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -168.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.329 6.6 t0 63.62 -70.99 0.06 Allowed 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.93 115.08 3.99 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.004 1.288 . . . . 0.0 114.135 -168.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.46 142.75 27.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.932 2.093 . . . . 0.0 110.792 169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -126.05 117.34 22.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.945 1.698 . . . . 0.0 111.349 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -86.22 21.59 2.0 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 -162.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.73 -154.62 12.07 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.88 -1.137 . . . . 0.0 114.341 -168.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.434 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.5 mt -136.39 144.08 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 127.502 2.321 . . . . 0.0 108.977 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.71 142.37 51.54 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -125.62 134.56 51.86 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.136 0.975 . . . . 0.0 112.789 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.47 37.16 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 128.902 2.881 . . . . 0.0 115.855 -171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.15 126.72 78.77 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 120.984 -1.072 . . . . 0.0 110.973 -169.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -61.26 160.45 26.83 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.76 2.307 . . . . 0.0 112.031 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -57.65 134.81 56.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 111.404 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.49 2.9 90.07 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.915 1.721 . . . . 0.0 115.621 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.6 m -61.07 129.42 90.5 Favored Pre-proline 0 N--CA 1.478 0.968 0 CA-C-N 120.528 2.164 . . . . 0.0 112.631 167.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -69.54 129.88 18.62 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.484 2.79 . . . . 0.0 111.229 175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.7 mm -103.18 137.94 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.142 1.777 . . . . 0.0 108.594 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -122.29 150.82 41.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.25 1.42 . . . . 0.0 110.574 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.66 118.83 55.15 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 118.271 -0.871 . . . . 0.0 109.574 169.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.42 -30.87 23.13 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.292 2.661 . . . . 0.0 112.38 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.5 p -136.31 166.84 22.52 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 127.763 2.425 . . . . 0.0 110.83 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -68.65 126.81 30.87 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.168 -0.957 . . . . 0.0 110.094 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -155.42 -169.91 20.36 Favored Glycine 0 N--CA 1.468 0.805 0 C-N-CA 123.351 0.501 . . . . 0.0 114.214 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -142.1 137.29 30.87 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.859 1.264 . . . . 0.0 111.083 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.5 t -66.34 125.68 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.479 0.581 . . . . 0.0 112.35 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.9 p -116.05 -16.64 11.04 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -163.02 156.33 19.57 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 118.793 0.724 . . . . 0.0 111.463 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.6 mt -139.5 125.08 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.121 1.368 . . . . 0.0 109.204 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -154.0 173.55 15.85 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -149.06 154.2 38.94 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -150.0 -172.0 4.05 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.94 2.096 . . . . 0.0 111.299 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -75.85 -29.33 58.54 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.2 tt -118.62 -41.37 2.81 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.348 1.059 . . . . 0.0 112.068 -168.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.63 -20.45 70.07 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 121.602 -0.686 . . . . 0.0 112.4 161.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.41 -136.11 39.44 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 118.789 1.295 . . . . 0.0 110.547 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -78.05 133.67 37.88 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.838 0.855 . . . . 0.0 111.568 167.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 t -119.02 132.73 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.141 1.776 . . . . 0.0 112.468 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 32.2 tp -103.37 135.15 45.53 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 0.0 110.433 165.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -119.91 127.11 52.39 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 175.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.8 mt -126.35 149.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 126.084 1.754 . . . . 0.0 110.119 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.89 130.94 57.0 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.403 1.481 . . . . 0.0 110.455 165.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -60.98 163.32 5.98 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -49.09 -46.19 44.33 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 -175.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -69.71 -3.72 16.56 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.57 12.26 83.15 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.688 1.613 . . . . 0.0 116.556 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -131.0 -27.25 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -90.39 137.7 32.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 166.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -123.79 151.78 42.94 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.746 1.218 . . . . 0.0 111.703 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -133.71 132.8 41.05 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.2 1.0 . . . . 0.0 111.614 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -109.65 141.73 41.78 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.427 1.491 . . . . 0.0 113.066 165.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -125.46 119.81 29.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 126.2 1.8 . . . . 0.0 106.371 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.22 164.22 15.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.946 0.899 . . . . 0.0 112.971 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 66.87 21.17 10.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.873 2.469 . . . . 0.0 114.28 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.37 153.46 22.78 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.292 1.437 . . . . 0.0 111.574 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -94.97 -32.15 13.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.675 0.79 . . . . 0.0 109.366 169.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 36.3 tttp -156.97 156.86 33.72 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 112.441 -159.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -115.94 143.17 45.81 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.289 1.435 . . . . 0.0 112.517 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -107.56 -17.06 14.2 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.006 0.922 . . . . 0.0 113.336 168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.73 166.0 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.359 1.463 . . . . 0.0 111.932 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -129.87 151.87 49.97 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 126.374 1.87 . . . . 0.0 112.814 -175.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -52.34 126.68 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 122.855 0.462 . . . . 0.0 112.091 174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 98.23 -10.82 63.65 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 125.264 1.412 . . . . 0.0 115.44 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -74.73 122.65 23.59 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.309 1.554 . . . . 0.0 114.861 174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.48 128.42 33.87 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.305 1.042 . . . . 0.0 108.705 168.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 32.1 m -122.85 154.5 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.325 1.45 . . . . 0.0 113.446 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 150.11 35.64 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.819 1.248 . . . . 0.0 110.365 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.53 105.64 0.19 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.295 1.038 . . . . 0.0 111.935 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 113.48 5.63 22.5 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.818 1.675 . . . . 0.0 115.904 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -81.64 131.14 35.26 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 127.248 2.219 . . . . 0.0 114.569 175.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.9 mm -62.92 126.26 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 119.813 1.188 . . . . 0.0 110.064 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 28.0 pt -112.96 -28.47 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.963 1.305 . . . . 0.0 112.787 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -171.82 -175.51 1.54 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.711 1.204 . . . . 0.0 111.191 -171.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.31 141.53 45.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.252 0.621 . . . . 0.0 112.252 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -64.14 150.64 45.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.737 1.215 . . . . 0.0 112.034 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.66 -157.58 8.57 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.017 1.294 . . . . 0.0 112.331 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -136.63 28.87 2.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.067 0.947 . . . . 0.0 112.552 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.2 p -64.79 -14.01 57.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.019 1.328 . . . . 0.0 113.158 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -125.88 18.67 6.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.175 1.369 . . . . 0.0 114.271 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.0 mt -129.62 127.52 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 118.488 1.144 . . . . 0.0 110.246 -170.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -84.46 25.1 0.91 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.866 1.667 . . . . 0.0 114.394 -169.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.2 t -159.8 164.99 33.27 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.154 2.182 . . . . 0.0 109.169 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.29 0.7 OUTLIER -67.2 -13.22 61.76 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 169.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.44 61.62 0.85 Allowed Glycine 0 CA--C 1.537 1.466 0 C-N-CA 126.689 2.09 . . . . 0.0 114.658 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.59 149.38 8.17 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.465 2.306 . . . . 0.0 113.549 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -161.72 141.79 10.39 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.172 0.989 . . . . 0.0 112.135 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 53.1 tp -70.5 138.67 51.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.017 168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -102.42 126.03 49.32 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.541 1.064 . . . . 0.0 108.691 153.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.256 47.5 t80 -112.66 126.65 55.61 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.018 1.727 . . . . 0.0 114.394 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -134.38 110.87 9.73 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.891 0.876 . . . . 0.0 111.825 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -87.14 135.19 33.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.331 1.852 . . . . 0.0 110.874 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 37.8 mtm -136.78 156.06 49.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.189 1.796 . . . . 0.0 110.899 -175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -131.48 122.75 26.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.236 1.014 . . . . 0.0 112.533 -171.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 80.0 -10.95 37.85 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.51 1.052 . . . . 0.0 115.483 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.15 -169.3 33.97 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 125.184 1.373 . . . . 0.0 111.138 171.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -124.5 129.45 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -175.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 136.78 162.09 9.27 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.366 1.46 . . . . 0.0 112.024 -172.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -56.64 -32.14 65.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.986 0.915 . . . . 0.0 112.924 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.98 68.55 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.04 -2.72 57.61 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.204 1.402 . . . . 0.0 113.962 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.86 143.46 56.85 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -171.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -142.76 157.45 44.62 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.78 1.232 . . . . 0.0 112.007 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -55.01 111.65 3.24 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.974 2.11 . . . . 0.0 114.391 -167.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.434 ' HG2' HD12 ' A' ' 79' ' ' ILE . 41.2 Cg_endo -87.14 -15.8 3.55 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.899 3.066 . . . . 0.0 113.267 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -55.48 -52.01 75.33 Favored Pre-proline 0 N--CA 1.484 1.27 0 CA-C-N 121.088 1.767 . . . . 0.0 111.995 -176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.7 -16.27 21.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.902 2.402 . . . . 0.0 112.684 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.254 1.9 t80 -75.84 -22.83 55.84 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.423 2.009 . . . . 0.0 116.423 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.8 mt -83.06 -36.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.679 1.191 . . . . 0.0 111.798 171.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -55.19 -24.83 29.0 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -91.63 -8.77 46.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.31 2.244 . . . . 0.0 115.037 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.47 151.18 91.73 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.271 1.028 . . . . 0.0 112.194 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.93 -33.33 42.74 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.645 2.897 . . . . 0.0 112.886 -172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -102.81 3.92 37.26 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.18 -140.52 37.77 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.738 -1.226 . . . . 0.0 110.927 -171.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -58.35 -24.63 60.36 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 120.966 -1.314 . . . . 0.0 112.522 173.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 31.0 mtt-85 -75.03 -3.64 33.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 112.757 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.8 m -72.04 -21.67 61.5 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.138 -0.976 . . . . 0.0 112.482 163.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.16 -25.26 29.75 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.689 1.131 . . . . 0.0 112.798 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -147.65 154.14 40.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.458 1.026 . . . . 0.0 112.557 -169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.11 98.54 8.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.277 1.431 . . . . 0.0 114.209 174.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.445 1.498 . . . . 0.0 110.316 167.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.104 0 CA-C-O 119.583 -0.565 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -78.37 153.33 31.72 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.037 1.335 . . . . 0.0 111.697 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.1 mmtt -132.56 166.51 21.92 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.211 1.404 . . . . 0.0 112.821 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -104.4 -51.92 3.01 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.0 112.532 166.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -78.94 160.06 27.42 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.351 1.061 . . . . 0.0 113.265 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.296 1.0 OUTLIER -134.42 157.54 46.18 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 178.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.277 63.0 m-85 -74.48 80.15 1.93 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 117.829 2.529 . . . . 0.0 117.829 -170.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.258 29.6 t80 -59.8 131.44 50.91 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 168.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 mpt_? -70.46 15.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -75.14 -21.58 77.87 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 120.702 -1.249 . . . . 0.0 113.854 162.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 97.4 p -159.92 -179.51 7.87 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.22 1.408 . . . . 0.0 112.529 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -111.27 26.51 10.6 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.205 1.802 . . . . 0.0 112.934 157.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.66 139.0 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 120.446 -1.409 . . . . 0.0 113.868 -166.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -103.96 -45.63 4.7 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.913 2.085 . . . . 0.0 114.548 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 mp0 -142.54 128.63 19.7 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.134 1.774 . . . . 0.0 110.279 175.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.384 0.2 OUTLIER -88.65 179.02 6.34 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.29 1.436 . . . . 0.0 114.023 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -78.21 153.31 32.07 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.19 -149.09 21.15 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.433 1.016 . . . . 0.0 112.243 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -50.47 143.05 9.62 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.753 1.276 . . . . 0.0 112.948 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . 0.279 51.0 t80 -111.95 179.0 4.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.902 1.681 . . . . 0.0 114.725 -168.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -51.95 156.24 1.58 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.672 1.189 . . . . 0.0 112.061 170.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -63.69 124.99 22.86 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.601 -1.312 . . . . 0.0 112.193 -174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 m -175.22 148.82 1.1 Allowed Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.102 1.761 . . . . 0.0 112.892 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.17 -24.82 14.31 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.263 2.642 . . . . 0.0 115.86 -172.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -128.33 -12.76 5.04 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -174.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -95.79 14.33 23.63 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.072 2.149 . . . . 0.0 116.317 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.0 -6.99 40.93 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -156.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -136.7 134.97 37.78 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.156 1.478 . . . . 0.0 110.184 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -103.35 109.26 20.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.907 1.683 . . . . 0.0 109.256 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.255 85.8 m-85 -78.46 27.4 0.21 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -170.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -175.39 -155.56 12.93 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.16 1.362 . . . . 0.0 113.415 -168.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 mt -135.51 138.01 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.746 2.019 . . . . 0.0 110.149 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -111.98 129.52 56.16 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -117.5 127.44 54.01 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.91 97.12 1.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.398 1.479 . . . . 0.0 111.117 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 52.7 mt -136.68 132.25 18.51 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 126.066 1.746 . . . . 0.0 108.302 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.78 162.6 40.64 Favored 'Trans proline' 0 C--O 1.243 0.73 0 C-N-CA 122.912 2.408 . . . . 0.0 112.629 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -50.21 135.04 21.89 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.088 1.355 . . . . 0.0 111.13 170.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.41 3.82 86.46 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.898 1.237 . . . . 0.0 115.977 -178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.6 m -60.83 127.14 86.96 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-N 120.523 2.161 . . . . 0.0 112.927 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.76 129.63 19.05 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.061 2.508 . . . . 0.0 111.708 175.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 29.6 mm -105.11 134.35 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 125.885 1.674 . . . . 0.0 109.311 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.94 151.48 32.24 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 110.58 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.21 124.91 90.83 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.848 169.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.09 -34.54 13.3 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.658 2.239 . . . . 0.0 112.694 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.3 p -130.29 153.39 48.69 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.965 2.506 . . . . 0.0 109.759 -175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -63.6 128.15 34.55 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 121.38 -0.825 . . . . 0.0 111.298 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.84 -162.74 10.27 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -140.86 138.6 34.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.91 2.084 . . . . 0.0 110.682 171.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.3 t -70.11 124.78 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.039 0.836 . . . . 0.0 112.06 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -117.25 -17.3 10.23 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -173.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -160.51 151.47 18.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.201 1.0 . . . . 0.0 111.226 172.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.8 mt -133.07 134.5 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.596 1.159 . . . . 0.0 110.497 169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -154.1 172.07 18.12 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.936 1.295 . . . . 0.0 113.773 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -148.43 150.02 32.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.762 0.825 . . . . 0.0 112.589 172.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -153.43 162.79 40.92 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.333 1.053 . . . . 0.0 112.977 -174.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.27 -28.17 65.01 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -174.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.32 -18.69 25.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 114.242 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.06 -13.35 4.06 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 125.221 1.391 . . . . 0.0 114.907 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.79 -142.04 32.84 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 118.459 1.13 . . . . 0.0 111.965 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -74.97 125.94 29.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.476 1.111 . . . . 0.0 111.439 169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.0 t -110.42 134.84 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.458 1.503 . . . . 0.0 112.696 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.7 tp -111.97 131.1 55.61 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 110.472 167.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -117.99 129.54 55.65 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.5 mt -134.44 132.04 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.16 1.384 . . . . 0.0 110.713 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -97.93 125.6 42.91 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.676 1.19 . . . . 0.0 111.538 171.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -62.82 146.18 53.23 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -66.92 -16.14 64.13 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -74.46 -4.06 34.39 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.332 1.053 . . . . 0.0 113.714 166.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.46 24.83 60.09 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 116.041 1.176 . . . . 0.0 116.041 157.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.43 -24.46 0.24 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.369 1.989 . . . . 0.0 116.369 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . 0.255 64.7 m-85 -89.03 146.17 25.02 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -127.33 131.4 50.44 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.74 2.016 . . . . 0.0 109.849 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.48 139.23 42.31 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.921 1.688 . . . . 0.0 111.849 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -114.51 140.03 49.07 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.368 1.867 . . . . 0.0 112.726 162.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.5 119.78 32.98 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.5 mt -107.46 165.46 11.39 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.079 0.952 . . . . 0.0 111.889 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 64.64 25.09 13.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.258 1.823 . . . . 0.0 115.427 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.05 154.78 25.81 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.059 -1.026 . . . . 0.0 111.487 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.76 -32.45 12.71 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 165.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -155.35 155.62 33.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.929 0.891 . . . . 0.0 112.322 -160.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -117.13 134.3 54.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.848 1.259 . . . . 0.0 111.316 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -97.06 -12.99 22.53 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.456 1.102 . . . . 0.0 112.615 170.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.34 166.04 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.791 2.037 . . . . 0.0 111.608 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -135.38 158.82 43.4 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.756 1.622 . . . . 0.0 112.105 -177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.2 128.42 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.314 0.578 . . . . 0.0 111.23 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.99 -20.67 44.69 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.91 1.719 . . . . 0.0 115.07 -167.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -70.35 127.65 33.48 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -80.59 127.06 32.03 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.875 1.27 . . . . 0.0 111.05 170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 33.1 m -119.41 143.1 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.282 1.033 . . . . 0.0 113.666 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -104.39 151.19 23.79 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 125.918 1.687 . . . . 0.0 111.45 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.43 103.78 0.44 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.555 1.142 . . . . 0.0 111.618 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.03 2.08 39.1 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 126.47 1.986 . . . . 0.0 115.188 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -81.13 136.86 35.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.01 125.26 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 124.255 1.022 . . . . 0.0 109.804 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 41.0 pt -108.04 -29.31 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.444 1.098 . . . . 0.0 112.535 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.03 -175.63 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 120.82 -1.175 . . . . 0.0 111.25 -170.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -135.1 137.79 43.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.245 0.618 . . . . 0.0 110.471 176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.2 t -66.27 148.79 51.33 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.398 1.479 . . . . 0.0 112.182 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.12 -152.69 6.25 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.537 1.065 . . . . 0.0 112.233 -177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.474 ' HA ' HD12 ' A' ' 151' ' ' ILE . 13.3 t30 -141.37 29.37 1.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.02 1.328 . . . . 0.0 111.495 -172.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -73.92 130.47 39.95 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.814 -1.178 . . . . 0.0 109.285 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 64.03 10.95 42.73 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 148' ' ' ASN . 42.7 mt -74.09 -31.42 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.295 2.047 . . . . 0.0 112.487 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 51.84 29.44 5.96 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.443 1.497 . . . . 0.0 113.78 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.329 0.2 OUTLIER -143.81 34.35 1.26 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.812 2.045 . . . . 0.0 116.415 -169.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.362 0.2 OUTLIER 69.13 -25.64 0.14 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 119.8 3.259 . . . . 0.0 119.8 175.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -167.41 167.04 39.68 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 120.535 1.516 . . . . 0.0 116.358 -177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.55 146.67 53.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.083 2.623 . . . . 0.0 118.083 -163.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -157.33 147.4 20.75 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.963 2.105 . . . . 0.0 110.13 154.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.8 tp -78.18 133.71 37.73 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.401 -0.812 . . . . 0.0 109.362 168.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -91.5 135.44 33.85 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.087 0.858 . . . . 0.0 109.769 159.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -124.54 124.49 42.38 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.38 1.072 . . . . 0.0 112.993 168.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -137.13 125.13 22.79 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.823 1.249 . . . . 0.0 110.299 -172.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 64.4 ttt-85 -122.06 135.41 54.82 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.98 1.312 . . . . 0.0 110.644 -175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 36.6 mtm -138.94 135.56 34.52 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.912 1.285 . . . . 0.0 110.749 -162.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -107.99 131.64 54.35 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.364 1.066 . . . . 0.0 112.228 -174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 78.89 -14.28 14.58 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.409 1.004 . . . . 0.0 114.845 173.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -174.43 -159.46 20.8 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 127.208 2.337 . . . . 0.0 109.258 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 131.99 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -171.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 131.77 172.91 13.19 Favored Glycine 0 CA--C 1.54 1.618 0 C-N-CA 126.429 1.966 . . . . 0.0 112.845 -170.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.76 -38.69 70.17 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -75.12 -9.92 58.99 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -103.17 -12.3 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.196 0.999 . . . . 0.0 111.162 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.78 145.09 56.4 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.149 0.98 . . . . 0.0 113.251 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.4 157.1 46.04 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.735 1.214 . . . . 0.0 111.702 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -63.64 110.97 4.3 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.268 1.427 . . . . 0.0 111.831 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -83.99 -16.91 6.07 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.509 3.472 . . . . 0.0 112.795 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -49.61 91.57 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.347 1.459 . . . . 0.0 112.681 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.76 -24.28 13.52 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.92 2.414 . . . . 0.0 112.889 174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -69.27 -26.45 64.77 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 170.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 53.3 mt -80.39 -38.65 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.563 1.145 . . . . 0.0 111.301 171.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.07 -26.69 16.99 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.88 -12.2 55.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 0.0 114.03 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.5 149.95 95.6 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 121.156 -0.965 . . . . 0.0 112.026 -176.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.62 -23.55 49.31 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 124.053 3.169 . . . . 0.0 113.58 -173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -113.2 4.01 16.31 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.745 2.018 . . . . 0.0 116.156 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.81 -138.15 39.61 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 120.567 -1.333 . . . . 0.0 111.141 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.45 -19.25 65.86 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.566 -1.549 . . . . 0.0 112.741 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 33.1 mtm-85 -71.54 -7.85 50.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.995 0.918 . . . . 0.0 113.147 174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -69.03 -19.48 64.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.215 -0.928 . . . . 0.0 112.634 162.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mp -97.01 -22.38 16.85 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 117.743 -1.122 . . . . 0.0 113.513 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -135.84 141.59 44.69 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 117.185 2.291 . . . . 0.0 117.185 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -101.26 74.85 1.59 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.779 1.232 . . . . 0.0 110.778 176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 124.203 1.001 . . . . 0.0 113.511 -167.652 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.2 t -90.76 169.66 10.77 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.639 1.175 . . . . 0.0 111.838 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -56.37 136.97 53.44 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.986 1.714 . . . . 0.0 112.176 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -84.48 151.33 24.68 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 59.0 mp0 -68.32 117.01 9.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.855 1.262 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.04 136.94 49.95 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 115.629 1.715 . . . . 0.0 115.629 -174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.367 8.1 p90 -109.1 -1.77 18.58 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.594 3.183 . . . . 0.0 119.594 -172.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.295 47.8 t80 -64.74 139.64 58.78 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -62.77 -6.04 3.3 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.86 143.7 45.08 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.193 0.906 . . . . 0.0 113.581 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.0 p -49.04 127.99 15.36 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.39 1.876 . . . . 0.0 115.143 -176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -107.92 -3.3 19.0 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -154.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 tt -66.55 148.16 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-N 119.546 1.066 . . . . 0.0 113.356 -163.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -110.58 -42.21 4.13 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.548 1.539 . . . . 0.0 114.418 172.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -135.85 123.92 22.92 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.165 1.386 . . . . 0.0 111.021 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.41 0.0 OUTLIER -87.93 160.11 18.06 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.551 1.14 . . . . 0.0 112.777 169.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . 0.332 41.3 t80 -66.33 153.1 43.55 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.22 -139.37 14.43 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.396 0.998 . . . . 0.0 113.118 -177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -59.17 150.59 24.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.348 1.074 . . . . 0.0 113.36 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -150.74 126.65 10.4 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 117.84 2.533 . . . . 0.0 117.84 -164.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -59.68 -32.47 70.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -163.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -83.57 -6.81 59.55 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 119.859 1.209 . . . . 0.0 113.484 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -107.92 156.62 37.85 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.003 1.721 . . . . 0.0 111.098 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -63.36 176.65 1.98 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.735 2.957 . . . . 0.0 115.839 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -47.82 -43.75 28.24 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 117.304 2.335 . . . . 0.0 117.304 175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.5 p30 -94.19 15.55 17.0 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.77 165.21 43.74 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.726 1.631 . . . . 0.0 114.662 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.77 143.2 29.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.105 1.762 . . . . 0.0 110.93 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -91.92 118.2 30.52 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.67 0.788 . . . . 0.0 109.492 164.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.286 97.6 m-85 -81.08 30.19 0.33 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -164.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.49 -147.19 10.75 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.531 1.539 . . . . 0.0 112.048 -169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.4 141.33 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.912 1.685 . . . . 0.0 111.279 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -111.74 131.2 55.48 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.03 126.61 50.31 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.37 106.54 5.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.955 1.302 . . . . 0.0 112.181 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.5 mt -142.04 137.76 16.21 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.287 1.835 . . . . 0.0 107.969 -176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.95 154.49 69.78 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.682 2.255 . . . . 0.0 111.315 174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -65.87 136.96 56.84 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.689 0.757 . . . . 0.0 110.36 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.93 16.49 72.36 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.399 0.999 . . . . 0.0 114.335 -169.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 31.8 m -68.06 130.1 92.76 Favored Pre-proline 0 N--CA 1.469 0.504 0 CA-C-N 119.216 1.508 . . . . 0.0 110.478 160.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -68.96 122.54 9.43 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 110.792 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.1 mm -94.84 134.77 31.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 125.411 1.484 . . . . 0.0 108.54 176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -119.88 152.31 37.55 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.711 1.604 . . . . 0.0 109.57 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.97 132.61 84.58 Favored Pre-proline 0 CA--C 1.551 0.999 0 CA-C-O 118.763 -0.637 . . . . 0.0 110.957 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.79 -24.71 17.77 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.796 2.997 . . . . 0.0 112.629 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.1 p -135.93 161.46 35.59 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.248 2.219 . . . . 0.0 112.943 -173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 -77.11 84.55 3.6 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 122.226 1.013 . . . . 0.0 110.874 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -107.18 -175.85 22.72 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.638 1.113 . . . . 0.0 114.082 -174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -137.1 133.54 35.46 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.397 -1.061 . . . . 0.0 111.127 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.46 131.09 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.989 0.916 . . . . 0.0 113.122 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.7 p -134.96 6.51 3.4 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.815 1.246 . . . . 0.0 113.279 -171.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 179.84 146.23 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 126.798 2.039 . . . . 0.0 111.538 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.4 mt -145.13 129.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.839 1.655 . . . . 0.0 109.476 171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.21 172.89 15.9 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.532 1.133 . . . . 0.0 112.626 -172.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -119.89 137.77 53.82 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 109.341 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -125.93 145.31 50.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.45 1.9 . . . . 0.0 111.927 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -62.92 -25.49 68.36 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -173.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.49 -41.72 4.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.261 1.425 . . . . 0.0 111.659 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.77 -17.06 68.8 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.792 1.187 . . . . 0.0 115.64 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.31 -140.8 30.18 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.03 1.415 . . . . 0.0 111.928 -173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -72.23 124.16 24.47 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.532 1.133 . . . . 0.0 112.072 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -111.36 132.72 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 113.168 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.6 tp -105.23 133.49 49.92 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.312 1.045 . . . . 0.0 110.276 164.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -118.71 131.52 56.14 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.6 mt -131.94 134.73 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.19 1.396 . . . . 0.0 109.896 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.36 129.78 43.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.817 1.247 . . . . 0.0 111.398 169.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -71.98 156.37 39.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.538 1.135 . . . . 0.0 113.782 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -67.07 -23.66 65.89 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.01 -21.08 63.24 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.6 89.4 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.159 1.361 . . . . 0.0 114.506 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -112.85 -33.07 6.2 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.078 1.439 . . . . 0.0 113.64 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -88.39 146.01 25.49 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 117.57 2.433 . . . . 0.0 117.57 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -130.74 152.67 49.84 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.844 2.057 . . . . 0.0 110.184 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -129.1 140.67 51.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.21 1.404 . . . . 0.0 111.651 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -118.84 141.43 48.65 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.397 1.879 . . . . 0.0 112.901 168.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -124.37 127.67 47.93 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 171.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.1 167.21 17.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.953 0.901 . . . . 0.0 112.402 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 64.0 24.8 13.69 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.683 1.993 . . . . 0.0 114.233 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 83.9 mt -67.23 155.05 39.81 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.929 0.892 . . . . 0.0 111.999 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -93.25 -38.01 11.76 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.456 1.102 . . . . 0.0 110.098 167.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -155.13 157.08 36.9 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.571 0.749 . . . . 0.0 111.945 -156.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.31 135.06 54.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.216 1.407 . . . . 0.0 112.302 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -102.9 -9.17 20.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.17 159.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.024 2.13 . . . . 0.0 111.453 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -134.49 161.54 34.77 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.867 1.667 . . . . 0.0 112.594 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . 0.283 12.2 t -56.53 134.78 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.819 -0.551 . . . . 0.0 112.272 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.25 63.1 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 126.031 1.777 . . . . 0.0 115.522 -166.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.7 131.51 44.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.392 1.596 . . . . 0.0 115.142 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.36 125.07 34.98 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.461 1.105 . . . . 0.0 109.231 174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.2 m -120.17 166.95 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.608 1.163 . . . . 0.0 114.068 -175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -130.9 148.17 52.63 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 125.86 1.664 . . . . 0.0 112.291 -168.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.17 105.09 0.3 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.312 1.045 . . . . 0.0 112.071 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 97.0 9.05 56.45 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.535 1.54 . . . . 0.0 115.324 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -85.92 137.37 32.79 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 172.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 40.4 mm -66.77 126.03 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.671 1.188 . . . . 0.0 110.39 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 30.7 pt -110.28 -28.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.1 1.36 . . . . 0.0 113.046 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.34 -177.37 2.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.487 1.115 . . . . 0.0 111.264 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.62 141.9 48.88 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 111.127 174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 81.0 p -64.05 148.23 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.939 0.896 . . . . 0.0 112.247 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -140.03 -150.28 5.46 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.506 1.051 . . . . 0.0 110.68 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.17 31.48 3.52 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.15 0.98 . . . . 0.0 112.117 168.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.4 p -69.74 139.65 53.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.335 1.054 . . . . 0.0 113.178 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.54 -31.14 1.01 Allowed Glycine 0 CA--C 1.54 1.655 0 C-N-CA 124.999 1.285 . . . . 0.0 115.677 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.1 mt -66.4 133.68 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.264 1.532 . . . . 0.0 111.73 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.55 38.32 2.96 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.01 1.724 . . . . 0.0 111.966 173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.253 1.3 t -142.17 156.55 45.35 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.474 2.31 . . . . 0.0 112.885 167.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.268 1.7 m -70.56 -25.69 63.21 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.97 97.79 0.94 Allowed Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.764 1.173 . . . . 0.0 114.464 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.37 147.43 52.12 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.76 0.78 . . . . 0.0 111.956 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -164.92 153.04 11.83 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.78 1.232 . . . . 0.0 111.799 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.5 tp -77.05 135.67 38.64 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 163.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -96.21 125.58 40.83 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 157.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.269 64.8 t80 -117.65 127.0 53.52 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -138.24 114.93 10.61 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.011 0.924 . . . . 0.0 111.329 -168.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.4 ttt-85 -103.49 135.2 45.52 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.631 1.572 . . . . 0.0 110.637 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.9 mtm -133.12 135.51 45.26 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.417 1.487 . . . . 0.0 110.381 -171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -108.05 130.91 55.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.229 1.012 . . . . 0.0 110.744 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 82.59 -9.16 59.8 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.737 1.161 . . . . 0.0 115.942 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.93 -169.33 40.0 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.988 1.28 . . . . 0.0 112.379 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.72 124.39 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 133.48 168.72 11.95 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.487 1.994 . . . . 0.0 113.002 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -55.21 -32.64 62.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.261 1.024 . . . . 0.0 113.417 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -68.14 -14.65 63.14 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.43 -5.83 26.55 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.52 146.4 54.9 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -131.46 165.95 22.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.567 1.547 . . . . 0.0 111.661 171.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.38 112.39 7.62 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.744 1.618 . . . . 0.0 110.936 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -86.39 -15.7 4.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.67 2.914 . . . . 0.0 112.347 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.1 -50.09 85.83 Favored Pre-proline 0 N--CA 1.478 0.948 0 CA-C-N 120.866 1.666 . . . . 0.0 112.907 -174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -67.06 -27.05 42.57 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 121.757 1.638 . . . . 0.0 112.455 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -67.47 -27.72 67.26 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 169.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 57.5 mt -83.57 -40.83 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.621 1.568 . . . . 0.0 111.467 171.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -58.8 -12.62 4.57 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 117.579 2.437 . . . . 0.0 117.579 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -92.48 -14.71 28.07 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.068 1.747 . . . . 0.0 114.7 171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 76.9 mt -72.49 153.63 91.8 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 124.862 1.265 . . . . 0.0 113.17 -167.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.15 -24.93 58.43 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.428 2.752 . . . . 0.0 113.528 -174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -112.9 5.18 17.24 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.18 1.792 . . . . 0.0 115.074 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 62.25 -137.24 45.39 Favored Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.633 -1.292 . . . . 0.0 111.738 -171.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.49 -24.91 64.0 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.116 -1.226 . . . . 0.0 112.799 173.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -74.43 -5.6 43.41 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 m -66.59 -19.81 65.86 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.058 1.299 . . . . 0.0 112.104 165.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -86.76 -21.44 26.53 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.206 1.002 . . . . 0.0 112.946 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -143.08 143.89 32.04 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -169.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -99.91 74.79 1.84 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.816 1.247 . . . . 0.0 108.365 173.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.5 tm? . . . . . 0 C--O 1.24 0.579 0 C-N-CA 126.354 1.862 . . . . 0.0 111.551 -172.649 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.963 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -65.31 143.99 57.41 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.152 1.381 . . . . 0.0 114.169 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 tptt -68.06 -30.14 69.27 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.639 0.775 . . . . 0.0 112.49 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -67.61 -19.44 65.23 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -74.57 -21.32 59.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.848 0.859 . . . . 0.0 112.444 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -57.88 144.88 37.4 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.665 1.358 . . . . 0.0 114.665 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -72.82 81.9 1.17 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.955 1.302 . . . . 0.0 112.169 168.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 38.1 t80 -62.71 130.38 44.7 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -176.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -71.3 147.51 48.04 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -162.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.17 -11.84 0.68 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.126 1.346 . . . . 0.0 115.774 170.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 98.6 p -69.32 139.35 54.26 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -94.44 28.15 2.69 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.825 1.65 . . . . 0.0 112.894 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -78.92 159.38 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.01 1.324 . . . . 0.0 113.601 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.33 0.6 OUTLIER -118.88 -48.38 2.46 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -141.95 137.51 31.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.546 1.539 . . . . 0.0 112.294 168.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.447 0.1 OUTLIER -91.85 179.68 5.55 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 168.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -70.27 149.61 47.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 111.36 -173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.12 -165.92 12.45 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.106 1.336 . . . . 0.0 112.614 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.47 133.04 53.23 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.497 -1.59 . . . . 0.0 111.113 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -54.13 152.27 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 164.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -75.08 -32.48 61.47 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -155.66 133.88 11.54 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.403 2.281 . . . . 0.0 110.12 165.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.6 t -160.48 114.04 1.38 Allowed Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.837 1.255 . . . . 0.0 111.607 169.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -83.67 22.34 0.94 Allowed 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 123.692 2.928 . . . . 0.0 113.499 176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -134.5 -52.49 0.82 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -105.58 -27.02 11.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.92 -70.73 0.96 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.13 1.347 . . . . 0.0 113.513 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HE2' ' CE2' ' A' ' 77' ' ' TYR . 72.8 tttt -95.07 122.72 38.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.747 1.619 . . . . 0.0 109.998 169.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -76.48 97.36 4.3 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.973 0.909 . . . . 0.0 109.684 172.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE2' ' HE2' ' A' ' 75' ' ' LYS . 94.2 m-85 -78.73 91.84 4.73 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.147 -0.346 . . . . 0.0 111.009 164.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.09 -165.78 27.27 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.324 0.964 . . . . 0.0 114.595 174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD12 ' HG2' ' A' ' 175' ' ' PRO . 2.0 mt -128.58 140.35 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.945 2.098 . . . . 0.0 109.053 171.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.71 132.94 54.98 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.9 1.28 . . . . 0.0 114.054 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -119.18 129.02 54.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.92 90.78 1.15 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.004 1.322 . . . . 0.0 111.692 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.3 mt -136.44 122.57 13.68 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.404 1.482 . . . . 0.0 110.077 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.71 160.38 32.99 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.914 3.076 . . . . 0.0 113.242 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -61.44 128.83 38.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.502 0.668 . . . . 0.0 110.796 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.51 8.27 74.35 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.338 0.97 . . . . 0.0 114.785 -172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 26.6 m -63.16 128.52 92.45 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 120.373 2.086 . . . . 0.0 111.798 166.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -70.77 131.53 19.99 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.814 2.343 . . . . 0.0 111.636 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.6 mm -108.68 130.49 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.588 1.555 . . . . 0.0 109.32 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.02 153.19 23.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.697 1.599 . . . . 0.0 110.538 -177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 126.54 91.9 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 119.242 -0.409 . . . . 0.0 109.954 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.22 -37.22 14.61 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.565 2.177 . . . . 0.0 111.656 176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 47.3 p -131.88 165.8 23.04 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 128.248 2.619 . . . . 0.0 108.999 -174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -70.98 130.76 42.42 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.822 -1.174 . . . . 0.0 108.996 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.4 -176.42 26.68 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 116.444 1.338 . . . . 0.0 116.444 173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -129.22 133.3 47.48 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.266 -1.138 . . . . 0.0 110.224 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.2 t -63.48 128.07 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.4 p -116.79 -17.38 10.49 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.021 0.928 . . . . 0.0 110.864 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 51.7 mt -139.39 128.77 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 126.253 1.821 . . . . 0.0 109.246 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -151.44 173.29 14.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 -174.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -121.27 157.78 29.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.482 1.513 . . . . 0.0 110.571 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -146.63 156.45 43.21 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.365 1.866 . . . . 0.0 111.267 164.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -55.63 -54.87 38.82 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -175.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.82 6.41 47.86 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.829 1.251 . . . . 0.0 113.527 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.88 -30.87 7.67 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.758 1.17 . . . . 0.0 113.052 169.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 -145.3 46.95 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.212 -1.169 . . . . 0.0 110.694 -162.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.88 128.96 38.55 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.345 1.058 . . . . 0.0 112.422 169.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 135.31 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.436 1.894 . . . . 0.0 112.727 170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.0 tp -111.07 131.59 54.94 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.198 0.999 . . . . 0.0 110.26 165.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.65 127.36 52.83 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 24.3 mt -133.79 137.91 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.566 1.546 . . . . 0.0 110.756 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -100.77 126.18 47.31 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.997 1.319 . . . . 0.0 111.572 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -67.67 152.22 45.97 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.277 -0.889 . . . . 0.0 113.121 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . 0.31 78.7 m-20 -67.0 4.0 0.97 Allowed 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 165.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -74.59 -12.78 60.54 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.72 2.008 . . . . 0.0 115.47 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.92 6.1 87.14 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 172.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -157.93 2.73 0.11 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -176.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -117.66 145.04 44.66 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.421 2.008 . . . . 0.0 116.421 -174.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -131.83 159.64 37.96 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.872 1.669 . . . . 0.0 111.753 177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.53 145.8 41.17 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.053 1.341 . . . . 0.0 112.666 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -122.39 138.22 54.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.409 2.284 . . . . 0.0 112.568 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -121.31 131.73 54.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.829 1.652 . . . . 0.0 106.786 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 159' ' ' HIS . 4.8 mp -127.14 163.72 23.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.747 1.158 . . . . 0.0 113.743 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 66.34 16.99 10.61 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.878 2.471 . . . . 0.0 114.591 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.3 mt -56.9 151.32 14.83 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.692 1.197 . . . . 0.0 112.302 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -88.49 -32.54 18.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.895 1.278 . . . . 0.0 110.035 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -163.67 159.51 21.69 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.315 1.446 . . . . 0.0 111.363 -159.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -119.34 143.49 47.36 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.112 1.365 . . . . 0.0 110.469 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -99.89 -20.53 16.1 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.288 0.635 . . . . 0.0 112.706 164.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.66 168.75 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.169 1.388 . . . . 0.0 112.54 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -138.35 155.52 48.47 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.684 1.593 . . . . 0.0 111.747 -174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.74 132.1 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 121.4 0.619 . . . . 0.0 111.839 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.45 84.96 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 117.946 -1.475 . . . . 0.0 115.614 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -87.77 135.98 33.15 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 121.009 2.404 . . . . 0.0 110.799 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.6 135.65 33.71 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.955 1.702 . . . . 0.0 109.572 177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 19.4 m -128.2 153.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 125.75 1.62 . . . . 0.0 113.56 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -111.72 148.33 33.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.802 1.641 . . . . 0.0 111.541 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -51.05 113.47 0.93 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 110.896 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 100.74 0.31 55.28 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.845 1.688 . . . . 0.0 115.025 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -86.9 144.47 26.96 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.17 1.485 . . . . 0.0 108.782 177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.2 mm -65.04 129.5 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 124.054 0.942 . . . . 0.0 110.905 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.7 pt -111.88 -29.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.228 1.411 . . . . 0.0 112.607 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.76 -178.05 2.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.803 1.241 . . . . 0.0 111.072 -170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -128.82 139.54 52.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.342 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.3 t -68.15 151.74 46.54 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.381 1.073 . . . . 0.0 111.706 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.0 6.56 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.969 1.271 . . . . 0.0 112.154 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -136.1 23.89 3.28 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 p -67.6 -3.92 10.3 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -167.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.16 41.57 0.9 Allowed Glycine 0 CA--C 1.536 1.366 0 CA-C-N 120.586 1.539 . . . . 0.0 115.25 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 88.9 mt -125.66 139.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.867 1.334 . . . . 0.0 111.091 -173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -97.8 -14.89 20.52 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 p -74.47 168.93 18.75 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.129 -0.982 . . . . 0.0 113.615 162.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . 0.331 0.2 OUTLIER -74.72 -0.99 19.92 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 169.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -88.4 -177.03 47.24 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.949 1.261 . . . . 0.0 115.441 -177.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -145.16 134.96 23.57 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.063 1.745 . . . . 0.0 110.49 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -156.01 147.24 22.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.2 1.0 . . . . 0.0 111.682 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.5 tp -74.82 132.71 41.75 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 167.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 24.0 t60 -94.69 134.66 37.04 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 118.825 -0.607 . . . . 0.0 109.773 159.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.279 52.1 t80 -131.87 133.5 44.69 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -145.43 133.91 21.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.429 1.091 . . . . 0.0 110.646 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -115.55 133.66 55.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.971 1.708 . . . . 0.0 110.856 -176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.3 mtm -112.81 149.49 32.99 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.66 1.584 . . . . 0.0 111.704 175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -121.98 135.82 54.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.589 1.156 . . . . 0.0 110.728 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.82 -6.38 33.65 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.434 1.492 . . . . 0.0 115.66 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -179.56 -164.66 32.37 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.655 1.598 . . . . 0.0 111.742 176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.3 135.95 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.101 0.96 . . . . 0.0 112.671 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 121.4 159.66 10.77 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.833 1.682 . . . . 0.0 111.775 -172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -55.13 -29.17 57.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -69.52 -19.1 63.72 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -95.2 -8.19 36.91 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.086 1.355 . . . . 0.0 114.312 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.07 152.59 39.93 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.533 1.133 . . . . 0.0 113.127 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -131.04 161.51 31.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.054 1.341 . . . . 0.0 112.551 168.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -64.29 111.65 5.97 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.036 1.334 . . . . 0.0 112.121 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.454 ' HG2' HD12 ' A' ' 79' ' ' ILE . 37.1 Cg_endo -82.89 -14.07 8.94 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.081 3.187 . . . . 0.0 112.686 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -54.36 47.94 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-N 121.291 1.86 . . . . 0.0 111.637 -177.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.12 -22.68 30.08 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.105 1.87 . . . . 0.0 113.076 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.15 -31.81 66.3 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 65.1 mt -80.68 -41.05 19.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.106 1.362 . . . . 0.0 110.936 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -54.94 -19.19 6.14 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.52 -7.53 34.39 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 127.024 2.13 . . . . 0.0 115.087 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 78.6 mt -71.78 155.69 91.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.254 1.422 . . . . 0.0 112.995 -176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -62.55 -25.82 75.77 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.786 2.991 . . . . 0.0 114.353 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -112.8 6.72 18.18 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.173 1.789 . . . . 0.0 115.822 167.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.77 -139.14 40.62 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 120.165 -1.585 . . . . 0.0 110.638 -170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -58.11 -25.12 60.96 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.848 -1.383 . . . . 0.0 113.418 170.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -76.27 0.7 18.32 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.846 1.258 . . . . 0.0 111.384 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.2 m -76.11 -20.66 57.45 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.254 1.022 . . . . 0.0 113.59 161.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.44 -28.42 23.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.997 0.817 . . . . 0.0 112.161 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -140.35 162.63 34.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.641 1.11 . . . . 0.0 113.615 -168.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -121.44 68.95 0.9 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.19 1.396 . . . . 0.0 111.474 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.4 tm? . . . . . 0 N--CA 1.469 0.509 0 C-N-CA 125.597 1.559 . . . . 0.0 112.45 -163.85 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.854 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 m -61.95 161.27 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.72 0.808 . . . . 0.0 112.57 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -51.79 -27.1 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -163.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -77.03 9.47 2.95 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -60.25 111.83 1.69 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.956 1.702 . . . . 0.0 113.461 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 p-10 -81.92 36.24 0.45 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 116.762 2.134 . . . . 0.0 116.762 -172.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.264 15.8 t80 -50.37 -35.69 29.21 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -56.3 -31.53 63.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.8 ttt-85 -80.95 -5.56 57.65 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.768 2.027 . . . . 0.0 112.814 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.49 5.76 89.17 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.616 1.579 . . . . 0.0 114.307 -172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.5 m -68.24 126.23 28.89 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.549 1.175 . . . . 0.0 112.644 -173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -90.88 23.76 3.02 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 126.307 1.843 . . . . 0.0 113.767 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 tt -77.13 151.39 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 120.707 -1.246 . . . . 0.0 111.669 -175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.8 p -119.18 -35.93 3.5 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.071 1.748 . . . . 0.0 115.12 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -135.04 128.43 32.3 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.107 1.763 . . . . 0.0 109.859 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.398 0.1 OUTLIER -100.65 170.05 8.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.09 1.356 . . . . 0.0 113.378 176.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -73.58 155.65 38.89 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -167.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.36 -49.98 3.78 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 126.388 1.947 . . . . 0.0 113.164 172.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -135.28 141.89 45.78 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.952 1.301 . . . . 0.0 112.98 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -87.48 152.34 22.3 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.857 2.063 . . . . 0.0 108.238 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -85.66 -13.98 46.92 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 32.7 t60 -153.89 58.65 0.73 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.838 1.255 . . . . 0.0 114.114 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 t -84.54 121.9 74.96 Favored Pre-proline 0 N--CA 1.478 0.969 0 O-C-N 120.244 -1.535 . . . . 0.0 110.582 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.97 -30.01 14.33 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.137 2.558 . . . . 0.0 112.782 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -119.12 157.87 27.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.544 1.538 . . . . 0.0 112.935 166.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -55.17 145.62 20.81 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.41 -178.7 41.84 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.826 0.69 . . . . 0.0 114.826 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 ptpt -135.1 151.44 50.73 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.052 1.341 . . . . 0.0 113.451 -173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -113.78 107.3 15.55 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 111.891 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.408 6.6 m-30 -90.67 27.86 1.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.283 2.327 . . . . 0.0 117.283 -172.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -167.5 -155.38 9.18 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.615 1.579 . . . . 0.0 113.03 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 mt -144.17 151.79 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.139 2.176 . . . . 0.0 110.153 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -133.01 142.54 48.88 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -124.74 128.39 48.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.47 100.84 2.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.644 1.977 . . . . 0.0 112.896 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 mt -134.52 146.62 59.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.617 1.567 . . . . 0.0 109.314 -176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.15 161.55 44.29 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.283 2.655 . . . . 0.0 111.884 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.28 142.12 57.07 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.746 1.26 . . . . 0.0 111.944 -177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 69.21 15.06 69.53 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.096 1.331 . . . . 0.0 114.999 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 67.1 m -60.83 130.98 91.25 Favored Pre-proline 0 N--CA 1.475 0.818 0 CA-C-N 119.742 1.771 . . . . 0.0 109.692 171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -66.26 131.14 25.78 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.864 3.043 . . . . 0.0 111.571 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mm -106.19 136.68 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 126.76 2.024 . . . . 0.0 108.048 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -119.49 151.46 38.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.858 1.663 . . . . 0.0 110.383 -171.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.81 119.84 64.04 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-O 118.395 -0.812 . . . . 0.0 108.971 167.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.31 -35.08 52.83 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.823 2.349 . . . . 0.0 111.967 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.3 p -131.14 163.2 28.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 128.417 2.687 . . . . 0.0 107.989 -171.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -66.82 128.49 36.49 Favored 'General case' 0 CA--C 1.552 1.031 0 O-C-N 121.164 -0.96 . . . . 0.0 109.918 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -154.98 -164.2 12.77 Favored Glycine 0 N--CA 1.478 1.476 0 N-CA-C 115.929 1.132 . . . . 0.0 115.929 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -144.27 140.24 29.09 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.925 1.69 . . . . 0.0 110.156 171.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.42 132.72 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.934 0.894 . . . . 0.0 113.192 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 p -131.89 -1.96 3.71 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.341 1.056 . . . . 0.0 113.58 -169.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -176.06 146.44 0.69 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 126.128 1.771 . . . . 0.0 111.507 175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.0 mt -140.45 127.39 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.435 1.094 . . . . 0.0 109.702 172.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -154.6 -162.33 1.37 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.385 1.074 . . . . 0.0 112.993 -170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -146.96 179.96 7.23 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.634 1.574 . . . . 0.0 111.997 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . 0.25 13.1 t30 65.33 -80.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.03 2.532 . . . . 0.0 114.964 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 32.67 -91.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 129.148 2.979 . . . . 0.0 114.233 -174.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt -143.94 25.87 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 127.309 2.244 . . . . 0.0 110.832 171.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.01 27.55 0.08 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 117.844 1.898 . . . . 0.0 117.844 -165.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 67.45 -130.62 29.08 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-N 119.159 1.479 . . . . 0.0 112.141 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.4 ' H ' HG21 ' A' ' 149' ' ' THR . 62.1 mttp -62.75 133.11 54.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.278 1.031 . . . . 0.0 113.136 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.02 133.72 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.602 1.561 . . . . 0.0 113.289 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.2 tp -107.28 139.03 42.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.133 1.373 . . . . 0.0 109.788 165.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -126.32 130.53 51.01 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 41.6 mt -128.93 137.49 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.751 1.62 . . . . 0.0 109.315 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.61 132.15 53.6 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.049 0.94 . . . . 0.0 111.481 168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -69.35 158.2 35.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.623 1.169 . . . . 0.0 113.411 170.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.7 -34.34 62.22 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 119.72 3.23 . . . . 0.0 119.72 -165.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -72.2 -6.98 46.69 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 114.719 1.378 . . . . 0.0 114.719 175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 69.54 14.45 69.57 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.984 1.278 . . . . 0.0 114.822 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -107.96 -29.55 8.95 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.253 1.527 . . . . 0.0 112.842 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.92 135.51 44.47 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 116.82 2.155 . . . . 0.0 116.82 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -130.88 138.3 49.74 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.481 1.113 . . . . 0.0 111.505 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 137.67 52.9 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.69 1.596 . . . . 0.0 112.018 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -115.15 146.58 41.23 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 126.922 2.089 . . . . 0.0 113.448 170.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -133.29 125.13 28.6 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 mp -128.55 168.31 15.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.659 1.184 . . . . 0.0 111.866 177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 61.44 27.93 17.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.889 1.676 . . . . 0.0 113.399 -167.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.7 151.95 44.35 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.315 -0.865 . . . . 0.0 111.075 170.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -105.06 -26.91 11.93 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.132 -0.98 . . . . 0.0 109.094 168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -153.33 154.47 34.63 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.844 0.858 . . . . 0.0 112.088 -163.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.51 140.94 45.69 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.179 1.391 . . . . 0.0 111.948 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -100.44 -19.0 16.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.806 1.242 . . . . 0.0 111.79 170.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.06 172.91 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.821 2.448 . . . . 0.0 110.982 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.0 ptmt -143.58 165.38 27.75 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.376 1.47 . . . . 0.0 112.082 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.71 132.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.341 -0.85 . . . . 0.0 112.048 -172.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.39 -22.0 40.66 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.687 1.613 . . . . 0.0 114.129 -166.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.83 124.82 23.49 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.37 127.34 31.96 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.514 1.125 . . . . 0.0 109.641 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.36 158.62 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -120.11 153.32 36.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.544 2.338 . . . . 0.0 111.446 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -50.77 117.48 2.51 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 122.4 1.095 . . . . 0.0 111.454 173.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 94.08 0.76 65.56 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 126.647 2.07 . . . . 0.0 115.427 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.68 128.68 37.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.141 1.47 . . . . 0.0 112.711 172.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 29.9 mm -62.62 126.98 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 119.0 0.818 . . . . 0.0 110.241 172.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 35.5 pt -116.16 -25.68 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 125.902 1.681 . . . . 0.0 112.89 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -169.02 -177.1 2.83 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.715 -1.24 . . . . 0.0 111.366 -174.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -136.84 130.52 31.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.733 0.813 . . . . 0.0 109.264 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -72.61 153.14 41.4 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.38 -140.24 3.03 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.152 1.358 . . . . 0.0 112.515 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.579 ' HA ' HD12 ' A' ' 151' ' ' ILE . 11.3 p-10 -133.37 3.72 3.64 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -163.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.4 HG21 ' H ' ' A' ' 108' ' ' LYS . 11.0 t -61.55 131.69 50.92 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.154 0.888 . . . . 0.0 112.345 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.79 15.8 71.65 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.44 1.019 . . . . 0.0 115.518 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' A' ' 148' ' ' ASN . 41.0 mt -89.71 130.14 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.903 1.351 . . . . 0.0 111.699 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 8.49 12.25 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.3 1.44 . . . . 0.0 113.619 163.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -76.71 179.79 5.83 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.805 1.642 . . . . 0.0 114.399 161.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -16.1 64.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 -176.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 179.82 179.67 48.79 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.053 -1.029 . . . . 0.0 114.877 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.5 150.44 18.83 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.155 1.382 . . . . 0.0 113.251 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -163.21 175.29 11.11 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.966 1.306 . . . . 0.0 111.65 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.3 tp -97.84 133.51 42.24 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 117.585 -1.198 . . . . 0.0 109.042 158.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -90.24 136.7 32.89 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.592 1.087 . . . . 0.0 109.877 153.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -129.25 134.29 47.9 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -149.85 133.58 16.82 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.973 0.909 . . . . 0.0 111.056 -170.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -122.06 138.64 54.37 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.339 1.455 . . . . 0.0 111.156 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -133.43 151.17 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.992 1.717 . . . . 0.0 111.021 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -128.31 129.79 46.84 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.466 1.507 . . . . 0.0 111.194 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.97 -7.24 9.96 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 126.482 1.992 . . . . 0.0 115.463 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -178.36 -167.88 36.88 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 126.317 1.913 . . . . 0.0 111.242 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -125.6 128.55 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.22 172.45 13.14 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.863 1.22 . . . . 0.0 113.121 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -61.83 -30.85 71.11 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.597 -0.943 . . . . 0.0 113.342 -171.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.33 73.91 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.067 -1.021 . . . . 0.0 113.113 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -88.09 -12.86 42.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.235 1.414 . . . . 0.0 112.884 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.27 143.85 56.96 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.045 0.938 . . . . 0.0 112.957 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -146.28 159.73 42.95 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.215 1.806 . . . . 0.0 111.464 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -56.62 119.1 26.58 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.754 1.621 . . . . 0.0 112.692 -167.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -87.02 -15.37 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.757 3.638 . . . . 0.0 113.689 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -57.13 -51.61 80.38 Favored Pre-proline 0 N--CA 1.482 1.136 0 CA-C-N 120.967 1.712 . . . . 0.0 112.58 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.77 -10.71 25.26 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.894 2.396 . . . . 0.0 113.007 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . 0.253 5.5 t80 -82.75 -29.97 29.32 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 166.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 69.3 mt -79.83 -39.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.426 1.09 . . . . 0.0 111.266 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -56.78 -11.1 1.24 Allowed 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -104.43 -13.24 16.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.575 1.95 . . . . 0.0 114.275 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 53.7 mt -66.35 152.06 94.99 Favored Pre-proline 0 N--CA 1.472 0.659 0 C-N-CA 124.101 0.96 . . . . 0.0 112.086 -173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -60.66 -43.71 30.7 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.343 2.696 . . . . 0.0 112.655 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.271 58.6 m-20 -95.77 7.68 45.64 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 64.48 -137.91 40.23 Favored Glycine 0 CA--C 1.528 0.896 0 O-C-N 120.652 -1.28 . . . . 0.0 111.078 -172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -58.6 -26.13 63.34 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.025 -1.28 . . . . 0.0 112.91 171.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -75.55 -1.45 24.45 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.351 1.06 . . . . 0.0 112.832 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.3 m -74.62 -16.42 60.79 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 162.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.82 -21.61 21.4 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.81 1.187 . . . . 0.0 113.641 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -145.6 162.0 38.49 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.341 0.973 . . . . 0.0 112.86 -171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -122.68 87.58 2.78 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.297 1.046 . . . . 0.0 108.516 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 N--CA 1.47 0.531 0 C-N-CA 124.559 1.143 . . . . 0.0 113.436 -167.151 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.355 0 N-CA-C 111.975 -0.45 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -68.16 125.85 27.69 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.475 1.11 . . . . 0.0 112.27 176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -152.52 -6.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -168.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -87.92 142.87 27.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.882 1.273 . . . . 0.0 110.117 -169.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -103.44 -1.75 28.0 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -130.87 171.54 13.05 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.265 81.4 m-85 -112.65 -20.1 11.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 174.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.272 17.5 t80 -50.86 122.01 6.78 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 58.64 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.422 2.689 . . . . 0.0 116.344 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.59 -32.3 74.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.637 1.589 . . . . 0.0 113.658 174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.7 m -57.81 132.71 54.15 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.074 1.35 . . . . 0.0 112.066 175.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -112.49 12.99 20.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.357 1.463 . . . . 0.0 114.361 -171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.2 tt -74.76 144.86 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.509 -0.745 . . . . 0.0 111.952 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . 0.257 1.3 p -112.53 -50.78 2.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.153 1.781 . . . . 0.0 114.131 179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -124.02 123.35 40.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.259 1.824 . . . . 0.0 109.549 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.25 1.4 p -88.06 174.74 8.09 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.811 1.644 . . . . 0.0 113.203 176.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.32 133.47 43.87 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.154 -1.591 . . . . 0.0 113.539 -170.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.65 -77.06 0.4 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.074 1.321 . . . . 0.0 113.444 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -125.86 153.68 43.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.971 2.508 . . . . 0.0 112.875 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.72 119.52 24.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.482 1.913 . . . . 0.0 115.304 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 50.57 -164.15 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.257 1.823 . . . . 0.0 114.782 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -69.65 -45.5 68.29 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.706 -1.246 . . . . 0.0 112.306 163.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.8 t 38.37 72.3 0.93 Allowed Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 127.833 2.453 . . . . 0.0 114.912 163.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.68 -22.28 57.8 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.378 2.052 . . . . 0.0 112.855 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.335 27.6 t80 -79.02 -73.44 0.33 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 169.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -81.15 -49.7 10.51 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -167.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.85 -60.21 0.96 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 127.603 2.525 . . . . 0.0 115.997 170.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.1 pttm -71.14 152.02 43.84 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.674 1.99 . . . . 0.0 112.658 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -138.03 93.73 2.8 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.853 0.835 . . . . 0.0 112.731 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . 0.263 65.0 m-85 -80.08 25.58 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 116.461 2.022 . . . . 0.0 116.461 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -171.07 -155.3 10.45 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.881 1.229 . . . . 0.0 112.868 -168.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.03 139.3 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 126.715 2.006 . . . . 0.0 110.526 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -112.78 121.23 44.09 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -112.72 124.6 52.94 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.12 94.28 0.24 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.265 1.826 . . . . 0.0 112.575 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 59.4 mt -137.79 125.73 14.14 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.988 1.315 . . . . 0.0 109.226 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.1 162.69 31.73 Favored 'Trans proline' 0 C--O 1.242 0.717 0 C-N-CA 123.162 2.575 . . . . 0.0 112.442 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.6 139.21 56.24 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.424 0.69 . . . . 0.0 110.436 175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.93 7.29 87.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.721 1.153 . . . . 0.0 115.61 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 m -65.4 125.3 89.25 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.56 1.68 . . . . 0.0 112.858 165.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.44 130.01 20.17 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.606 2.87 . . . . 0.0 111.4 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.1 mm -106.22 134.97 46.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.956 1.703 . . . . 0.0 109.109 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -116.14 151.51 35.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.485 1.514 . . . . 0.0 110.811 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 121.78 80.4 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 118.325 -0.845 . . . . 0.0 109.772 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.06 -33.51 25.29 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.027 2.485 . . . . 0.0 111.731 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 30.8 p -130.55 164.35 25.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.057 2.543 . . . . 0.0 111.927 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -67.92 127.81 34.19 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.62 -0.675 . . . . 0.0 110.305 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -147.7 -169.94 15.37 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 115.44 0.936 . . . . 0.0 115.44 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -138.11 137.79 38.06 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.313 1.845 . . . . 0.0 109.827 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.4 t -68.7 123.17 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.394 0.543 . . . . 0.0 112.147 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.7 p -122.78 -11.76 8.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.926 0.89 . . . . 0.0 112.025 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 15.9 ttm-85 -160.39 154.76 23.52 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.11 1.323 . . . . 0.0 111.967 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.2 mt -135.63 139.81 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.519 1.527 . . . . 0.0 109.49 168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -159.03 172.01 18.96 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.602 1.561 . . . . 0.0 114.019 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -127.45 122.46 33.54 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.835 0.854 . . . . 0.0 111.426 164.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -98.08 147.65 24.33 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.432 1.493 . . . . 0.0 112.331 -173.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.76 -12.02 31.61 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.89 -31.52 5.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.629 1.572 . . . . 0.0 112.659 167.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.65 -13.2 70.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.079 1.323 . . . . 0.0 115.583 -168.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -148.73 51.56 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 119.771 1.786 . . . . 0.0 111.406 -167.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.16 127.0 29.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.925 0.89 . . . . 0.0 111.93 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.96 131.93 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.711 2.004 . . . . 0.0 112.028 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.8 tp -105.42 134.64 48.19 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.884 0.874 . . . . 0.0 110.225 165.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -120.23 128.07 53.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.55 0.74 . . . . 0.0 112.815 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.2 mt -128.93 134.8 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.514 1.526 . . . . 0.0 109.547 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -96.6 129.54 43.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.997 0.919 . . . . 0.0 111.498 168.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.81 152.67 44.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.956 1.302 . . . . 0.0 113.934 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.54 -20.55 13.52 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 168.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.48 -9.52 5.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.485 1.514 . . . . 0.0 115.068 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.71 3.2 72.3 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 124.978 1.275 . . . . 0.0 114.943 171.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.49 -18.94 0.43 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.518 1.527 . . . . 0.0 114.337 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -90.85 140.73 29.53 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.06 153.04 49.73 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.164 1.785 . . . . 0.0 110.119 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -135.46 140.55 44.94 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.441 1.097 . . . . 0.0 111.736 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 27.8 m0 -117.55 143.81 45.73 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.88 2.072 . . . . 0.0 112.976 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -129.79 118.44 21.82 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 mp -117.21 167.99 10.71 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.386 0.994 . . . . 0.0 113.021 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 66.91 13.46 9.45 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.779 2.432 . . . . 0.0 114.314 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 79.3 mt -58.17 151.05 19.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.572 1.549 . . . . 0.0 112.172 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -87.19 -34.59 18.97 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.32 1.048 . . . . 0.0 110.155 171.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -158.88 156.37 29.45 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -159.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -112.79 138.36 49.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.462 1.505 . . . . 0.0 111.639 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -100.08 -13.87 18.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.912 0.885 . . . . 0.0 112.517 167.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.25 162.38 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.845 1.658 . . . . 0.0 111.552 -176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -126.85 160.05 32.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.845 1.258 . . . . 0.0 112.551 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.65 126.09 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.435 0.636 . . . . 0.0 111.043 173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 101.19 -14.13 58.43 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.704 1.621 . . . . 0.0 115.275 -167.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -75.51 125.93 30.0 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.907 1.853 . . . . 0.0 115.952 177.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -80.67 135.71 36.07 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.929 0.892 . . . . 0.0 111.286 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 17.3 m -131.69 161.74 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -125.89 151.49 46.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.445 1.898 . . . . 0.0 111.935 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 108.09 0.5 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.508 1.123 . . . . 0.0 112.559 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 102.99 7.54 43.83 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.564 2.03 . . . . 0.0 115.052 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -90.73 143.28 26.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 120.172 1.986 . . . . 0.0 108.395 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.03 129.98 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.422 1.089 . . . . 0.0 110.882 178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 32.3 pt -115.81 -28.31 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 112.676 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -170.89 -175.56 1.8 Allowed 'General case' 0 N--CA 1.466 0.327 0 O-C-N 120.812 -1.18 . . . . 0.0 110.584 -171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.46 142.4 47.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.377 0.671 . . . . 0.0 111.924 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.8 t -66.73 153.31 43.58 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.34 1.056 . . . . 0.0 112.081 175.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.53 -161.61 11.66 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 127.365 2.412 . . . . 0.0 108.695 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . 0.261 1.5 p-10 -122.37 26.2 8.52 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.467 -1.019 . . . . 0.0 112.875 172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -61.16 -13.97 21.56 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 117.461 2.393 . . . . 0.0 117.461 -173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -122.37 12.72 8.97 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.234 1.397 . . . . 0.0 114.625 170.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.4 mt -125.6 123.35 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.259 1.424 . . . . 0.0 108.734 -172.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -76.08 -32.12 59.1 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.355 0.662 . . . . 0.0 112.656 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 t -67.43 152.39 45.76 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 167.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 2.8 p -68.49 -15.58 63.59 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.67 104.2 1.66 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.194 0.902 . . . . 0.0 112.367 174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.23 147.99 51.45 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.69 0.796 . . . . 0.0 112.552 175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -151.51 145.93 25.53 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.611 1.165 . . . . 0.0 112.158 167.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.1 tp -76.38 126.61 31.3 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.448 -0.786 . . . . 0.0 109.068 164.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -87.95 120.12 28.98 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 156.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . 0.274 63.4 t80 -111.04 130.14 55.69 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -141.65 126.33 17.96 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.895 0.878 . . . . 0.0 111.107 -170.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 33.0 ttt180 -112.79 140.61 47.43 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.032 1.333 . . . . 0.0 110.417 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.6 mtm -137.88 152.03 48.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.416 1.487 . . . . 0.0 110.689 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -127.96 130.34 48.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 -173.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.93 -6.32 34.8 Favored Glycine 0 CA--C 1.541 1.666 0 C-N-CA 125.665 1.603 . . . . 0.0 114.821 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 175.87 -163.22 32.69 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.769 1.652 . . . . 0.0 110.438 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.8 132.8 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.2 -177.93 18.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 126.149 1.833 . . . . 0.0 115.068 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -50.41 -51.31 47.6 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.8 1.64 . . . . 0.0 115.163 -168.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.17 61.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -95.25 -13.97 24.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.282 1.033 . . . . 0.0 112.466 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.23 146.56 54.79 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -131.61 164.49 25.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.311 2.244 . . . . 0.0 110.986 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -67.6 110.69 5.77 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 127.575 2.35 . . . . 0.0 115.08 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -84.79 -22.43 2.96 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.072 2.514 . . . . 0.0 112.934 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -52.99 -52.3 66.67 Favored Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 125.684 1.594 . . . . 0.0 113.6 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.86 -23.7 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.134 2.556 . . . . 0.0 113.43 175.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -69.95 -25.75 63.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.307 1.965 . . . . 0.0 116.307 169.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 58.8 mt -82.74 -34.43 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.497 1.519 . . . . 0.0 111.601 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -54.3 -25.45 23.8 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -91.45 -9.09 45.86 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.386 1.874 . . . . 0.0 114.513 177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 70.8 mt -72.23 150.08 91.93 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.014 -1.054 . . . . 0.0 111.889 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.84 -24.92 67.87 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.926 3.084 . . . . 0.0 113.533 -173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -111.8 0.5 16.22 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.26 -142.53 41.24 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -167.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.57 -20.03 59.27 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.889 -1.36 . . . . 0.0 112.949 175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -72.71 -5.83 40.35 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.943 1.297 . . . . 0.0 113.504 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.2 -23.29 62.93 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.496 1.119 . . . . 0.0 112.592 164.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -85.05 -25.73 27.44 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.119 0.872 . . . . 0.0 112.423 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -142.45 147.57 36.33 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -109.31 84.12 1.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.123 1.369 . . . . 0.0 111.475 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -165.577 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_